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Lipids are rapidly moving to center stage in many fields of biological sciences 
and technological advancements in lipid analysis is a major driving force for the 
emergence of lipidomics, the systems-level scale analysis of lipids and their interacting 
factors. In this thesis, I describe the development of a novel mass spectrometry-based 
approach for comprehensive profiling of glycerophospholipids and sphingolipids in 
complex lipid mixtures. The first step includes semi-quantitative surveys of lipids in an 
untargeted fashion, termed ‘differential profiling’, and is particularly powerful for 
detection of changes during a cellular perturbation which cannot easily be anticipated. 
This leads to the identification of ions with increased or decreased signal intensity. 
Subsequent targeted analysis using tandem mass spectrometry and collision-induced 
dissociation allows for quantification of glycerophospholipids and sphingolipids. The 
method was validated in experimental models based on mammalian tissues/ cells and the 
eukaryotic model organisms, Saccharomyces cerevisiae and Drosophila melanogaster. 
The methodology detailed the comprehensive characterisation of major 
glycerophospholipids and sphingolipids in these organisms, which is currently lacking in 
the field particularly for the non-mammalian species. Given the high degree of 
conservation in pathways of lipid metabolism between different organisms, it can be 
expected that this method will lead to the discovery of novel enzymatic activities and 
modulators of known enzymes, in particular when used in combination with genetic and 
chemogenetic libraries and screens.  
 
 vii
One of the greatest challenges in biology is to understand how the intricate 
balance of composition, distribution and interactions of lipids in a cell is regulated.  
Sterols and sphingolipids are mainly limited to eukaryotic cells and their interaction has 
been proposed to be central for formation of lipid microdomains. While there is abundant 
biophysical evidence demonstrating the interactions of different classes of lipids in 
artificial systems in vitro, little evidence of how lipids function together in cells exist. 
These issues were addressed through an interdisciplinary approach, based on lipidomics, 
genetics and cell biology. The analytical approach described in this thesis was applied to 
survey glycerophospholipids and sphingolipids in yeast single deletion mutants in sterol 
metabolism. It was demonstrated that cells adjust their membrane lipid composition in 
response to mutant sterol structures mainly by changing their sphingolipid composition. 
The interactions between sterols and sphingolipids were further probed genetically by 
combining mutations in sterol biosynthesis with mutants in sphingolipid hydroxylation 
and headgroup turnover. This resulted in a large number of synthetic and suppression 
phenotypes, demonstrating that the two classes of lipids function together to carry out a 
wide variety of processes. Our data revealed that cells have a mechanism to sense their 
membrane sterol composition and proteins might recognize sterol-sphingolipid 
complexes, which is critical for their localisation and function. Furthermore, the 
observations also led us to hypothesize the co-evolution of sterols and sphingolipids.  
 viii
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All glycerophospholipids cited in this work are based on the nomenclature x:y Z, where x 
denotes the length of the fatty acid chain, y, the number of double bonds and Z the lipid 
specie based on its backbone and headgroup moiety. For instance, a 18:1 GPIns is a 
glycerophosphoinositol (Z) with a 18-carbon (x) fatty acid chain containing 1 (y) double 
bond.  
 
All sphingolipids are represented with the nomenclature d/t x1:y1/x2:y2 Z, where d and t 
denotes the number of hydroxyl groups on the sphingoid base (d, di; t, tri), x1 and x2, the 
length of the sphingoid base and fatty acyl chain respectively, y1 and y2, the number of 
double bonds on the sphingoid base and fatty acyl chain respectively, and Z the lipid 
specie based on its backbone and headgroup moiety. For instance, d18:1/19:0 Cer is a 
ceramide (Z) with a 18-carbon (x1) sphingosine (d, dihydroxy; y1, one double bond) and a 
19-carbon acyl chain (x2) without any double bond (y2).  
 
For sphingolipids found in S. cerevisiae, the suffix ‘A’, ‘B’, ‘C’ and ‘D’ is used to 
indicate the degree and site of hydroxylation. For instance, phytoceramide-A is a 
dihydroceramide with two hydroxyl groups on the sphingoid base; -B, is a phytoceramide 
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additional hydroxyl group on its fatty acyl chain; and -D, is a phytoceramide with two 
hydroxyl groups on its fatty acyl chain.  
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Chapter 1. Introduction 
 2
The definition of lipids has undergone dramatic changes with the constant 
revelation of novel structures (Ito et al., 2008;Korekane et al., 2007) and discovery of the  
functions of these compounds. With the burgeoning appreciation of the critical functions 
of lipids in biological processes, and aided by advances in technologies that afford an ‘-
omic-centric’ view of the lipid inventory of biological systems, the field of lipidomics, 
which is the systems-level analysis of lipids and their interacting partners, has emerged in 
recent years (Wenk, 2005). Although lipidomics has lagged in comparison to the 
development of genomics and proteomics, numerous analytical and information 
technology tools have been put in place over the last five to ten years by various 
international initiatives such as the LIPID MAPS consortium in the US, the European 
Lipidomics Initiative (ELIfe), the LipidX initiative in Switzerland, as well as other 
research groups, to better understand the lipidome of various biological systems.  The 
field of lipidomics is advancing, and has indeed made important contributions to our 
understanding of lipids in various pathobiological phenomena. The impact of lipidomics 
(integrated with other ‘omics’ fields) on biology, drug discovery and developments and 
personalized medicine is immense. However, this emerging field is facing many issues 
which need to be overcome in order for its full potential to be realized. The achievements 
in the fields of genomics and proteomics has taught us an important lesson – development 
of sophisticated instrumentation is desired to advance the field of lipidomics, but just as 
important is a good understanding of the capability of available technologies and 
developing sensible lipidomic strategies. Here I will review some of the recent strategies 
in analysis of lipids based on mass spectrometry (MS) without attempting  exhaustive 
descriptions of lipid functions and analytical technologies as excellent reviews on these 
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aspects are widely available (Maxfield and Tabas, 2005;Liscovitch and Cantley, 
1994;Merrill et al., 1997;Serhan et al., 2008;Escriba et al., 2008;Di Paolo and De 
Camilli, 2006;Vance, 2008;Balazy, 2004;Hou et al., 2008;Isaac et al., 2007;Zehethofer 
and Pinto, 2008;Schiller et al., 2007;Han and Gross, 2003;Merrill, Jr. et al., 2005). In 
addition, due to the diverse nature of the systems involved in this study, a separate 
introduction will be included in each chapter to provide an overview to the 
biology/chemistry under investigation.  
 
1.1 Membrane Lipids 
1.1.1 Structural diversity 
While it is increasingly appreciated that lipids have diverse biological functions, it 
is not well understood why nature has created such an immense combinatorial and 
structural heterogeneity among lipids (Fig.1.1). William Christie restricts the use of 
‘lipids’ to “fatty acids, their naturally-occurring derivatives (esters or amides), and 
substances related biosynthetically or functionally to these compounds” (refer to 
http://www.lipidlibrary.co.uk/Lipids/whatlip/index.htm), which is probably one of the 
most widely accepted definitions for lipids.  The estimation of the number of lipids that 
exist is a daunting task, because lipids are not genetically encoded and are instead the 
products of enzymatic and chemical reactions (e.g. oxidation, Schiff base formation, etc). 
A conservative theoretical estimation of the number of lipids covering major lipid classes 
is close to 180 000 molecular species (Yetukuri et al., 2008) and this might still be an 
underestimate because even with completely sequenced genomes, annotation of genes 
and functions is still on its way and many enzymes, regulators of lipid metabolism and 
novel lipids remained to be discovered. The construction of databases and information 
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exchange between various users of this diverse range of metabolites is a great challenge 
and a unifying nomenclature, built on a scalable structure with eight categories was 
recently proposed by Fahy and co-workers to facilitate communication within the lipid 
community (Fahy et al., 2005).  
 
Glycerophospholipids, sphingolipids and sterols are the three major classes of 
lipids that make up the bulk of eukaryotic cell membranes. Table 1.1 summarizes the 
different classes of membrane lipids found in various model organisms.  The structural 
information of lipids serve as an important starting point for their analysis, and a review 
of mass spectrometry-based analytics will be incomplete without first introducing lipids 
and their structures, which entail the inherent ionisation property of a lipid.  
 
Table 1.1 Membrane lipids of various organisms. 














            
GPA + + + + + + 
GPGro + + + + + + 
GPEtn + + + + + + 
GPCho   + + + + 
GPSer  + + + + + 
GPIns +   + + + + 
Sterols             
ergosterol   +  +  
cholesterol       + + + 
Sphingolipids     + + + + 
* sterols auxotrophs 
 
The general structure of a simple glycerophospholipid consists of a polar 
headgroup with a phosphate moiety, a fatty acyl, alkyl or alkenyl group at the 
stereospecifc numbering (sn) position 1 (sn-1) and a fatty acyl group at the sn-2 position 
of a glycerol backbone (Fig. 1.1A). Common head group substitutions include choline, 
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ethanolamine, inositol, serine, glycerol or hydrogen, which may not be found in all 
organisms (Table 1.1 and Fig. 1.1D). Additional structural diversity of this class of lipid 
exists in the chemical moiety present at the sn-1 and sn-2 positions, which vary in carbon 
chain length and degree of unsaturation, and often undergo extensive enzyme-mediated 
remodeling (Fig. 1.2). Variations from the ‘classical’ glycerophospholipids are minor, but 
structurally more complex lysobisphosphatidic acid, cardiolipins, and N-acylated 
glycerophospholipids.  
 
The backbone of sphingolipids comprises of a long-chain amino alcohol (also 
known as a sphingoid base or long chain base) to which a fatty acid can be covalently 
linked to form ceramide (Fig. 1.1B). Again, structural variants arise from head group 
substitutions as well as chain length differences and hydroxylation in the sphingoid base 
and fatty acyl chains (Fig. 1.1D and Fig. 1.2). Naturally occurring sphingoid bases alone 
are now known to encompass hundreds of compounds (Pruett et al., 2008). Although 
sphingolipids have a ‘two-tailed’ nature like the major glycerophospholipids, there are 
many more restrictions to the chain length and degree of saturation. An interesting 
phenomenon in sphingolipid biology is the structural uniqueness of phosphosphingolipids 
between various eukaryotic model organisms. Unlike glycerophospholipids, which 
comprise of a variety of headgroups, the unique substitutions for phosphosphingolipids 
are inositol, ethanolamine and choline, forming inositolphosphorylceramide (IPC), 
phosphorylethanolamine ceramide (PE-ceramide) and sphingomyelin (SM) in yeast, fruit 
fly and mammals respectively (Fig. 1.1D). Note however that in mammals, 
glycerophosphoethanolamine:ceramide-ethanolaminephosphotransferase activity is 
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present as an alternative pathway for sphingomyelin biosynthesis but the precise function 
of PE-ceramide in mammals is unknown (Maurice and Malgat, 1990;Nikolova-
Karakashian, 2000). Sphingolipids in higher eukaryotes can be further decorated with 
highly complex glycoconjugates, introducing yet another level of diversity to the 
structures of sphingolipids (Merrill, Jr. et al., 2007).   
 
Sterols are a subgroup of steroids and are derivatives of 
cyclopentanopherhydrophenanthrene, with a C3 hydroxyl (-OH) group and a branched 
aliphatic side chain of 8 to 10 carbon atoms at the C17 position. Most vertebrate cells 
contain cholesterol, while ergosterol is the main yeast sterol (Fig. 1.1C). Humans derive 
their cholesterol from two sources, de novo synthesis and diet, while other organisms 
may favour either source as the predominant supply. Saccharomyces cerevisiae, for 
instance, relies on de novo sterol biosynthesis under aerobic growth conditions, while 
Drosophila melanogaster and Caenorhabditis elegans are sterol auxotrophs. Sterols can 
be found as free sterols, acylated (sterol esters), alkylated, sulfated, or linked to a 
































































































Figure 1.1 Structural diversity of membrane lipids. 
 (A) Glycerophospholipids. (B) Sphingolipids and possible headgroup modifications (R). Stereospecific 
numbering positions 1 and 2 (sn-1 and sn-2): acyl, alkyl or alkenyl substitutions: (C) Major sterols found in 
eukaryotic cells. For shorthand purposes, a nomenclature for sphingoid base similar to fatty acid can be 
used: the chain length and number of double bonds are denoted in the same manner with the prefix 'd' or 't' 
to designate di- and trihydroxy bases, respectively. In this case, (B) represents a sphingosine, which is 
denoted as d18:1.  
 
1.1.2 Biological functions of lipids 
The organisation and diversity of the lipid inventory of different organisms (Table 
1.1), cell types, organelles, and even between the lipid bilayer of biological membranes is 
impressive. Even the simplest life forms, viruses, require a high level of organisation of 
lipids for their propagation and survival (Campbell et al., 2002;Chan et al., 2008;Ye, 
2007). Unlike proteins which possess localisation signals, the intracellular organisation of 
lipids is attributed to the localisation of the biosynthetic and remodeling machineries, 
transport mechanisms as well as the interactions with other lipids and proteins. In fact, 
the tight regulation of lipid metabolism and localisation are essential, and mutations in 
genes, and deficiencies and defects in proteins mediating these processes have been 
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implicated, directly or as a predisposition factor, in many human diseases (Goker-Alpan 
et al., 2008;Guldberg et al., 1997;Puri et al., 1999;Akiyama, 2006;Allikmets et al., 1997).  
 
Lipids were once thought to be merely structural components of biological 
membranes defining permeability barriers of cells and organelles and providing great 
flexibility and stability as membranes constantly undergo morphological changes and 
fusogenic processes. As lipid research progresses, our knowledge on the functions of 
lipids are constantly evolving. Each unique structural entity is believed to encode for 
specific, but not necessarily exclusive, cellular function. Metabolic (and non-enzymatic) 
conversion of membrane lipids produce a wide range of bioactive mediators, including 
eicosanoids (Balazy, 2004), endocannabinoids (Devane et al., 1992) and oxidized 
glycerophospholipids (Subbanagounder et al., 2000), and signalling molecules such as 
platelet activating factors (Benveniste et al., 1977), the phosphorylated derivatives of 
glycerophosphoinositol (phosphoinositides) (Hokin and Hokin, 1955) and sphingolipids 
(Ghosh et al., 1990). In addition, membrane lipids are critical for cellular functions 
through their regulatory role on proteins via various mechanisms, including post 
translational modifications, regulation of the location and activity, and defining 
membrane microdomains that serve as spatio-temporal platforms for interacting 
signalling proteins.  
 
Functions of lipids are not only defined by their structural and elemental 
composition, but are also dependent on the specific metabolic source (e.g. de novo 
synthesis versus breakdown), their sub-cellular localisation, and their environment (van 
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Meer et al., 2008). A classical example is the phosphoinositides (PIs), phosphorylated 
derivatives of GPIns, which are are optimal mediators of signalling events in cellular 
compartments due to the differential intracellular distribution and their high metabolic 
turnover.  An important feature of these lipids is the inositol headgroup which can be 
reversibly phosphorylated by kinases and phosphatases (Vanhaesebroeck et al., 2001). 
Seven naturally occurring phosphoinositides, which differ in their position and degree of 
phosphorylation, are known to date in eukaryotes.  The functions of PIs are mediated by 
(i) interactions between the phosphorylated headgroups and effector molecules bearing 
specific phosphoinositide binding domains (e.g. PH, PX, FYVE, ENTH, etc) (Lemmon, 
2003), (ii) soluble metabolites (inositol phosphates and diacylglycerols) which are 
generated through the action of phospholipases, and (iii) fatty acyl derivatives which 
originate from the membrane bound portion of the lipid molecule. Thus, the PIs can be 
considered “high-power” signalling entities. Sphingolipids are also emerging as key 
cellular mediators which share similar features as PIs in terms of their ‘elasticity’ in their 
metabolism, structures and functions. For instance, ceramide and sphingosine 1-
phosphate are antagonistic in their functions in apoptosis and their metabolic 
juxtaposition constitute a rheostat system that determines cellular life and death (Taha et 
al., 2006).   
 
Another prominent lipid which exhibits spatio-dependence for its function is 
glycerophosphoserine (GPSer), which in normal resting cells are found in the inner 
leaflet of the lipid bilayer. Exposure of GPSer on the outer leaflet of plasma membrane is 
a hallmark of apoptosis and serves as a signal to allow the safe clearance of apoptotic 
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waste by phagosomes without triggering inflammatory response (Fadok et al., 1992). 
Interestingly and probably coincidentally, the enrichment of GPSer on vaccinia virus 
envelope adopts the process for successful cellular entry (Mercer and Helenius, 2008). 
Many lipids in fact have been identified as potent ligands mediating a wide range of 
cellular processes. 
 
An additional level of complexity of membrane lipid functions lies in the 
metabolic and/or regulatory relationship between lipid classes. Ceramide transport 
protein (CERT) mediates the transport of ceramide from the endoplasmic reticulum to the 
Golgi apparatus where it is converted to sphingomyelin. Targeting of CERT to the Golgi 
and its activation are dependent on phosphoinositides and sterols, respectively (Hanada et 
al., 2003;Perry and Ridgway, 2006). Furthermore, while many studies have reported the 
individual functions of lipids on a particular cellular process, the molecular links between 
distinct classes of lipids are recently beginning to be revealed. Mutants of enzymes 
involved in phospholipid metabolism have been isolated in various genetic screens in S. 
cerevisiae for suppressors of sphingolipid defects, suggesting that these classes of lipids 
may function together (Beeler et al., 1998;Nagiec et al., 1993). Tabuchi and Kobayashi 
and their co-workers had independently reported a molecular link between 
phosphoinositides and sphingolipid signalling in the regulation of actin cytoskeleton 
organisation and cell viability (Tabuchi et al., 2006;Kobayashi et al., 2005). These 
examples clearly illustrate the interactions and dependence of different classes of lipids in 
regulating lipid metabolism, transport and function, even though the existence of such 




























Figure 1.2 The complex life of a membrane glycerophospho- or sphingo-lipid. 
Lipid undergoes extensive enzymatic as well as non-enzymatic modifications, which changes their 
properties and functions. General enzyme classes are indicated. CAPS: glycerophospholipid-specific. Bold: 
sphingolipid-specific. X- choline, ethanolamine or inositiol.  
 
Why does nature need to invest on a bioenergetically expensive process to create 
and organise such an impressive catalogue of lipids that defines distinct life forms? An 
obvious reason for the structural diversity is complementation of cellular function. 
Apparently, there is a ‘redundancy’ of lipids under ‘normal’ growth condition evidenced 
by the ‘knocking out’ of certain lipids which do not cause lethality (Kawai et al., 
1998;Takamiya et al., 1996;Choi et al., 2004). However, the maintenance of lipid 
diversity will be appreciated when allostatic forces are applied to a system. Organisms in 
fact exploit lipid-remodeling mechanisms to recreate structural diversity that allow them 
to adapt to their environments. Membrane remodeling during temperature acclimation 
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has been well documented (Overgaard et al., 2008;Polozov et al., 2008;Bhattathiry, 
1971;Goldman, 1975). In addition, although sphingolipid biosynthesis is required for 
growth in eukaryotes, a mutant strain of S. cerevisiae lacking sphingolipids, which 
compensates for the defect by synthesis of a set of novel GPIns (Lester et al., 1993), has 
been isolated. Clearly, lipids have evolved functionally to allow the survival, proving the 
worth of the system which cells have paid a high price for.  
 
In the past, lipid research had been relatively focused on a specific lipid (class) of 
interest and neglected the natural environment of lipids and the important fact that lipids 
often do not function as a standalone entity. For instance, sphingolipids are structural 
components of eukaryotic cell membranes, often described in context with sterols to form 
specialized functional microdomains, commonly known as lipid rafts (Simons and 
Ikonen, 1997). As discussed, perturbation of membrane lipids often result in extensive 
remodeling, suggesting the intimate interactions between the various membrane 
components. Interest towards the understanding how lipids and their interacting partners 
function in such a systems context is immense and the definition of lipidomics to include 
both lipids and their interacting partners and the advances in analytics that allow a global 
snapshot of cellular lipidome cannot be more appropriate and timely. From a translational 
viewpoint, the influence of lipids on protein functions and biological processes and 
sometimes, the high specificity of function of a unique chemical entity, offers the 
possibility to modulate these metabolites as an alternative therapeutic approach, which 
has been termed membrane-lipid therapy (Escriba et al., 2008). In fact, our knowledge 
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about the many aspects of lipid function and regulation is still very limited and the road 
ahead for lipid research is definitely long but exciting.  
 
1.2 Biochemical analysis of lipids 
Unlike proteins or genes, which are made up of a limited number of monomeric 
units, lipids comprise of a structurally diverse collection of molecules that vary in 
physicochemical properties and dynamic range, which poses a huge technical challenge 
to analysts. Biochemical analytics of lipids have made enormous progress in the past ten 
to twenty years.  Although the term lipidomics was coined to define the global study of 
the lipid components of cells, tissues or organisms, it is a far-fetched dream to be able to 
capture the entire lipidome in a single analysis, a reality that even the advanced field of 
proteomics faces. The field definitely needs further technological breakthroughs but 
adopting combinatorial strategies based on currently available 
methodologies/technologies may be the way to circumvent the problem. In this section, I 
limit my discussion to the isolation, and mass spectrometry-based detection, 
characterisation and quantification of major membrane lipids (Fig. 1.3). However, it is 
important to acknowledge the contribution of conventional methods, such as metabolic 
labelling and thin layer chromatography, as well as more advanced technologies such as 
nuclear magnetic resonance, and imaging using lipid-based optical probes, which had 
greatly complemented and advanced lipid research.  
 
1.2.1 Isolation and purification of membrane lipids 
The structural diversity found in lipids challenges common textbook definitions of 
lipids as molecules that are highly soluble in organic solvents. Polarity differs depending 
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on the lipid backbone as well as the headgroup modification (Fig. 1.1) (Guan and Wenk, 
2008). Sugar modification and phosphorylation render some of these lipids highly polar, 
and thus they may escape into the aqueous milieu during isolation. For instance, 
phosphoinositides, due to their polar nature and low abundance, are poorly recovered 
using conventional Bligh and Dyer or Folch methods of extraction, which is commonly 
used for bulk membrane lipids including sterols, ceramides, sphingomyelin and major 
glycerophospholipids. Modifications such as acidification or use of ion pair agents to aid 
in solubility, and therefore recovery, of this important class of bioactive lipids in organic 
solvents, have been reported (Gray et al., 2003;Pettitt et al., 2006;Wenk et al., 2003). 
Often, a compromise has to be made when isolating lipids, for instance, alkaline 
hydrolysis enriches for sphingolipids, at the expense of the removal of the bulk cellular 
glycerolipids (Jiang et al., 2007). This may itself be an added advantage, as selective 
enrichment of lipids is a way to overcome the dynamic range of current instruments. 
Chemoselective probes for the capture and enrichment of metabolites (Carlson and 
Cravatt, 2007) which are typically of low abundance, or easily lost during generic 
extraction, offers the possibility to explore the deep end of the lipidome. In general, the 
choice of extraction protocol depends on the nature of the biological sample (e.g. tissue, 
cells or fluids) and the chemistry of the lipid of interest, and ultimately, quantitative 
isolation of lipids with maximal recovery and purity is desired. 
 
Isolation of lipids, although dating back to the 1800’s, has not made significant 
advances in terms of throughput and automation. Lipids of all major classes can be 
recovered via chloroform/methanol extraction, typically according to Folch and co-
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workers (Folch et al., 1957) or Bligh and Dyer (Bligh and Dyer, 1959), in which they are 
mostly enriched in the chloroform phase. Because of the higher density of chloroform 
compared with a water/methanol mixture, it forms the lower phase of the two-phase 
partitioning system, and tends to be a rate-limiting step and a technical challenge for 
automation of the extraction procedure. Replacement of chloroform by methyl-tert-butyl 
ether is suited for automation because the low density, lipid-containing organic phase 
forms the upper layer during phase separation (Matyash et al., 2008). Monophasic 
extraction followed by separation such as the increasingly common solid phase extraction 
is amenable to medium to high throughput developments (Jemal et al., 1999). 
Furthermore, direct analysis of tissue and even intact single cell by mass spectrometry 
(MS) is possible (Altelaar et al., 2007), and incremental technological advances have 
been made for lipidomic applications.  
 
1.2.2 Mass spectrometry 
The precipitous advances in mass spectrometry (MS), particularly the development 
of soft ionisation methods, electrospray ionisation (ESI) and matrix-assisted laser, 
desorption/ionisation (MALDI) mass spectrometry, has led to the realisation of a new 
level of sensitivity, resolution and throughput for simultaneous analysis of multi-
component lipid mixtures (Brunelle and Laprevote, 2008;Han and Gross, 2005a;Isaac et 
al., 2007;Pulfer and Murphy, 2003;Schiller et al., 2007;Zehethofer and Pinto, 2008). Han 
and co-workers demonstrated the differential ionisation efficiency of lipid classes based 
on their inherent electrical propensities (Fig. 1.3A) and termed this separation and/or 
selective ionisation of different lipids as ‘intrasource separation’ (Han and Gross, 2005a). 
Enhanced sensitivity of microfluidics-based ionisation (Han et al., 2008) and ultra high 
 16
resolution MS such as Fourier Transform Ion Cyclotron (FT-ICR) MS (Schwudke et al., 
2007) have tremendously improved the separation of lipids, providing an unparalleled 
platform for MS-based profiling to provide a global and high density fingerprint of the 
cellular lipidome. Information of the fine details of molecular species is indicated by the 
mass-to-charge ratio (m/z) and the ion intensity correlates to quantity (Zacarias et al., 
2002) (Fig. 1.3A). The convenience of direct analysis of lipid mixture with minimal 
sample processing by mass spectrometry is confounded by suppression of ionisation due 
to competition with other ions within the complex environment for charge during the 
ionisation process. For quantitative purposes, a suitable cocktail of internal standards that 
has the same ionisation properties as the analyte(s) of interest needs to be spiked into the 
mixture, which however is an issue due to the choice and availability of relevant 
standards. Upfront chromatographic separation of mixtures reduces suppression effects 
and resolves isobaric complications, therefore allowing the sensitive profiling of extracts 
harbouring lipids of considerable chemical complexity (Shui et al., 2007). 
 
The ideal of capturing the entire lipidome is challenged by the diverse chemistries, 
the wide dynamic range of the abundance of the heterogeneous catalogue of lipids as well 
as their rapid turnover. For instance, cholesterol is highly abundant in the mammalian 
brain but due to its poor ionisation efficiency in the negative ion mode, is not represented 
in the profile shown in Figure 1.3A. The use of additives to promote ionisation, 
alternative ionisation polarities and sources such as Atmospheric Pressure Chemical 
Ionisation (APCI) which is more suitable for less polar lipids such as cholesterol, and/or 
coupling to liquid chromatography (LC) represent solutions to improve the range of lipids 
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to be measured. Clearly, there is no one single method available to probe the entire 
cellular lipidome.  
 















































































































Figure 1.3 Analysis of brain lipids by negative ion mode ESI-MS. 
(A) Single stage electrospray ionisation mass spectrum (ESI-MS) in the negative ion mode. The majority of 
phospho- and sphingo-lipids are detected in the mass range of 400-1200. The ions can be tentatively 
assigned by their mass-to-charge (m/z) ratio. Characterisation of ions can be achieved by collision-induced 
dissociation (CID) and tandem mass spectrometry (MS/MS). (B) MS/MS spectra of ions with m/z 885. An 
ion of interest can be selected in the first mass analyser (MS1) and after CID, the fragment ions are 
analysed in the second mass analyser (MS2). The product ions of the parent with m/z 885 (38:4 GPIns) 
includes m/z 153, 241, 283 and 303, which correspond to ions arising from the glycerol phosphate 
backbone, inositol phosphate headgroup and fatty acyls, respectively. Such information on a common 
fragment ion that is characteristic and specific for a class of lipids can be used for other MS experiments, 
such as multiple-reaction monitoring (MRM) and precursor ion scans. (C) Precursor ion scans for lipids 
containing inositol phosphate headgroup (m/z 241). The second mass analyser is fixed at m/z 241 and the 
first analyser scans the mass range of interest. Consequently, ions with the propensity to form fragment 
ions with m/z 241 is selectively detected. Samples can be spiked with internal standards (IS), which is 
typically not found naturally in the samples under investigation, to allow for semi-quantitative profiling. 
(D) Overlay of chromatogram (left panel) and standard curve (right panel) obtained from quantification of 
varying concentrations of a commercially available 34:2 GPIns by MRM. The first and second mass 
analysers are fixed at the parent ion of interest and its unique fragment ion respectively and selective 
quantification can be attained with a reasonably good linearity. Note that 34:2 GPIns is a minor ion in the 
complex lipid mixture and MRM offers a selective and sensitive method for quantification.  
 
The term ‘shotgun lipidomics’ was first coined and refers to the direct analysis of 
individual lipid molecular species from a crude lipid extract, but it quickly evolved and is 
inseparable from multi-dimensional ESI-MS (Ekroos et al., 2002;Han and Gross, 
2003;Han et al., 2004). For long, tandem mass spectrometry has aided in characterisation 
and identification of lipids (Fig. 1.3B). An ‘-omic-centric’ view of a sublipidome can be 
acquired by experimentally filtering for specific classes of lipids using precursor (PREIS) 
or neutral-loss (NL) scanning (also known as focused lipidomics) (Fig. 1.3C) (Taguchi et 
al., 2005). These methods are based on selective monitoring of common fragment ions 
and can be conveniently achieved with triple quadrupole instruments. The fragmentation 
pattern and structure has to be pre-determined as it is prudent to find a product ion that is 
unique to the structure. This, however, is not an issue for well-characterised lipids such as 
major glycerophospholipids, sphingolipids and sterols (Table 1.3). For instance, multiple 
precursor ion scans of the inositol phosphate headgroup and fatty acyl fragments (Fig. 
1.3B) can be used to selectively and unambiguously measure glycerophosphoinositol in 
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complex lipid mixtures (Fig. 1.3C). This method has been more commonly applied than 
global analysis to fingerprint cellular lipidome (Ekroos et al., 2002), partly because of 
enhanced selectivity and sensitivity (Taguchi et al., 2005;Han et al., 2004). With the 
information of parent and fragment ions, the mass spectrometer can be set to selectively 
quantify a compound of interest in a mixture when used with pertinent internal standards, 
a method known as multiple-reaction monitoring (MRM) (Fig. 1.3D), which is highly 
selective and sensitive. Combining the collection of dataset from sublipidome analyses 
will eventually lead to extensive lipidome maps of the various samples and species types.  
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Table 1.2 Sublipidome analysis by tandem mass spectrometry (MS/MS) – list of precursor ions for 





Modes Fragment Reference 
Sterol         
Cholesterol  [M+NH4]+ PREIS 369 Cholestane cation (Liebisch et al., 2006) 
Cholesterol 
ester [M+NH4]+ PREIS 369 Cholestane cation 
(Han and Gross, 
2005a;Liebisch et al., 
2006;Hutchins et al., 2008) 
Glycero-
phospholipid         
GPA [M-H]- PREIS 153 Glycerophosphate derivative (Han and Gross, 2005a) 
GPGro [M-H]- PREIS 153 Glycerophosphate derivative (Han and Gross, 2005a) 
 [M+NH4]+ NL 189 Phosphoglycerol (Taguchi et al., 2005) 
GPCho [M+H]+ PREIS 184 Phosphocholine 
(Brugger et al., 
1997;DeLong et al., 
2001;Han and Gross, 
2005a) 
GPEtn [M-H]- PREIS 196 
Glycerophosphoethanolamine 
derivative 
(Brugger et al., 1997;Han 
and Gross, 2005a) 
 [M+H]+ NL 141 Phosphoethanolamine 
(Taguchi et al., 
2005;DeLong et al., 
2001;Brugger et al., 1997) 
GPSer [M-H]- NL 87 Serine 
(Brugger et al., 1997;Han 
and Gross, 2005a) 
 [M-H]- PREIS 153 Glycerophosphate derivative 
(Brugger et al., 1997;Han 
and Gross, 2005a) 
 [M+H]+ NL 185 Phosphoserine 
(Brugger et al., 
1997;Taguchi et al., 2005) 
GPIns [M-H]- PREIS 241 Cyclic inositol phosphate 
(Brugger et al., 1997;Han 
and Gross, 2005a) 
 [M-H]- PREIS 153 Glycerophosphate derivative 
(Brugger et al., 1997;Han 
and Gross, 2005a) 
 [M+NH4]+ NL 277 Phosphoinositol (Taguchi et al., 2005) 
GPInsP [M-H]- PREIS 321 Phosphoinositol phosphate 
(Han and Gross, 
2005a;Wenk et al., 2003) 
GPInsP2 [M-H]- PREIS 401 Diphosphoinositol phosphate 
(Han and Gross, 
2005a;Wenk et al., 2003) 
GPInsP3 [M-H]- PREIS 481 Triphosphoinositol phosphate (Milne et al., 2005) 
Sphingolipid         
Ceramide [M-H]- NL 256 Sphingosine derivatives 
(Hsu and Turk, 2002;Han, 
2002) 
 [M-H]- NL 327 Sphingosine derivatives 
(Hsu and Turk, 2002;Han, 
2002) 
 [M-H]- NL 240 
Loss of 2-trans-palmitoyleyl 
alcohol (for d18 sphingoid 
base) (Han, 2002) 
 [M+H]+ PREIS 264 
Double dehydration product of 
d18:1 sphingoid base 
(Liebisch et al., 
1999;Sullards and Merrill, 
Jr., 2001) 
Sphingomyelin [M-CH3]- PREIS 168 
Dimethyl-
ethanolaminephosphate (Brugger et al., 1997) 
 [M+H]+ PREIS 184 Phosphocholine (Han and Gross, 2005a) 
Ganglioside [M-H]- PREIS 290 
N-acetylneuraminic acid 
derivative  (Tsui et al., 2005) 
Sulfatide [M-H]- NL 97 Sulfuric acid 
(Hsu et al., 1998;Whitfield et 
al., 2001) 
 [M+H]+ PREIS 264 
Double dehydration product of 
d18:1 sphingoid base 
(Hsu et al., 1998;Whitfield et 
al., 2001) 
Mono- and di- 
glycosylated 
ceramides [M+H]+ PREIS 264 
Double dehydration product of 
d18:1 sphingoid base 
(Sullards and Merrill, Jr., 
2001) 
Abbreviations: PREIS, Precursor ion scan; NL, Neutral loss scan. 
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Technology is constantly improving to overcome many of these present issues, 
which include the development of hybrid instruments, interchangeable ionisation source, 
and rapid polarity switch of quadrupole instruments, the latter of which  allows 
acquisition in both the positive and negative ion modes within a single analytical run 
(Hou et al., 2008;Zehethofer and Pinto, 2008). An exciting technology in the field is the 
possibility to perform imaging MS, most commonly enabled by MALDI, desorption 
electrospray ionisation (DESI), surface-enhanced laser desorption/ionisation (SELDI) MS 
and time-of-flight secondary ion mass spectrometry (ToF-SIMS), which will add a new 
dimension, particularly spatial information, to lipid analysis. In addition, with the 
possibility to laterally resolve lipid location in model membrane systems (McQuaw et al., 
2007), it will be highly attractive such resolution can be applied to intact cells as many 
fundamental questions regarding membrane organisation remain to be unraveled. 
 
The volume of data generated by mass spectrometry is immense and interpretation 
of data was hampered during the dawn of lipidomics when there was a virtual absence of 
comprehensive and integrated reference databases which can aid in the annotation of 
known lipid metabolites and the identification of novel lipid metabolites, for instance. 
Nonetheless, the landscape is rapidly changing. Several public databases (Table 1.3) and 
open source as well as proprietory software tools for lipid MS data analysis (Table 1.4) 
now exist. As a refinement of Fahy and co-workers’ classification system to improve 
computational queries, Baker and co-workers recently proposed structural definitions for 
different classes of lipids and presented an ontology-driven lipid bibliosphere navigation 
infrastructure (Baker et al., 2008). Automated MS analysis and data processing has set 
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the stage for high comprehensive and high throughput profiling of cellular sublipidomes 
(Ejsing et al., 2006a). It should be acknowledged that the advancement of the field is not 
solely attributed by state-of-the-art instrumentation, but can only be achieved with 
complementation by bioinformatics and data processing tools (Yetukuri et al., 2008).  
 
Table 1.3 List of lipid-related databases 
Database Content URL 
LIPID MAPS Largest curated lipid database containing i) mass 







Subset of LIPID MAPS database, encompassing 
structures and annotations of biologically relevant 
lipids. Structures of lipids in the database come from 
four sources: (i) LIPID MAPS Consortium's core 
laboratories and partners; (ii) lipids identified by LIPID 
MAPS experiments; (iii) computationally generated 
structures for appropriate lipid classes; (iv) biologically 
relevant lipids manually curated from LipidBank 
LIPIDAT and other public sources. (Sud et al., 2007) 
http://www.lipidmaps.org/data/
structure/index.html 
LipidBank A Japanese library containing > 7000 lipid species, 
partly with experimental information including MS data 
and references. (Taguchi et al., 2007) 
http://lipidbank.jp/ 
MassBank A database of comprehensive high-resolution mass 
spectra of metabolites. (Taguchi et al., 2007) 
http://www.massbank.jp/index-
e.html 
LIPIDAG A relational database of lipid miscibility and associated 




LIPIDAT A central depository for information on lipid 
mesomorphic and polymorphic transitions and 
miscibility. (Caffrey and Hogan, 1992) 
http://www.lipidat.ul.ie/ 
 
SphingoMap A curation of pathway map for sphingolipid 
biosynthesis that includes many of the known 
sphingolipids and glycosphingolipids arranged 








A database of biological systems, consisting of genetic 
building blocks of genes and proteins (KEGG GENES), 
chemical building blocks of both endogenous and 
exogenous substances (KEGG LIGAND), molecular 
wiring diagrams of interaction and reaction networks 
(KEGG PATHWAY), and hierarchies and relationships 
of various biological objects (KEGG BRITE). 
http://www.genome.jp/kegg/ 
Lipid Library A collection of links and information, including lipid 
biochemistry and analytical techniques, such as mass 
spectra, NMR techniques, Ag+ chromatography. 
http://www.lipidlibrary.co.uk/ 
CyberLipids A collection of links and information, including 





Table 1.4 List of MS-related softwares for lipidomic analysis 
Software Utility Source URL 
LipidSearch A high-throughput and 
automatic system for 
glycerophospholipids 
identification by various types 




of Medicine, the 
University of 
Tokyo 






Find mass, number of carbons, 
number of double bonds, 
abbreviation, MS/MS product 
ions (neutral loss), formula, 
and ion based on input criteria, 
with links to structure and 
isotopic distribution. 
LipidMaps 
(Fahy et al., 2007) 
http://www.lipidmaps.org/tools/in
dex.html 
LipidInspector Lipid profiling and identification 
by multiple precursor and 
neutral loss scanning based in 
specified criteria in a data-
dependent fashion. 
Scions 




Lipid Profiler Identification and quantification 
of molecular species of 
glycerophospholipids by 
automated interpretation of 
multiple precursor ion scan 
spectra. 
MDS Sciex 
(Ejsing et al., 
2006a) 
Enquiries on software can be 
made to MDS Sciex 
http://www.mdssciex.com/ 
Fatty Acid 
Analysis Tool,  
FAAT 
Analyse high-resolution mass 
spectra of lipids obtained with 
FT-ICR instruments, includes 
assignment of ions from a 
user-defined library based on 
their exact mass, and 
comparative analysis of 









Peak detection and integration 
tool for identification (based on 













For display of LC-MS 
chromatograms as two-
dimensional “maps” for visual 
inspection and extraction of 












Automated identification and 
quantification of complex lipid 
molecular specis in mixtures. 
Library of reference spectra is 
built based on previous 
fragmentation pattern of known 






et al., 2007) 
Access to LipidQA software can 
be obtained through Haowei 
Song (hsong@im.wustl.edu), 
John Turk (jturk@wustl.edu), or 
the Washington University 




1.3 Lipidomics as a pathway discovery tool 
The contributions of lipidomics research is very obvious in a few aspects of science 
– (i) making advances in analytical and information technology, (ii) understanding the 
biological roles of lipids, and discovery of novel lipids, genes and proteins functions 
(van, 2005), (iii) contribution to systems biology through the integration with other –
omics fields to systematically study the complex interactions in biological systems, (iv) 
application of the toolset in health and environmental research and assessment (Wenk, 
2005) and (v) therapeutics (Escriba, 2006). Functional lipidomics aims at providing novel 
insight into lipid functions, and comparative analysis is highly appealing for unravelling 
previously unknown correlation between lipid metabolism and a perturbation of interest 
(Fig. 1.4) (Rilfors and Lindblom, 2002;Wenk, 2006;Li and Prestwich, 2005). Changes in 
lipid species patterns provide a wealth of information for further studies and can 
potentially have predictive or diagnostic value. Comparative analysis is not new in lipid 
research as exemplified by previous studies based on metabolic labelling and thin layer 
chromatography (TLC), which had led to the characterisation of many lipid enzymes 
(Sawai et al., 2000;Leber et al., 1997), and lipid factors of medical importance, such as 



















Organic extracts and 
(i) phase separation, 
(ii) solid phase 











QuantitativePrior knowledge of lipids is not 
required
Targeted AnalysisNon-targeted AnalysisApproach
Lipid Species SelectiveLipid-Class SelectiveUnbiased, powerful for 
discovery of novel lipid species 
and/or novel lipid mediators 
involved in a biological process
Advantage
-Minimize Data Redundancy
Consist of an ‘inclusive’ list and may miss important 
information on lipids that are not measured
Requires reproducible and unique fragments
Requires prior knowledge of lipids and fragments
Sensitive
Neutral Loss and/or 
Precursor Ion Scans
“Biasness”
MS Method Single-Stage MS Profiling Multiple Reaction 
Monitoring
Disadvantages Isobaric complications e.g. 
between GPCho and GPEtn, 
requires upfront LC separation
Requires MS of high mass 
resolution
Not suitable for minor lipid 
species
Not suitable for comprehensive 
quantification  
Figure 1.4 Lipidomic strategy for pathway discovery. 
(A) Integration of lipidomics, proteomics and genomics tools for systems-level scale analysis of lipids and 
pathway discovery (Modified from (Wenk, 2005). Lipidomics based on biochemistry is the main focus. In 
such cases lipids are typically extracted with organic solvents from the source material and are then 
analysed by chromatography and spectrometry, for example. A lipid profile, which is a biochemical 
snapshot of the lipid inventory of the cell or tissue under investigation, is generated. Different functional 
states of the system under investigation can produce differences in such profiles. Based on the aberrations 
of the lipid metabolites, a hypothesis on the metabolic pathways that might be affected can be formulated. 
(B) Comparison of non-targeted and targeted analysis by mass spectrometry. 
 
Discovery, based on lipidomics, in general, has taken two approaches (i) non-
targeted and (ii) targeted analysis which will be described in this section.  
 
1.3.1 Unbiased discovery lipidomics 
The capacity for global profiling has driven biology into a dimension, in which 
large volumes of complex, but inter-related data can be mined for patterns that will 
stimulate new hypotheses for experimental validation.  Analysis of total lipid extracts by 
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high resolution mass spectrometry (with or without upfront LC) allows the simultaneous 
measurement of hundreds of lipids species and represents an attractive top-down 
approach to study global changes in the lipidome upon perturbation. In this ‘brute-force’ 
approach, the instrument is programmed to collect data on whichever ions that are 
detectable to provide a ‘fingerprint’ and the ions are surveyed in a non-targeted fashion to 
determine changes in profiles between experimental conditions. However, the technique 
of labelling proteins or genes with isotopes or dyes to allow comparative analysis in a 
multiplex context is not available for lipids, primarily due to a lack of common functional 
groups between various classes of lipids, which limits the possibility of integrating 
currently existing platforms for proteomics analysis for lipidomics. Selective labelling of 
specific classes of lipids for comparative lipidomics, is however possible, for targeted 
analysis (see Section 1.3.2).  
 
Comparative analysis of high resolution (and high density) profiles can be 
achieved by specialized softwares (Table 1.4) which include functions such as peak 
detection and isotopic correction. A list of ions (or identified lipids) and their abundance 
can be generated for further computation of differences in paired sample sets.  Forrester 
and co-workers described the possibility of identifying more than 450 
glycerophospholipids, and used a computational algorithm which performs statistical 
normalisation to compare the lipid profiles of mast cells during degranulation (Forrester 
et al., 2004). Quantitative information of individual lipids is however lost in the final 
lipid array presented. Nonetheless, computational strategies, using mathematical and 
statistical algorithms, provide a compelling approach for non-targeted analysis of lipid 
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profiles. Multivariate analyses can serve as exploratory tools for huge data sets such as 
MS data to uncover unknown trends in a relatively unbiased fashion (Pietilainen et al., 
2007;Ding et al., 2008;Schwudke et al., 2007). For instance, Principal Components 
Analysis (PCA) is a common tool in metabolomic research used to reduce data 
dimensionality by performing a covariance analysis between factors (lipids) and deriving 
a small set of variables that can explain the original data set and possibly reveal 
groupings between data sets. However, PCA is biased against small signals and 
appropriate scaling is required. Furthermore, statistical testing has to be included to 
determine the significance of difference in the ions that had the major impact on the data 
grouping. Pattern and trend recognition of lipid profiles by clustering analysis provide a 
powerful alternative to survey the high volume of information in a unsupervised fashion 
that allow associations of lipids to phenotypes. In principle, these data analyses methods 
can also be applied to datasets derived from targeted lipid analysis (Yetukuri et al., 2007) 
(See section 1.3.2).  
 
In general, high resolution MS fingerprints of multiple conditions can be 
compared to ‘detect’ differences in lipid profiles. Misregulated ions can then be selected 
for identification and further targeted analysis (Fig. 1.4), thereby bypassing the tedious 
process of first characterizing the entire spectra of ions. With development of LC/ESI-
MS methodology to simultaneously profile lipids of diverse chemistry, including sterols, 
glycerolipids, glycerophospholipids and sphingolipids (Shui et al., unpublished data), 
such unbiased method for analysis will allow a more dynamic view of the interactive 
nature of lipid classes in cellular processes.  
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An unbiased approach is highly practical at a stage whereby the inventory of the 
entire cellular lipidome is incomplete. Furthermore, for samples that have not been 
previously characterised, as long as the lipids ionise and are detected, rapid analysis can 
be achieved. The likelihood of discovering an unexpected lipid mediator under a given 
condition and/or a previously uncharacterised lipid moiety makes unbiased profiling 
highly appealing. However, the likelihood of missing a relevant lipid cannot be ruled out 
because of the incomplete detection of all lipid species due to the dynamic range and 
complex chemistries of lipids in a mixture, which is beyond the capacity of existing 
instrumentations. 
 
1.3.2 Targeted lipidomic analysis 
The LIPID MAPS initiative is organised into different cores, based on major lipid 
categories, to map the lipidome and identify lipid metabolites and pathways in 
macrophage cells during immunogenic perturbations, reflecting the more common 
strategy of a targeted lipidomics approach for discovery. The criteria for targeted analysis 
include (i) defining the target(s) of interest to measure (here a target is defined as a 
specific lipid class, or a specific lipid species), and often, this is hypothesis-driven and 
(ii) development of a method by which these target metabolites is selectively measured. 
Liquid chromatrography-mass spectrometry (LC-MS) operated in selected ion monitoring 
mode, precursor ion (PREIS) or neutral loss (NL) scan and multiple-reaction monitoring 
(MRM), with the latter offering the highest sensitivity and selectivity. This approach is 
highly information-based and is dependent on robust characterisation and selective 
detection of the class of lipids of interest. The process of target characterisation and 
measurement is greatly facilitated by automated information-dependent acquisition, 
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whereby the mass spectrometer is set to run a survey scan and several tandem MS events, 
which is usually user defined, to identify as many putative compounds as possible in a 
mixture within a single run (Schwudke et al., 2006). 
 
Precursor and neutral ion scanning provide a fingerprint of a sub-lipidome and it 
is possible to perform multiplex differential analysis for specific lipid class if the unique 
functional group of the lipid class of interest can be labelled (Zemski Berry and Murphy, 
2006). On the other hand, analysis by MRM with appropriate internal standards, allow for 
absolute quantification of each metabolite tested. Targeted analysis offers the advantages 
of enhanced sensitivity and also, the inherent redundancy in data collection and analysis, 
particularly in applications with a working hypothesis, is eliminated. Furthermore, 
targeted analysis is the approach of choice when specific lipids, particularly isobaric 
compounds with different chemistry but exact same mass, have to be unambiguously 
measured. 
 
Quantification by targeted MS analysis is of high relevance, for instance in 
diagnostic work. Biochemical diagnosis based on cholesterol and triglycerides levels has 
a sufficiently long history in clinical applications. Selective monitoring of lipid 
metabolites by mass spectrometry is increasingly common and have provided robust 
readouts for a few pathologies with known aberrations in lipid metabolism, including 
Barth syndrome (cardiolipin) (Kulik et al., 2008), sphingolipidosis (sphingolipids) 
(Kitagawa et al., 2005;Cui et al., 2008),  various cancers (lysoglycerophospholipids) 
(Sutphen et al., 2004;Zhao et al., 2007;Xiao et al., 2000), as well as detection of foreign 
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microbial lipids (Hamasur et al., 2001). However, these are relatively straightforward 
applications of targeted lipid analysis and the real challenge arises at the systems-level 
scale. In the context of systems biology, it is essential that identical sets of metabolites 
are precisely quantified in multiple samples, such as those derived from differentially 
perturbed system, for downstream applications such as modelling and simulations. 
Considerable knowledge of the biology and information of the lipidome of the system of 
interest is essential for the success of a targeted approach and its applications in systems 
biology. A further complication is the diversity and differences in lipid catalogues 
between various systems. For instance, a list of MRM transitions for quantification of the 
lipidome of a neuronal cell line may not be fully applicable to a red blood cell, not to 
mention the transferability of methods between different tissues, organs, and obviously 
organisms. 
 
Even with the most comprehensive set of target lists, the approach tends to be 
biased since analytes are pre-determined and discovery rates for novel lipid mediators is 
compromised. Unbiased and targeted analyses each have their own strengths and 
weaknesses, but both approaches are highly complementary and their combination is a 
powerful discovery tool for lipidomics.  
 
1.4 Motivations and aims 
Novel analytical approaches, primarily based on liquid chromatography and mass 
spectrometry, have driven lipid research to a level that allows the systems-level analysis 
of these metabolites and their interacting partners. However, at its dawn, the field was 
met with many obstacles, including a lack of robust and versatile platform to quantify the 
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entire lipidome, computer algorithms for automated data analysis and data integration 
with other omics, and inadequate database, amongst other issues. In fact, the field of 
lipidomics is at such a young stage, a complete catalogue of cellular lipidome is not even 
available, in particular for different biological species.  
 
The aim of this study is to develop a combinatorial approach of both unbiased and 
targeted lipidomic analyses that can be generally applied to any biological systems of 
interest. With a time of flight (ToF) instrument, high resolution lipid profiles from a 
crude lipid extract will be generated and a computational tool will be developed for non-
targeted comparative lipidomics, with a focus on glycerophospholipids and sphingolipids.  
The aim is to develop a rapid method for differential profiling, analogous to other –omics 
platform such as microarray or isobaric tag for relative and absolute quantification 
(iTRAQ)-LC-MS for proteomic analysis, but under a label-free constraint. Such a method 
will allow an unbiased survey of the (sub-)lipidome that is captured by the mass 
spectrometer and lead to the identification of lipid mediators during a perturbation of 
interest. The method will first be validated using lipid extracts isolated mammalian 
tissues and cells, for which the isolation and characterization of the lipids have already 
been previously described and allow for unambiguous description of the lipids (Brugger 
et al., 1997;Sullards and Merrill, Jr., 2001). It should be noted that although the focus of 
this work is on glycerophospholipids and sphingolipids which are a subset of the entire 
lipidome, the the novel analytical approach developed is also termed ‘lipidomic’ as a 
global snapshot of multiple metabolites is captured.  
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With the successful endeavour of determining the complete genome sequences in 
many organisms, and annotation of gene products, the creation of genome wide knock 
out or knock down mutant libraries for various model organisms has been an 
indispensable tool for research. The wide range of yeast mutants, for instance, offers 
unparalleled opportunities for genome-wide screens to discover and/ or characterise 
mutants involved in lipid metabolism, transport and turnover (Daum et al., 
1999;Proszynski et al., 2005). I will next develop methods for isolation and analysis of 
glycerophospholipids and sphingolipids from S. cerevisiae. Deletion mutants of known 
lipid metabolism pathways obtained from publicly available libraries will be selected to 
validate the analytical approach developed. The availability of these mutants offers the 
opportunity to characterise lipids that would otherwise be present in low abundance, and 
will not be detected under ‘normal’ conditions. In addition, a simple theoretical lipid 
database that will facilitate the tentative assignment of ions will be built based on 
arithmetic. Given the relatively simple composition of yeast lipids, I will 
comprehensively characterise yeast major glycerophospholipids and sphingolipids and 
establish a more targeted method for relative quantification of individual molecular 
species.  
 
The intricate balance of composition, distribution and interactions of lipids in a cell 
is critical for normal function and one of the greatest frontiers in biology is to understand 
how this is mediated. The appreciation of the fine coordination of lipids and cellular 
function can be illustrated by the image of the lipid bilayer in eukaryotic cells, which has 
undergone a distinct change recently. The original fluid-mosaic model predicted free 
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diffusion of all components within the plane of the membrane, but lately it has been 
proposed that eukaryotic plasma membranes are composed of micro/nanodomains, 
commonly called rafts, and it has been shown that proteins and lipids do not freely 
diffuse over the entire surface of the cell (Simons and Ikonen, 1997;Kusumi et al., 
2005;Jacobson et al., 2007). This membrane specialization seems to correlate with the 
presence of sterols and sphingolipid species, which, in contrast to the 
glycerophospholipids, are found with few exceptions only in eukaryotic cells. There is 
now clear biophysical evidence that sterols and sphingolipids can segregate from other 
lipids in simple artificial membrane systems to form liquid-ordered domains (Ahmed et 
al., 1997). Some evidence exist, suggesting genetic interactions between mutants in sterol 
and sphingolipid biosynthesis (Eisenkolb et al., 2002;Baudry et al., 2001;Swain et al., 
2002). However, there is little, if any, convincing evidence showing that these two lipid 
species function together in complex biological membranes of living cells. Genetic 
manipulation of lipid metabolism in live cells provides an invaluable set of reagents to 
probe lipid functions and the lipidomic approach described will be applied, in 
combination with yeast genetics, to study the functional interactions of membrane lipids 
in cells and how this affects cell physiology.  
 
Finally, the glycerophospholipidome and sphingolipidome of D. melanogaster will 
be characterised. The fruit fly offers an opportunity to study biology from the subcellular 
to the whole organism level and methods to isolate lipids from different parts of the will 
be established and comparative lipidomics will be performed to biochemically 
characterise a mutant deficient in a fatty acid desaturase, Desat1.  
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In summary, although the use of mass spectrometry to characterise and quantify 
lipids is not new (Table 1.5), these are often lipid class specific. This thesis presents a 
novel analytical approach to measure glycerophospholipids and sphingolipids in samples 
derived from mammalian tissue/cells, yeast and fly in a global fashion and the methods 
described in this thesis have in fact found wide-spread applications which have 
contributed to (i) characterisation of various glycerophospholipids and sphingolipids not 
previously described (Guan and Wenk, 2006); (ii) novel lipid regulators/ enzymes (Kutik 
et al., in press); (iii) elucidation of lipid interactions and functions (Mousley et al., 2008) 




Table1.5 MS-based analysis of glycerophospholipids (GPL) and sphingolipids (SPL) in mammals, yeast and fly and lipids analysed in this thesis 
Glycerophosphospholipid (GPL)# Sphingolipid (SPL)# Reference Application 
 PC PE PI PS PG PA CL others Cer Phospho-SPL 
and/or glyco-SPL
SB   
Mammalian cells/tissues (relatively well-established) 
Profiling, characterisation and quantification of GPL and SPL + + + + + +  + + +   This thesis (Guan et al., 
2006) 
S. cerevisiae 
Characterisation of substrate utilisation for phospholipid biosynthetic enzymes + +      +    (Boumann et al., 2004a; 
Boumann et al., 2004b) 
Lipid remodeling associated with glycerophosphocholine depletion + +          (Boumann et al., 2006) 
Biochemical characterisation of glycerophosphocholine deficient strains + +          (Choi et al., 2004) 
Cardiolipin and Bax-mediated cytochrome c release from mitchondria       +     (Iverson et al., 2004) 
Biochemical characterisation of human homologue of gene,TAZ1, causing Barth 
syndrome 
      +     (Vaz et al., 2003;Gu et al., 
2004) 
Identification of a very long chain-substituted glycerophosphoinositol   +         (Schneiter et al., 2004) 
Role of glycerophosphoethanolamine in growth and membrane structure + +      +    (Storey et al., 2001) 
Characterisation of a novel acyl-coenzyme A 1-acylglycerol-3-phosphate O-
acyltransferases, Slc1p and Slc4p 
+ + + + +       (Benghezal et al., 2007) 
Characterisation of a novel  O-acyltransferase, Lpt1p + +          (Tamaki et al., 2007) 
Characterisation of a functional homologue of human seipin, FLD1, with a 
potential role in GPL metabolism* 
+ + + +        (Fei et al., 2008) 
Characterisation of Schizosaccharomyces pombe ceramide desaturase           + (Garton et al., 2003) 
Organisation of membrane lipids + + + +     + +  (Schneiter et al., 1999) 
+ + + +     + +  (Faergeman et al., 2004) 
+ + + + + +      (Feddersen et al., 2007) 
Role of acyl coA binding protein, Acb1p, on lipid metabolism, regulation and 
membrane functions 
+ + + +  +    +  (Gaigg et al., 2001) 
Functional and biochemical characterisation of a mitochondrial translocator, 
FOMP7** 
    + + +     Kutik et al., in press 
Functional substitution of sphingolipids by GPL containing C26 very long chain 
fatty acids 
  +       +  (Gaigg et al., 2006) 
Regulation of sphingolipid levels in mitochondria         + +  (Kitagaki et al., 2007) 
Structural and functional characterisation of sphingosine phosphate lyase, Dpl1p           + (Mukhopadhyay et al., 2008) 
Fatty acid requirement of yeast sphingolipid   +       +  (Cerantola et al., 2007) 
Regulation of ceramide biosynthesis by target of rapacymin complex 2 (TORC2)         +  + (Aronova et al., 2008) 
Membrane dynamics, ceramide homeostasis and cellular signalling**         + +  (Mousley et al., 2008) 
Sec14-dependent secretion and non-dependence on SPL biosynthesis          +  (Stock et al., 1999) 
SPL and heat stress         +   (Wells et al., 1998) 
Discrimination of yeast strains based on cell surface lipid profiling + + + + +  +     (Jungnickel et al., 2005) 
Characterisation and quantification of inositol containing SPL          +  (Hechtberger et al., 1994) 
Quantitative analysis of phosphoinositides   +     +    (Wenk et al., 2003; Pettitt et 
al., 2006) 
Characterisation of SPL          +  (Ejsing et al., 2006b) 
Profiling, characterisation and quantification of GPL and SPL and 
application to study functional interaction between membrane 
lipids 




Glycerophosphospholipid (GPL)# Sphingolipid (SPL)# Reference Application 
  PC PE PI PS PG PA CL others Cer Phospho-SPL 
and/or glyco-SPL
SB   
D. melanogaster 
Modulation of SPL biosynthetic pathway rescues photoreceptor degeneration         +   (Acharya et al., 2003) 
Effects of acclimation temperature on thermal tolerance and membrane GPL 
composition 
+ +          (Overgaard et al., 2008) 
A screen of 13 non-lepidopteran insects for presence of fatty acid amides        +    (Yoshinaga et al., 2007) 
Fast atom bombardment MS/MS analysis of GPL  + + + +        (Gamo et al., 1999) 
Zwitterionic and acidic glycosphingolipids of D. melanogaster embryo          +  (Seppo et al., 2000)  
Characterisation of free endogenous C14 and C16 sphingoid base           + (Fyrst et al., 2004) 
Identification and characterisation by ESI-MS of endogenous sphingadienes         +  + (Fyrst et al., 2008) 
Profiling, characterisation and quantification of GPL and SPL and 
application to biochemically characterise a desat1 deficient 
mutant 
+ + + +  +   + +  This thesis [Kohler et al., 
in preparation] 
# Due to space limit, the standard abbreviations for the various sub-classes of sphingolipids (SPL) and glycerophospholipids (GPL) have been replaced in the 
header of this table by the following: CL, cardiolipin; PA, phosphatidic acid; PC, glycerophosphocholine; PE, glycerophosphoethanolamine; PG, 
glycerophosphoglycerol; PI, glycerophosphoinositol; PS,  glycerophosphoserine. Other abbreviations used in this table include: Cer, ceramide; SB, sphingoid 
base.  
 
* Method developed in this thesis was adopted by others and cited in their studies.  
 
** Method developed in thesis was applied in these studies during the course of this thesis.  
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Chapter 2. Novel Analytical Approach to Study Mammalian 
Glycerophospholipids and Sphingolipids1 
                                                 
1 The work described in this Chapter is part of the following publications:  
 
1) Guan XL, He X, Ong WY, Yeo WK, Shui G and Wenk MR (2006). Non-targeted 
profiling of lipids during kainate induced neuronal injury. FASEB J. 20(8): 1152-61. 
 
2) He X, Guan XL, Ong WY, Farooqui AA and Wenk MR (2007). Expression, activity, 
and role of serine palmitoyltransferase in the rat hippocampus after kainate injury. J 
Neurosci Res. 85(2): 423-32.  
 
In addition, a manuscript is currently in preparation, which describes the analysis of 
human plasma lipidome and the use of multivariate statistics and supervised learning 
based on support vector machines for the classification of ovarian cancer.   
 
Fernandis AZ, Kothandaraman N, Chua GH, Guan XL, Shui G, Choolani M and Wenk 
MR. Classification of benign and malignant ovarian cancers by multiparametric analysis 




In this chapter, a mass spectrometry based method for non-targeted profiling of 
lipids from mammalian tissue and cell extracts is described. The approach can in 
principle be used whenever two lipid extracts of similar composition are to be compared. 
Indeed, this is very often the case in biological applications (Rapaka et al., 2005;Wenk, 
2005). This approach was employed to determine the changes of artificially perturbed 
brain lipid mixture. The application of the methodology was extended to unravel changes 
in hippocampal lipids during kainate induced neuronal injury, which is the first study that 
addresses lipid metabolism of neuronal damage in such a non-targeted fashion. In 
addition, candidate lipid metabolic pathways were identified based on the alterations 
observed and these pathways were pharmacologically modulated to examine their effects 
on rescuing cells from neurotoxic insults. These works have been published in 2006 in 
the FASEB Journal and Journal of Neuroscience Reseach (Guan et al., 2006;He et al., 
2006). However, it is not in the context of this thesis to rewrite these findings, but 
because the approach of ‘differential profiling’ I have developed can be generally applied 
to any sytems of interest and is the platform employed in many studies during the course 
of this thesis, it is thus imperative to describe in detail its development.  
 
2.2 Materials and Methods 
2.2.1 Chemicals and reagents 
In this study, all reagents were obtained from Sigma Aldrich, USA and organic 
solvents were obtained from Merck, Germany and are of analytical grade, unless 
otherwise stated.  
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2.2.2 Animal handling and collection of brain tissue 
Animals were acquired and cared for in accordance with guidelines published in 
the NIH Guide for the Care and Use of Laboratory Animals. All procedures involving 
animals were approved by the Animal Care and Use Committee of the National 
University of Singapore and performed in the laboratory of Dr Ong Wei Yi, the 
collaborator in this project. 
 
Male wistar rats weighing approximately 200grams were anesthetized deeply by 
intraperitoneal injection of 1.5mL of 7% chloral hydrate and sacrificed by decapitation. 
The hippocampi were promptly excised and snap frozen in liquid nitrogen. The right and 
left hippocampi of each rat were stored in separate tubes and analysed independently to 
minimize variations. The hippocampal samples were stored at -70°C until required.  
 
2.2.3 Sample preparation and collection of brain tissue 
Rat hippocampi were weighed and homogenized in 5 volumes of breaking buffer 
[500mM potassium chloride (KCl), 10mM magnesium chloride (MgCl2), 250mM 
sucrose, 25mM Tris, pH 8, 2mM EGTA, pH 8, 1mM dithiothreitol, and protease inhibitor 
mix] using a small tissue blender. A 150μL aliquot of the homogenate was used for 
subsequent lipid extraction step and the remaining was used for protein quantification.  
 
2.2.4 Internal standards 
Synthetic lipids with fatty acyl compositions that are naturally low abundant were 
used as internal standards. Phosphatidic acid (GPA) with C17 fatty acyl chains 
(diheptadecanoyl GPA, di17:0-GPA), C14-glycerophosphoserine (dimyristoyl GPSer, 
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di14:0-GPSer), C14-phosphatidyglycerol (dimyristoyl GPGro, di14:0-GPGro), C19-
ceramide (C19-Cer) and C12 sphingomyelin (C12-SM) were obtained from Avanti Polar 
Lipids (Alabaster, AL). Glycerophosphoinositol with C8 fatty acyl chains (dioctanoyl 
GPIns, di8:0-GPIns) was obtained from Echelon Biosciences, Inc (Salt Lake City, UT). 
The internal standards were solubilised in chloroform at a stock concentration of 
10μg/μL.  
 
2.2.5 Lipid extraction 
A modified protocol of Bligh & Dyer (Bligh and Dyer, 1959) was used to extract 
lipids from rat hippocampal tissue. Briefly, 400μL of chloroform-methanol, (1:2, 
volume-to-volume (v/v) was added to 20mg of tissue homogenate and 5μg of internal 
standards, di17:0-GPA and di8:0-GPIns were added. After a 10 minute incubation on ice, 
300μL of chloroform and 200μL of 1M hydrochloric acid (HCl) were added to the 
mixture. The mixture was centrifuged at 9000rpm for 2 minutes at 4°C and the lipids 
were isolated from the lower organic phase. The sample was vacuum dried (Thermo 
Savant SPD SpeedVac with UVS400A Universal Vacuum System) and the lipid film was 
resuspended in 2mL of chloroform-methanol (1:1, v/v) for subsequent analysis. 
 
2.2.6 Lipid analysis by electrospray ionisation mass spectrometry (ESI-MS) and 
tandem mass spectrometry (MS/MS) 
Electrospray Ionisation Mass Spectrometry (ESI-MS) was performed on a Waters 
Micromass quadrupole-Time of Flight (Q-ToF) micro (Waters Corp., Milford, MA) mass 
spectrometer. Typically, 2µL of sample were injected for analysis. The capillary voltage 
and sample cone voltage were maintained at 3.0 kilovolts (kV) and 50 volts (V), 
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respectively. The source temperature was 80°C and the nano-flow gas pressure was 0.7 
bar. The mass spectrum was acquired from m/z  400 – 1200 in the negative ion mode 
with an acquisition time of ten minutes and the scan duration was 1 second (s). The inlet 
system consisted of a Waters CapLC autosampler and a Waters CapLC pump and 
chloroform-methanol (1:1, v/v) at a flow rate of 3µL/min was used as the mobile phase. 
Individual molecular species were identified using tandem mass spectrometry. In general, 
the collision energy used range from 25 – 80 eV.  
 
Quantification of individual molecular species was performed using multiple-
reaction monitoring (MRM) with an Applied Biosystems 4000 Q-Trap mass spectrometer 
(Applied Biosystems, Foster City, CA). Tandem mass spectrometry (MS/MS) for 
characterisation/identification as well as quantification of lipid molecular species was 
performed using precursor ion scanning (PREIS), neutral loss scanning (NL) and 
multiple-reaction monitoring (MRM) respectively with an Applied Biosystems 4000 Q-
Trap mass spectrometer (Applied Biosystems, Foster City, CA) (Fig. 1.3). Based on 
product ion and precursor ion analysis of head groups and fatty acyls or sphingoid base, 
comprehensive sets of multiple-reaction monitoring (MRM) transitions were set up for 
quantitative analysis of various glycerophospholipids and sphingolipid, respectively. In a 
typical MRM experiment, the first quadrupole, Q1, was set to pass the precursor ion of 
interest to the collision cell, Q2, where it underwent collision-induced dissociation. The 
third quadruple, Q3, was set to pass the structure specific product ion characteristic of the 
precursor lipid of interest (Fig. 1.3D). Each individual ion dissociation pathway was 
optimised with regard to collision energy to minimize variations in relative ion 
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abundance due to differences in rates of dissociation (Merrill, Jr. et al., 2005). A high 
performance liquid chromatography system (Agilent Technologies, Santa Clara, CA) was 
coupled to the mass spectrometer and samples were introduced into the mass 
spectrometer by loop injections with chloroform-methanol (1:1, v/v) as a mobile phase at 
a flow rate of 200μL/min.  
 
2.2.7 Data processing 
Data was acquired using MassLynx 4.0 (Waters Corp., Milford, MA). The 
combined spectra lists were copied with MassLynx and saved as separate tab-delimited 
plain text files. All programs were coded in MATLAB 7 (The MathWorks Inc., Natick, 
MA) for Windows operating system (Microsoft Corp., Redmond, WA) and all data 
analyses were performed on a 1.5GHz Pentium 4 personal computer.  
 
The plain text files obtained from MassLynx were loaded into Matlab for 
processing (refer to Supplementary material 2.1 for the algorithm in Matlab format). 
Correlation optimised warping (COW) was used as a pre-processing method in order to 
obtain precise alignment of the normalized MS data (Nielsen et al., 1998). For averaging 
of spectra from replicate independent samples the normalized data of each replicate was 
warped against a reference set. After alignment of the spectra, the intensity values of 
individual m/z were then averaged to obtain one mean spectrum for each condition (i.e. 
spiked versus control, also refer to Fig. 2.2A). The mean spectrum for the ‘treated’ 
condition was then aligned relative to the mean spectrum for the control condition. After 
alignment of the mean spectra of the two conditions, relative differences at each data 
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point can be computed by simple arithmetic division and represented as the ratios, 
intensity of ‘treated’/ intensity of control, converted to a logarithmic scale (log10 ratios) 
against the m/z axis. In this work, the term ‘differential profile’ refers to the graphical 
readout which represents the differences in the MS profiles between two conditions under 
investigation. It should be noted that these changes are arbitrary in units. A ‘5-fold’ 
difference in a given peak means the ion response was 5-fold different at that particular 
m/z. This may, or may not, relate to a 5-fold difference in metabolite levels. In the case of 
internal glycerophospholipid standards used in this study a good linearity between 
metabolite concentration in the complex mixture and the ion response was observed 
however.   
 
Currently, the algorithm is implemented using C programming to increase the 
processing speed (Chua GH et al., unpublished data) and a Matlab graphical user 
interface is designed to allow end users to change various parameters including 
smoothing of spectra and peak detection.  
 
2.3 Results 
2.3.1 Profiling of mammalian brain lipids by negative ion ESI-MS 
Figure 2.1A shows a typical mass spectrum of a total lipid extract derived from 
rat hippocampal tissue. In this case, the lipid mixture was infused into a quadrupole-Time 
of Flight (Q-ToF) mass spectrometer by electrospray ionization (ESI) in negative mode. 
Ions of many prominent glycerophospholipids can readily be detected and tentatively 
assigned based on lipid masses (Murphy, 2002). Some of the most prominent ions 
detected include glycerophosphoethanolamines, GPEtn (18:1 GPEtn, 20:4 GPEtn, 22:6 
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GPEtn), glycerophosphoserines, GPSer (20:4 GPSer, 38:4 GPSer, 36:1 GPSer, 40:6 
GPSer) and glycerophosphoinositol, GPIns (38:4 GPIns) at m/z 478, 500, 524 (GPEtn), 
528, 766, 788, 834 (GPSer) and 885 (GPIns) respectively. Glycerophosphocholine 
(GPCho) as well as sphingolipids ionize well in the positive ionisation mode but 
considerable signals, for instance m/z 564 is a ceramide, can be detected in the negative 
ionisation mode. Therefore, single stage ESI-MS provides a considerably comprehensive 
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Figure 2.1 Differential lipid profiles of spiked complex lipid mixtures. 
Lipids were extracted from rat brain hippocampus using a standard chloroform-methanol protocol and the 
extracts were analysed using negative-ion mode ESI-MS (A). The same lipid extracts were next spiked 
with synthetic short chain glycerophosphoglycerol, 0.2μg of di14:0-GPGro, and spectra were recorded 
again (B). (C) A differential profile to represent difference in lipid composition between control and spiked 
extract. Lipid profiles of control and spiked extracts were aligned by correlation optimised warping and 
profiles of the spiked spectrum relative to the control spectrum were calculated and plotted as log10 ratios. 
The inset shows the response between the difference in ion intensity in m/z 665 for increasing amounts of 
spiked di14:0-GPGro. Data are presented as means from three independent experiments.  
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2.3.2 Non-targeted differential profiling based on ESI-MS and chemometry 
Figure 2.1B shows replicate analysis of the same extract, which has been spiked 
with a small amount (0.2μg) of synthetic glycerophosphoglycerol (di14:0-GPGro). 
Hence, the overall appearance of the mass spectrum is very comparable, yet the 
exogenously added GPGro leads to a small increase in the ion intensity at m/z 665 (Fig. 
2.1B, inset), the expected mass of di14:0-GPGro. Note that ToF analysis yields sharp 
signals with readily resolved isotopic peaks and high mass accuracy (e.g. Fig. 2.1A & B, 
inset).  
 
To identify differences in such high resolution mass spectra in a non-targeted 
fashion, a chemometric approach that allows comparison of differences in ion intensities 
of all detectable ions between two experimental conditions was developed (Fig. 2.2A). 
Slight differences in m/z values of ions between experiments are common due to small 
drifts in experimental conditions such as variations during ToF measurements and are a 
problem in particular when multiple spectra are to be processed. Note for example the 
slight differences in m/z values of some of the ions in Figure 2.1A and 2.1B (e.g. 478.30 
vs. 478.28, 524.28 vs. 524.27). In order to perform direct analysis of the entire mass 
spectra, and to utilize all collected data, the mass spectra should be properly aligned. 
Therefore, a previously developed chemometric method, which is based on correlation 
optimised warping (COW) (Nielsen et al., 1998), was adopted. COW builds on piecewise 
stretching and compression of spectra along the m/z axis to correct for drifts (Fig. 2.2B). 
Importantly, such warping does not affect the peak intensities (Nielsen et al., 1998).  
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As the total lipid concentration of different samples may vary slightly, it is 
important to normalize the data so that subsequent comparative studies based on 
differences in peak intensity is not due to differences in total lipid concentration. A 
challenge in lipid analysis is that because lipids are metabolites with high turnover, and 
are highly heterogeneous between biological sources, there is no one ‘housekeeping’ 
lipid, unlike proteins and genes, to control for amount of material. Normalisation in this 
case was performed in two ways – i) the peak intensity at each point (m/z) was first 
normalised to the sum of peak intensities of all the ions within the scan range or ii) the 
intensity value of each m/z was normalized to the tissue mass or protein amounts based 
on the di17:0-GPA internal standard, which was spiked according to the amount of 
material. Both methods for normalisation produced consistent results. It should however 
be noted that standardisation of the normalisation protocol is dependent on the nature of 
the samples.  
 
Using such chemometric warping it is hence possible to almost perfectly align 
spectra from multiple replicates of experimental condition A (A1…An) and condition B 
(B1…Bn). Once spectra are aligned they can be further processed arithmetically. A 
differential profile, DP, which is the ratio of averaged replicate spectra from condition A, 
<A>, and averaged replicate spectra from condition B, <B>, can be computed as a 
function of m/z. In the case of the spiking experiment mentioned above, this yields a 
‘differential profile’ which displays a single sharp peak at m/z 665, the expected mass of 
di14:0-GPGro (Fig. 2.1C). In addition, using a peak detection algorithm, a list of peaks 
that are differentially regulated is generated and these candidate ions are selected for 
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identification by MS/MS and quantification by multiple-reaction monitoring (MRM) 
(Fig. 2.2A).  
 
The ion response of such exogenously added lipids is linear as a function of the 
amount of spiked material for a variety of different chemistries (e.g. GPGro, GPSer and 
ceramides, [Fig. 2.1C inset and data not shown]). Thus, for samples of comparable 
similarity, which typically are at the source in many biological applications, this approach 
allows for detection of differences in lipid compositions. While this analysis is not as 
quantitative as for example MRM, it certainly has its advantages. Most importantly, the 
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Figure 2.2 Cartoon illustrating the general approach of the method applied here for identification of 
lipid metabolites that are altered in paired sample systems analysis.  
(A) Typically two conditions for which multiple independent replicate samples (e.g. lipid extracts A1…An) 
are available are at the origin of the approach. Each lipid extract yields a corresponding lipid profile (e.g. 
lipid profile A1…An, which are single stage mass spectra in this study). These replicate spectra are next 
aligned using chemometric alignment based on correlation optimised warping (COW, see panel B) and 
subsequently the ratio of the signal intensities is computed as a function of m/z (DP). (B) Correlation 
optimised warping of mass spectra. COW was used as a pre-processing method for the mass spectral data. 
Briefly, a sample mass spectrum profile (X2) is aligned to a reference spectra (X1) by piecewise linear 
stretching and compression - also known as warping - of the m/z axis of the reference (X1). The asterisk 




It is indeed becoming increasingly evident that lipids are important mediators in 
diverse biological functions, and the dynamics of lipid metabolism and trafficking is 
critical in these processes. Using lipidomic profiling, it is now becoming possible to 
determine the levels of many lipids, including membrane constituents (Han et al., 
2004;Forrester et al., 2004) as well as soluble lipid mediators (Balazy, 2004;Serhan, 
2005), with great sensitivity and selectivity. However, no platform for simultaneous 
determination in a single experiment was available at the point of this work. Instead 
existing approaches use highly selective and optimised conditions for the different classes 
of lipids and required sufficient knowledge on the chemistry of the lipids investigated.  
 
In this work, a unique approach for non-targeted profiling of lipids in complex 
mixtures is presented. The method does not require any prior knowledge of the identity 
nor chemical (and fragmentation) property of the lipids in the mixture. It is furthermore 
particularly sensitive to changes in intensities which arise from ions with low intensity 
which is very often the case for signalling compounds. Conceptually, the approach 
follows comparative analysis of paired samples which is reminiscent of other systems 
level scale methodologies. The results are plotted in ‘up-and-down’ format and for some 
lipid chemistries the signal intensities are linearly dependent on ion concentration (Fig. 
2.1).  
 
The Q-Tof based metabolite profiling as performed here is considered an excellent 
initial screening tool. It is particularly powerful when used in combination with 
alternative analytical methods, such as MS-based targeted analysis by multiple-reaction 
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monitoring (MRM), or lipid-based imaging, the latter which is able to provide spatial 
information. Indeed, I have characterised and optimised parameters to selectively 
quantify mammalian membrane glycerophospholipids and sphingolipids (Supplementary 
Table 2.1) by MRM (Fig. 1.3) and applied this method to quantify changes associated 
with (i) excitotoxicity in rat hippocampi, as a validation of our observations based on 
differential profiling (Guan et al., 2006) and (ii) quantitative analysis of the lipidome of 
biological fluids as a diagnostic tool for a few human pathologies, including ovarian 
cancer and Alzheimer’s disease (Fernandis et al., in preparation). In addition, elucidation 
of mechanisms/ enzymes underlying changes observed in lipid profiles to provide greater 
insights into a biological perturbation of interest can be complemented by proteomics and 
genomics approach (Fig. 1.4A and 2.2A).  
 
Note that measurement of the levels of other biologically important lipids, such as 
phosphorylated or breakdown products of glycerophospholipids and sphingolipids for 
example, was not attempted as these metabolites might have to be extracted with different 
methods due to their high solubility in aqueous solutions and therefore a tendency to 
escape during organic extraction. The method works well for lipids with different 
chemical structures if these lipids can be recovered in the extraction method of choice 
and ionize efficiently.  It will be interesting to extend such metabolite analysis to soluble 
lipid mediators (e.g. platelet activation factors, anandamides, sphingoid bases etc).  
 
This novel analytical approach should also be applicable to other modes of 
ionisation (e.g. APCI, MALDI, photoionisation) and mass spectrometric detection. An 
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important prerequisite is high mass resolution. Indeed, differential profiling of MS/MS 
scans such as PREIS and NL using high resolution ToF-quadrupole instruments can be 
achieved. In addition, future applications in combination with ultra-high resolution mass 
analysis, e.g. FT-ICR mass spectrometry (Schaub et al., 2003), will lead to enhanced 
mass resolution. This, together with the capabilities of mass spectrometers to allow 
unambiguous identification of ions based on very accurate mass measurements, makes 
this method a most promising new tool for lipidomics research. Modifications to the 
algorithm to process LC-MS data in a three-dimensional space, to include retention time, 
in addition to the current two-dimensions, m/z and intensity,  (Shui et al., unpublished 
data) have been made and allow for more comprehensive profiling of lipids, with 
enhanced resolution of isobaric compounds with the same m/z but different chemistries. 
 
Collectively, the current work describes a method for non-targeted profiling of 
lipids from tissue and cell extracts which is particularly useful for detection of ‘large 
changes on small signals’ (signalling lipids).   
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Chapter 3. High Resolution and Targeted Profiling of 
Glycerophospholipids and Sphingolipids in Extracts from 
Saccharomyces cerevisiae2 
                                                 
2 The work described in this Chapter has been published in the following publication:  
Guan XL, and Wenk MR (2006). High resolution and targeted profiling of phospholipids 
and sphingolipids in extracts from Saccharomyces cerevisiae. Yeast. 23(6): 465-77. 
 
In addition, the application of the approach described  in this Chapter has contributed to 
significant findings in the following publications: 
1) Kutik S, Rissler M, Guan XL, Guiard B, Shui G, Gebert N, Heacock P, Rehling P, 
Dowhan W, Wenk MR, Pfanner N and Wiedemann N. The translocator maintenance 
protein Tam41 is required for mitochondrial cardiolipin biosynthesis. Journal of Cell 
Biology. In press.  
 
2) Mousley CJ, Tyeryar K, He KE, Schaaf G, Brost R, Boone C, Guan XL, Wenk MR 
and Bankaitis VA (2008). Coordinate defects in Sec14 and Tlg2-dependent trans-
Golgi and endosome dynamics derange ceramide homeostasis and compromise the 




Lipids are small molecules which play important roles in physiology and disease. 
They are building blocks of cellular membranes, precursors for signalling molecules and 
they serve as storage of chemical energy in highly reduced form. At the moment, the field 
of lipid research is undergoing revolutionary developments driven by (i) technological 
advances for lipid detection, and (ii) insights from recent functional characterisation of 
lipid enzymes in model systems. 
 
Studies in S. cerevisiae have played a particularly crucial role in the 
advancements of our knowledge of lipid function. As a result, much is known about the 
pathways, and their regulation, of (glycerophospho)lipid biosynthesis in yeast (Daum et 
al., 1998;Vance, 2003;Kohlwein et al., 1996;Homann et al., 1987;Carman and Henry, 
1989). In addition, and more recently, elegant experiments using combined genetic, 
biochemical and functional approaches have shed light on the role of phosphoinositides 
in secretion (Odorizzi et al., 2000;Simonsen et al., 2001;Huijbregts et al., 2000), the role 
of sterols in endocytic events (D'Hondt et al., 2000;Heese-Peck et al., 2002), and 
triglyceride synthesis for storage of lipids in intracellular deposits (Mullner and Daum, 
2004;Zweytick et al., 2000).   
 
While many of these studies were aimed at investigating physiological processes 
(such as membrane trafficking) in yeast, it is clear that they also advanced tremendously 
our understanding of lipid metabolism in other organisms, including mammals. It is 
important to note that many pathways of lipid biosynthesis and metabolism are well 
conserved between species ranging from yeast to worm to mouse and human. There are 
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however also a number of notable differences in yeast lipids compared to mammalian 
counterparts. For example, S. cerevisiae synthesizes ergosterol as its major sterol lipids as 
opposed to cholesterol in mammalian cells (Munn et al., 1999;Zinser et al., 1993). Yeast 
sphingolipids contain inositol mannosyl residues rather than glucosyl sugars found in 
complex glycolipids in Man (Daum et al., 1998).  
 
 Traditional lipid analysis, such as thin layer and gas chromatography, is 
hampered with limited sensitivity, selectivity and resolution. Gas chromatography mass 
spectrometry (GC-MS), for example, is a powerful method for determination of fatty acyl 
heterogeneity but it requires derivatisation and pertinent standards. In addition, 
information on the origin of the fatty acyl moiety is generally lost. Metabolic labelling 
using lipid precursors (such as radiolabelled inositol, serine or fatty acyls) have been 
widely used to (selectively) label certain classes of lipids which are then typically 
separated using thin layer chromatography (TLC) and visualized by autoradiography. 
While these approaches are generally fairly easy to use and do not require specialized 
equipment, they do only deliver mass levels of lipids under conditions of steady-state 
incorporation of the label (which sometimes is difficult to achieve technically). In 
addition, TLC separation is generally of low resolution.  
 
 Electrospray ionisation mass spectrometry (ESI-MS) has been used for analysis 
of lipids with great success (Wenk, 2005;Forrester et al., 2004;Han and Gross, 2005a). 
Major advantages of this method is its capability to detect large numbers of individual 
lipid ions (currently in the order of hundreds to a few thousands), with different 
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chemistries, in complex mixtures and a single experiment (Han and Gross, 2005a;Hughey 
et al., 2002;Mougous et al., 2002). 
 
In this Chapter, the MS-based approach described in Chapter 2 is adopted to 
profile lipids from minimally processed organic extracts of S. cerevisiae. The method is 
based on (i) high resolution analysis for detection of global changes (‘non-targeted 
profiling’) followed (ii) by characterisation and quantification of changes of interest 
using tandem mass spectrometry (MS/MS), MS/MS/MS (MS3) and multiple-reaction 
monitoring (MRM). Furthermore, in order to facilitate tentative assignment and 
identification of ions, this work describes the comprehensive theoretical calculations of 
molecular masses for yeast glycerophospholipids and sphingolipids, of which a large 
number can be measured experimentally in a single extract using the present method. 
Given the high degree of conservation in pathways of lipid metabolism between different 
organisms it can be expected that this method will lead to the discovery of novel 
enzymatic activities and modulators of known ones, in particular when used in 
combination with genetic and chemogenetic libraries and screens. Specifically, mutants 
from the EUROSCARF library of non-essential deletion mutants to were obtained to 
validate the analytical approach. Mutants of SCS7, a fatty lipid hydroxylase, and SLC1, a 
putative acyl transferase with unknown substrate specificity, were profiled for their 
glycerophospholipid and sphingolipid content. The observed changes in lipid profiles are 
consistent with previous observations and extend our knowledge on in vivo substrate use 
under permissive growth conditions.  
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3.2 Materials and Methods 
3.2.1 Strains, media and culture condition 
The strains used in this study (Table 3.1) are obtained from the EUROpean 
Saccharoymces Cerevisiae ARchive for Functional analysis (EUROSCARF) library. 
BY4741 is a wild type strain while slc1Δ and scs7Δ are deletion mutants for genes 
encoding a putative acyltransferase (SLC1) and sphingolipid alpha-hydroxylase (SCS7), 
respectively. Cells were kept on YPD plates and single colonies were cultured overnight 
in YPD medium (1% yeast extract, 2% Bacto-peptone and 2% glucose (Difco 
Laboratories, USA). The cells were then diluted into fresh medium to an optical density 
(OD) at 600nm (OD600) of 0.075 and grown to an OD600 of ~ 0.65 – 0.85. All steps 
were carried out at 30°C in a rotary shaker.  
 
Table 3.1 List of S. cerevisiae strains used in this study 
Strain Genotype Source 
BY4741 (wild 
type, WT) 
MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0 EUROSCARF 
scs7Δ BY4741; Mata; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; 
YMR272c::kanMX4  
EUROSCARF 




3.2.2 Lipid standards 
Synthetic lipids with fatty acyl compositions that are naturally low abundant in S. 
cerevisiae were used as internal standards. Phosphatidic acid with a C17 chain (di17:0-
GPA), C19-ceramide (C19-CER), C8 glucosylceramide (C8-GC) and liver 
glycerophosphoinositol (GPIns) were obtained from Avanti Polar Lipids (Alabaster, AL). 
The internal standards were solubilised in chloroform at a stock concentration of 
10μg/μL.  
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3.2.3 Lipid extraction 
25 OD600 equivalents of yeast cells were harvested by centrifugation at 4000rpm 
for 5 minutes and washed twice with deionised water. Lipids were extracted by a method 
described by Angus and Lester, with slight modifications (Angus and Lester, 1972). 
Briefly, cells were resuspended in 2mL of 95% ethanol-water-diethyl ether-pyridine-
ammonium hydroxide (15:15:5:1:0.018, v/v/v/v/v). 0.1μg of C19-Cer, 0.05μg of C8-GC 
and 0.25μg di17:0-GPA were added as internal standards. Cells were broken by glass 
beads vortexing (two times for one minute each) and incubated for 20 minutes at 60°C. 
Debris was pelleted by centrifugation and the supernatant was transferred to a fresh tube. 
The pellet was re-extracted once more using the same procedure. The pooled 
supernatants were divided into three aliquots and dried under a stream of nitrogen. One 
aliquot was used for total lipid analysis (mainly glycerophospholipids) and the others for 
sphingolipid analysis (see also Fig. 3.1).  
 
For total lipid extraction, the dried lipid film was desalted by butanol extraction. 
Briefly, the lipid film was resuspended in 200μL of water-saturated butanol. 100uL of 
water was added and the mixture was vortexed for one minute, followed by 
centrifugation at 14 000rpm for two minutes to induce phase separation. The top butanol 
fraction was collected and the bottom aqueous phase was re-extracted with 200μL of 
water-saturated butanol. The two butanol fractions were pooled and dried under a stream 
of nitrogen and this extract constitutes the ‘total lipid extract’.  
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 A fraction enriched in sphingolipids was obtained by mild alkaline hydrolysis 
which degrades ester linkages found in many glycerophospholipids (Brockerhoff, 1963). 
To achieve this, the dried lipid films from the ethanol-water-diethyl ether-pyridine-
ammonium hydroxide extract were resuspended in 400μL of chloroform-methanol-water 
(16:16:5, v/v/v). Glycerophospholipids were deacylated by 400μL of 0.2N sodium 
hydroxide (NaOH) and incubation at 30°C for 45 minutes. 400μL of 0.5M EDTA was 
added and the samples were neutralized with 1N acetic acid. 400μL of chloroform was 
added and the mixture was vortexed for one minute, followed by centrifugation at 
9000rpm for two minutes at 4°C. The lower organic phase was collected and dried under 
nitrogen.   
 
3.2.4 Lipid analysis by ESI-MS, MS/MS and MS3 
ESI-MS was performed using a Waters Micromass Q-Tof micro (Waters Corp., 
Milford, MA) mass spectrometer. Lipid extracts were reconstituted in 2mL of 
chloroform-methanol (1:1, v/v). Typically, 2μL of sample was injected for mass 
spectrometry analysis. The capillary voltage and sample cone voltage were maintained at 
3.0 kV and 50 V respectively. The source temperature was 80°C and the nano-flow gas 
pressure was 0.7 bar. The mass spectrum was acquired from m/z 400 – 1400 in the 
negative ion mode with an acquisition time of three minutes, and the scan duration was 
1s. The inlet system, consisting of a Waters CapLC Autosampler and a Waters CapLC 
Pump, was used to provide the mobile phase and to inject samples. Chloroform-methanol 
(1:1, v/v) at a flow rate of 15μL/min was used as the mobile phase. Individual molecular 
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species were identified using tandem mass spectrometry and in general, the collision 
energy used ranged from 25 – 80 eV (see also Fig. 3.5). 
 
Tandem mass spectrometry for characterisation, identification as well as 
quantification of lipid molecular species was performed using MS3, precursor ion 
(PREIS) and neutral loss (NL) scanning and multiple-reaction monitoring (MRM) 
respectively with an Applied Biosystems 4000 Q-Trap mass spectrometer (Applied 
Biosystems, Foster City, CA) (see Section 2.2.6 and also Fig. 3.1 and 3.5). Samples were 
directly infused using a Harvard syringe pump at a flow rate of 10μL/min. Each 
individual ion dissociation pathway for the various scan modes was optimised with 
regard to collision energy to minimize variations in relative ion abundance due to 
differences in rates of dissociation. In MS3, the fragment ions themselves obtained from 
MS/MS are subjected to further fragmentation steps. The additional fragmentation 
provides more information about the molecular structure of the precursor ion, which is a 
powerful method for identification of complex molecule. The relative concentration of 
each lipid species was selectively measured by MRM and calculated by normalizing 
(dividing) its intensity to the intensity of the relevant internal standards. 
 
3.2.5 Data analysis 
Data was acquired using MassLynx 4.0 (Waters Corp., Milford, MA). The plain 
text files obtained from MassLynx were loaded into Matlab (The MathWorks Inc., 
Natick, MA) for processing (Guan et al., 2006) (See Chapter 2). Briefly, correlation 
optimised warping (COW) (Nielsen et al., 1998) was used as a pre-processing method in 
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order to obtain precise alignment of normalized MS spectra from replicate samples. 
Individual spectrum was normalized using total ion counts. For averaging of spectra from 
replicate independent samples the normalized data of each replicate was warped against a 
reference set. After aligning the peaks, the intensity values of individual m/z were then 
averaged to obtain one mean spectra representative of the replicates. To compare between 
different experimental conditions, the mean spectrum for one experimental condition 
(e.g. mutant) was warped against the mean spectrum for the control condition (wild type). 
After alignment, relative difference in the lipid compositions of the mixture can be 
computed by calculating the logarithm (log10) of the ratio of ion intensities relative to 
control samples and is represented as a ‘differential profile’. 
 
3.2.6 Statistical analysis 
Comparison of the wild type and mutant strains was performed using the mean of 
at least 4 independent samples ± standard error of the mean (SEM) from individual 
samples. Statistical significance between wild type and mutant yeast strains was 
determined using Student’s t-test. 
 
3.3 Results 
The main classes of lipids in S. cerevisiae, like in most other eukaryotic cells, are 
glycerophospholipids, sphingolipids, sterols and glycerolipids (such as diacylglycerols 
and triacylglycerols), with the polar lipids comprising of approximately 40% of total 
lipids and neutral lipids 60%, respectively (Blagovic et al., 2001). The goal of this study 
was to establish a simple and rapid method which allows profiling of total polar lipids, 
containing mainly glycerophospholipids and sphingolipids, and with a focus on 
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sphingolipids (Fig. 3.1). In order to validate the approach, mutant strains which have 
previously been implicated with aberrant (sphingo)lipid metabolism were obtained from 
















Figure 3.1 Workflow of method. 
A cell pellet from 25OD units of yeast is extracted using ethanol-water-diethyl ether-pyridine-ammonium 
hydroxide (‘total lipid extract’). This fraction contains both glycerophospholipids and sphingolipids. The 
fraction is then split and processed for analysis of major glycerophospholipid (which includes a ‘desalting’ 
step) and sphingolipids (which resist ‘mild alkaline hydrolysis’). Single stage mass spectrometry (MS) is 
used to profile the extracts in a non-targeted fashion. Tandem mass spectrometry (MSMS) and MS3 is 
employed to further characterise (MSMS, MS3) and quantify lipids of interest (precursor ion scanning, 
PREIS and multiple-reaction monitoring, MRM). 
 
3.3.1 Theoretical calculation of the masses of yeast glycerophospholipids and 
sphingolipid molecular species 
Similar to peptides, lipids can be identified through database match based on the 
mass-to-charge ratio (m/z). Several initiatives, including LIPID MAPS, have embarked 
on creating databases for lipids, their structures and even fragmentation patterns (Table 
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1.3). However, these databases were not available at the dawn of lipidomics, and their 
development is only making advance progress in recent years. Furthermore, the 
comprehensiveness of such databases is limited to the interest of the research group. For 
instance, the table of molecular and product ions published by Murphy is restricted to 
phospholipids (i.e. glycerophospholipids and sphingomyelins) (Murphy, 2002), and these 
molecular species are well-suited for analysis of samples derived from mammalian 
tissues or cells but clearly, the lipid inventory varies between organisms. Therefore, a 
simple database containing theoretical calculations of the m/z of yeast 
glycerophospholipids and sphingolipids is presented in this work, which will serve as a 
reference database for annotation of lipid metabolites detected by ESI-MS.  
 
Basically, the building block of a glycerophospholipid molecule comprises of a 
headgroup, hydrophobic tails (acyl, alkenyl or alkyl), and a glycerol backbone (Fig. 1.1). 
Sphingolipids, on the other hand, comprise of a sphingoid base, a fatty acyl chain and a 
headgroup (Fig. 1.1). For these relatively ‘simple’ and structurally defined lipids, the 
theoretical mass of each molecular species can be calculated based on the elemental 
composition and a library of lipids and their corresponding m/z can be built 
(Supplementary material 3.1). However, with isobaric complications, the assignment of 
ions of interest based solely on m/z will inevitably lead to a few possibilities and this 
requires further experimental validation, and confirmation.  
 
3.3.2 Rapid isolation and profiling of polar lipids from Saccharomyces cerevisiae 
Water-rich, slightly alkaline solvents appear to be more efficient in isolating 
inositol-containing lipids from S. cerevisiae (Angus and Lester, 1972). Figure 3.2A 
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shows a typical profile of a total lipid extract obtained from a wild type yeast strain 
(Table 3.1). The most prominent ions represent major glycerophospholipid species which 
ionize efficiently in negative mode. The major fatty acyls in yeast are C16 and C18 with 
none, one or two double bonds. Yeast, unlike mammalian cells, does not synthesize 
polyunsaturated fatty acids (Schneiter et al., 1999;Blagovic et al., 2005). The most 
prominent inositolphosphorylceramide (IPC) yields a weak signal at m/z 952 under these 



















































































































































































































































































Figure 3.2 (Differential) Profiling of glycerophospholipids and sphingolipids of yeast mutants 
Typical glycerophospholipid (left panels) and sphingolipid profiles (right panels) of wild type (WT) yeast 
(A), and deletion mutants of the slc1 (B & C) and scs7 (D & E) genes. Mass spectra from at least 4 
independent samples were averaged for each condition (n=4). Differential lipid profile, which are ratios of 
single stage mass spectrometry scans plotted as log10 ratios, are used to compare differences in 
glycerophospholipid and sphingolipid composition between slc1Δ and WT (C) and scs7Δ and WT (E). 
Note that this approach does not require knowledge of the underlying lipid species for a given ion of 
interest. Instead, it serves as an ‘unbiased’ screening tool for discovery of lipids which are present in 
different amounts between two conditions. Deletion of slc1, which encodes a putative acyl transferase, 
leads to pronounced differences in glycerophospholipid profiles (C, left panel) while sphingolipids are less 
affected when compared to WT (C, right panel). The opposite is the case for deletion of scs7, which 
encodes a ceramide hydroxylase. scs7Δ displays striking differences in the sphingolipids (E, right panel) 
with only minor alterations in glycerophospholipids (E, left panel).  
 
To improve detection of (other) sphingolipid molecular species, the total lipid 
extract was subjected to mild alkaline hydrolysis. This treatment hydrolyzes acyl bonds 
(and hence the majority of glycerophospholipids) but leaves amide linkages largely 
intact. It has in the past been successfully used for measurement of sphingolipids in 
mammalian cells and tissues (Merrill, Jr. et al., 2005). Figure 3.2A shows a high 
resolution Q-ToF scan of such a sphingolipid enriched fraction (right panel).  
 
The profiling of complex lipid mixtures in such a fashion, i.e. using single stage 
mass spectrometry, serves as a powerful initial screen when different conditions or strains 
are to be compared.  
 
3.3.3 Pilot screen of yeast mutants deficient in known lipid biosynthetic pathway 
The lipids of yeast mutants deficient in known lipid biosynthetic pathway were 
analysed using the non-targeted differential profiling described in Chapter 2. In addition, 
major yeast sphingolipids were characterized and MS conditions were optimised for their 
relative quantification. The rationale behind the use of knockout of lipid metabolic 
enzymes as a proof of concept is two-prong – 1) changes can be anticipated and 2) these 
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knockouts will accumulate various metabolic intermediates that normally occur in low 
abundance, which will be used for precise characterisation, overcoming the problem of a 
lack of pure lipid standards, particularly for the yeast inositol sphingolipids. 
 
3.3.3.1 Non-targeted profiling and characterization of glycerophospholipids and 
sphingolipids of slc1Δ by ESI-MS, MS/MS and MS3 
Figure 3.2B and 3.2D show profiles from slc1 and scs7 deletion strains (Table 
3.1). SLC1 encodes for a putative acyltransferase which has been implicated in the 
synthesis of phosphatidic acid from lysophosphatidic acid (Dickson et al., 
1990;Athenstaedt and Daum, 1997). It was originally discovered in a screen for bypass 
mutants that regain the ability to grow in the absence of sphingolipid biosynthesis. 
Indeed, slc1-1 is a suppressor of lcb1, which catalyzes the committed step of sphingolipid 
biosynthesis. These original experiments, due to the setup of the genetic screens, were 
mainly carried out in the absence of long chain bases (LCB) in the growth medium. 
Under these conditions, slc1-1 leads to the generation of unusual inositol containing 
glycerophosphospholipids (Lester et al., 1993).  
 
It is demonstrated that under permissive growth conditions, i.e. complete medium 
rather than media devoid of LCB, the glycerophospholipids resemble largely those found 
in the wild type strain (Fig. 3.2B, left panel). A differential profile which displays 
differences in ion response between the slc1Δ and wild type conditions is shown in 
Figure 3.2C (left panel). The major differences lie in ions at m/z 725 and 753, which, 
based on the mass, can tentatively be assigned to glycerophosphoinositols (GPIns) with a 
total fatty acyl carbon number of 26 and 0 double bonds (26:0-GPIns) as well as 28:0-
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GPIns, i.e. GPIns species with unusually short and saturated fatty acyls. Indeed, a 
precursor scan for m/z 241, which is an indicator fragment of inositol-containing lipids, 
reveals a GPIns profile which is devoid of these short chain species (Fig. 3.3). 
Interestingly, such short chain GPIns have previously been shown to be enriched at the 
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Figure 3.3 Molecular species of glycerophosphoinositol (GPIns) in slc1Δ. 
(A) Precursor ion scans of m/z 241 (the mass of dehydrated inositol phosphate, see also panel B) were used 
to selectively measure GPIns species in slc1Δ (red downward profiles) and wild type (WT, blue upward 
profiles).  Liver GPIns was spiked into the extracts prior to extraction and used as an internal standard (IS) 
for quantification. Note the almost complete absence of very short chain GPIns (26:0 GPIns & 28:0 GPIns) 
in the mutant strains (inset) which is highly selective. GPIns with a total carbon number of 30 and more are 
present in comparable amounts between slc1Δ and WT. (B) Tandem mass spectrometry and collision-
induced dissociation (CID) of m/z 725. Based on theoretical calculation of glycerophospholipid and 
sphingolipid molecular species (see Supplementary material 3.1) this ion can tentatively be assigned to 26:0 
GPIns. This is supported by analysis of the fragment ions which have m/z characteristic of an inositol (m/z 
241) containing glycerophospholipid (m/z 153) with C10:0 (m/z 171) and C16:0 (m/z 255) as major fatty 
acyl chains.  
 
The sphingolipids of slc1Δ using the alkali-treated fraction were analyzed next. 
Major ions correspond in m/z to those of the WT, albeit at altered levels. Ions at m/z 682, 
924, 936 and 952 correspond to t18:0/24:0 phytoceramide-C, t18:0/24:0 IPC-C, 
t18:0/26:0 IPC-B and t18:0/26:0 IPC-C, respectively (Figure 3.5 and Supplementary 
material 3.1). It should be noted that sphingolipids enter the gas phase efficiently in both 
negative and positive ionisation mode. Tandem mass spectrometry and collision-induced 
dissociation were used to further characterise and identify changes of interest (Figure 3.4 
and data not shown). The mannosyl inositolphosphorylceramides (MIPCs) in yeast are 
lipids with considerable structural complexity. Figure 3.4A shows the product ion spectra 
of a positive ion of m/z 1116 in positive mode (equivalent to m/z 1114 in negative ion). 
Two major fragments were observed with m/z 954 and 694. The daughter ion with m/z 
954 corresponds to the m/z of 26:0 inositol phosphoryl ceramide (IPC-C). Furthermore, it 
is equivalent to a loss of 162 mass units from the parent ion, suggesting a loss of a sugar 
group from MIPC-C. Tandem mass spectrometry of ceramides, and glycosylated 
derivatives, yield fragments which have to be further characterised for unambiguous 
identification. Hyphenated MS is a powerful tool for such analysis and figure 3.4B shows 
MS/MS/MS (MS3) of the most prominent product ion, m/z 694, derived from collision-
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induced dissociation of ion of m/z 1116.  MS3 of m/z 694 forms dehydration products of 
phytoceramide as well as (dehydration products) of the t18:0 sphingoid bases thus 
supporting m/z 1116 to originate from a C26 MIPC-C with a t18:0 sphingoid base 
(Figure 3.5 and Supplementary material 3.1). In conclusion, these results indicate that 
disruption of the SLC1 gene leads to moderate (yet highly specific) changes in molecular 
species in glycerophospholipids as well as sphingolipids, most notably complete 
elimination of very short chain GPIns and a concomitant increase in short chain 
sphingolipids, phytoceramide and IPC.  
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Figure 3.4 Biochemical characterisation of a complex sphingolipid using MSMS and MS3. 
The ion with m/z 1116.8 can be tentatively assigned (based on the mass) to mannosyl inositol-
phosphorylceramide (MIPC) of the C-series (t18:0/26:0, see also Figure 3.5 and Supplementary material 
3.1). Tandem mass spectrometry (positive mode) of m/z 1116.8 yields a dominant ion at m/z 694.6, the 
expected mass for the dehydrated phytoceramide backbone of t18:0/26:0 MIPC (A). This is supported 
experimentally by subsequent MS analysis using MS3 (on a linear ion trap) of m/z 694.6 (B) which 
produces the doubly dehydrated phytoceramide (m/z 676.6) and fragments corresponding to the long chain 
base (LCB) of the ceramides (e.g. m/z 282.2).   
 
3.3.3.2 Non-targeted profiling of glycerophospholipids and sphingolipids of scs7Δ 
In contrast, the total lipid profiles of the deletion mutant in the SCS7 gene 
displays glycerophospholipids which in their levels are almost identical to wild type 
conditions (Fig. 3.2D & E, left panels). Ions at m/z 936 and 952, which are shown in the 
differential profile, stem from abundant sphingolipid species (see also Fig. 3.2D & E, 
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right panels). SCS7 encodes for sphingolipid alpha hydroxylase, an enzyme involved in 
the generation of monohydroxylated inositol ceramides (Dunn et al., 1998;Haak et al., 
1997). In case SCS7 contributes in a major way to sphingolipid hydroxylation one would 
expect dramatic differences in sphingolipid species. This is indeed revealed 
experimentally. The levels of hydroxylated ceramides and mannosylated ceramides are 
drastically reduced in the mutant (Fig. 3.2D & E, right panels). This is mirrored with 
almost identical concomitant increases in the ‘B’ series for ceramide species, i.e. those 
ceramides which do not carry a hydroxyl group on the fatty-acyl chain (Fig. 3.5 & 3.6D).  
 
The above results demonstrate the power of comparative single stage analysis of 
complex lipid mixtures. The mass of glycerophospholipids and sphingolipids, including 
their mannosylated derivatives, is calculated based on chemical composition (Section 
3.3.1; Supplementary material 3.1) (Wenk and De Camilli, 2005;Marsh, 1990), leading to 
a large array of theoretical lipid species, of which 5-10% are found in typical yeast 
extracts. Such a combined experimental and theoretical approach is an excellent tool for 
discovery of unexpected changes in lipid levels and lipid species. It also sets the ground 
for subsequent targeted quantification of lipids of interest.  
 
3.3.4 Targeted quantification of yeast sphingolipids by multiple-reaction 
monitoring 
Multiple-reaction monitoring (MRM) is a highly selective and sensitive (though 
biased) way for quantification of small molecules in complex mixtures. It requires 
information of specific fragments as well as pertinent internal standards. The method is 
based on monitoring of specific parent ion/fragment ion pairs which are filtered in the 
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two quadrupoles of a tandem mass spectrometer. Based on the tandem MS profiles of all 
major yeast sphingolipids in the positive ion mode, the phytoceramides and the inositol 
sphingolipids share a common fragment derived from the sphingoid base. Precursor ion 
or neutral loss scans of sphingoid base fragments were used to obtain information on 
yeast sphingolipid compositions. Based on this information, a comprehensive list of 
MRM transitions (parent → sphingoid base fragment transitions) was set up to follow 
sphingolipid compositions. The signal intensity of each MRM value was normalized to 
the intensity of the C19 ceramide internal standard, which was spiked according to the 
starting amount of material, and therefore normalized value represents the relative 
quantity of each lipid species (note absolute quantity could not be obtained due to a lack 
of pertinent standards for yeast sphingolipids). Figure 3.5 contains the MRM pairs of 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.5 Sphingolipid pathway of S. cerevisiae and molecular species of lipids covered in this study.  
The table summarizes the precursor/product pairs, declustering potential (DP) and collision energies (CE) 
used for multiple-reaction monitoring (MRM) quantification of yeast sphingolipids. Results obtained using 
this method for two yeast mutants, slc1Δ and scs7Δ are shown in Figure 3.6. 
 
Multiple-reaction monitoring (MRM) was employed quantify changes in 
sphingolipids in slc1Δ and scs7Δ (Fig. 3.6). Although the detection and characterisation 
of M(IP)2C is reported, its quantification is excluded due to the presence of both a singly 
and doubly charged ions under the experimental condition used (Guan and Wenk, 2008). 
In addition, lipid standards with similar chemistry of the analytes are required for 
absolute quantification. However, there is currently no such standards available for 
inositol sphingolipids. In this study, a synthetic C19 ceramide standard was used as the 
reference standard for relative quantification of all sphingolipids measured. Nevertheless, 
note the generally good agreement between this full quantitative analysis and the semi-







































































































































































































































































Figure 3.6 Sphingolipid levels slc1Δ and scs7Δ relative to a wild type strain using MRM 
quantification.  
(A) and (B) show the ion response (in MRM quantification mode, see also Figure 3.5) for increasing 
amounts of t18:0 phytosphingosine and t18:0/18:0 phytoceramide standards, respectively. Comparison of 
sphingolipid molecular species in wild type (hatched bars), slc1Δ (C, open bars) and scs7Δ (D, open bars). 
Data are presented as means ± SEM of four independent experiments. Statistical significance between wild 




In this Chapter, I described a novel mass spectrometry-based approach for 
screening of lipid metabolites in the yeast S. cerevisiae, with a focus on 
glycerophospholipids and sphingolipids. Using a rather simple extraction protocol it is 
possible to obtain semi-quantitative information of overall changes in lipid levels (Fig. 
3.2) as well as fully quantitative levels of a large number of lipids in the sphingolipid 
pathway, including mannosylated inositol ceramides (Fig. 3.6). While full automation is 
difficult to achieve for liquid/liquid extraction, it is now feasible to analyse ~100 strains 
per day of mass spectrometry time. Extraction of yeast cells typically requires 6 hours 
including incubation and drying steps. It thus will be possible to screen libraries of 
mutant yeast strains for discovery of mutants with defects in certain aspects of 
glycerophospholipid and sphingolipid metabolism.  
 
A major advantage of this method is that it is does not require metabolic labelling 
(e.g. use of radioactive precursors), and sample preparation and cleanup is minimal. The 
method is robust and directly measures mass levels of these lipids. It can thus be used as 
a discovery tool in many applications ranging from experiments which address basic 
molecular mechanisms of membrane traffic (Odorizzi et al., 2000;Simonsen et al., 
2001;Huijbregts et al., 2000), to screening of (chemo)genetic libraries (Zewail et al., 
2003). In fact, a major motivation for the establishment of conditions which allow 
parallel determination of glycerophospholipids and sphingolipids in yeast is the aim to 
screen existing libraries, such as the EUROSCARF collection of (non-essential) deletion 
strains. It can be anticipated that careful examination of glycerophospholipid and 
sphingolipid profiles of yeast strains involved in sphingolipid biosynthesis (and 
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metabolism) will yield new insights into the crosstalk between these two classes of lipids. 
Indeed, there is a growing body of evidence which suggests that sphingolipid and 
glycerophosphoinositol lipid metabolism are functionally interconnected (Huijbregts et 
al., 2000;Kearns et al., 1998;Lester et al., 1993;Dickson et al., 1990;Nagiec et al., 2003). 
slc1-1, in absence of LCB, produces inositol-containing glycerophospholipids which can 
rescue the growth phenotype otherwise observed (Lester et al., 1993). 
 
An important ‘by-product’ of the results presented here is a better understanding 
of possibly non-essential lipids that are able to support growth despite alterations in their 
levels. The scs7Δ deletion strain for example is able to grow (in YPD) yet displays 
alterations is both glycerophospholipid and sphingolipid levels which range up to two 
fold. Indeed, deletion of SCS7 almost completely abolishes the ‘C series’ of inositol 
ceramides (Fig. 3.6D). Overlay of genetic libraries with pharmacological treatments 
offers enormous potential for identification of pathways which are required for a 
functional condition, such as sensitivity to wortmannin (Zewail et al., 2003), calcium 
(Ohya et al., 1986), heat shock (Ferguson-Yankey et al., 2002;Jenkins et al., 1997) or 
control of cell growth (Kunz et al., 1993). It will be interesting for example to use this 
method to analyse the precise lipid inventory of the strains used in this study when grown 
under calcium stress and in the absence of LCB precursors, rather than growth under 
fully permissive conditions (Dunn et al., 1998). This could lead to the discovery of lipid 
entities which are closely correlated with the calcium phenotype and which would yield 
important molecular information of mechanisms of action. 
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Glycerophospholipids and sphingolipids are two major classes of membrane 
lipids found in yeast. In the future, it will be important to include sterol and non-polar 
lipids, such as diacylglycerols and triacylglycerols, in screens such as the one presented 
here. However, this will likely require different modes of ionisation (such as atmospheric 
chemical pressure ionisation) as well as additional extraction procedures as these lipids 
are much more non-polar than glycerophospholipids and sphingolipids.  
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Chapter 4. A Combined Genetics and Biochemical Approach to 
Explore the Functional Interactions between Sphingolipids and 
Sterols in Biological Membranes3 
                                                 
3 The work described in this Chapter is presented in the following manuscript : 
Guan XL, Souza CM, Pichler H, Dewhurst G, Schaad O, Kajiwara K, Wakabayashi H, 
Ivanova T, Castillon GA, Piccolis M, Abe F, Loewith R, Funato K, Wenk MR and 
Riezman H. Functional interactions between sphingolipids and sterols regulating cell 





Sterols are major plasma membrane components of most eukaryotic membranes, 
although their precise structure differs between the kingdoms; animals contain 
cholesterol, plants have sitosterol, campesterol and stigmasterol, whereas fungi use 
mainly ergosterol. The plant and yeast sterols both differ from cholesterol in their side 
chain and yeast sterols also have an extra double bond in the B ring. As sterols appear 
only in eukaryotes, it is likely that they confer properties to membranes or provide 
functions that may not be required in prokaryotes and possibly not even in all eukaryotes 
(Matyash et al., 2004). Cholesterol has been shown to modulate membrane thickness in 
artificial membranes and this property has been proposed to play a role in membrane 
protein localisation in vivo (Bretscher and Munro, 1993) although an alternative 
explanation for the control of membrane thickness has been postulated (Mitra et al., 
2004). Recently it has been shown that proteins and lipids do not freely diffuse over the 
entire surface of the cell and it has been proposed that eukaryotic plasma membranes 
contain micro/nanodomains (for review see (Jacobson et al., 2007;Kusumi et al., 
2005;Simons and Ikonen, 1997), commonly called rafts, that act as platforms creating 
membrane heterogeneities with many proposed functions. There are two basic tenets of 
the raft hypothesis; one that sterols and sphingolipids interact specifically in biological 
membranes and second, that their interaction causes an increase in membrane order that 
affects protein function, diffusion, and/or localisation.  
 
There is clear biophysical evidence that sterols and sphingolipids can segregate 
from other lipids in simple artificial membrane systems to form liquid ordered domains 
(Ahmed et al., 1997). Sterol partitioning experiments between membranes in vitro also 
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suggest that they have affinity for membranes with a high content of sphingolipids 
(Wattenberg and Silbert, 1983). Sterols have been shown to have a condensing affect on 
artificial membranes (Radhakrishnan and McConnell, 2005) and sterol sphingomyelin 
condensed complexes have been characterised (Radhakrishnan et al., 2001). Some 
evidence exists in yeast suggesting a genetic interaction between mutants in sterol and 
sphingolipid biosynthesis (Baudry et al., 2001;Eisenkolb et al., 2002;Jin et al., 2008), 
however, little, if any, convincing evidence exists to show that these two lipid species 
function together in complex biological membranes. Sterols and sphingolipids are 
concomitantly affected in certain diseases. In Niemann Pick disease, although the 
primary defect is not yet completely certain, defects in sphingolipid and cholesterol 
trafficking seemed to be interdependent (Pagano et al., 2000;Puri et al., 1999;Vance, 
2006). One of the proposed functions of amyloid beta and presenilin is in control of 
sphingomyelin and cholesterol amounts in the brain (Grimm et al., 2005), which could 
affect the ontology of Alzheimer’s disease. Sphingolipid depletion has also been shown 
to influence the sterol response element binding protein (SREBP) pathway, controlling 
cholesterol and lipid biosynthesis (Scheek et al., 1997). 
 
In Chapter 3, a mass spectrometry-based approach to profile lipids from 
minimally processed organic extracts of S. cerevisiae was described. In this study, I 
extend the application of the methodology, in combination with genetics to study yeast 
mutants in sterol biosynthesis. This systematic analysis provides evidence that yeast cells 
have a mechanism to respond to the presence of specific sterol structures in their 
membranes and adjust their sphingolipid composition accordingly. The genetic analysis 
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provides convincing evidence that sterols and sphingolipids function together in cells to 
carry out multiple functions.  Furthermore, the results suggest that sterol and sphingolipid 
structures have co-evolved to provide optimal interaction properties between the two 
lipid species. 
 
4.2 Materials and Methods 
4.2.1 Strain construction 
All mutants used in this study were obtained from Howard Riezman (University 
of Geneva, Switzerland), which were created using standard gene disruption procedures, 
with complete removal of open reading frames, in their strain background. Double 
mutants were obtained by genetic crosses. Strains are listed in Table 4.1.  
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Table 4.1 List of S. cerevisiae strains used in this study. 
Name Genotype 
RH448 MATa his4 ura3 lys2 leu2 bar1 
RH5812 MATa erg2::LEU2 his4 ura3 lys2 leu2 bar1 
RH4213 MATa erg3::LEU2 his4 ura3 lys2 leu2 bar1 
RH4217 MATa erg4::URA3 his4 ura3 lys2 leu2 bar1 
RH6969 MATa erg4::ura3 his4 ura3 lys2 leu2 bar1 
RH6774 MATa erg5::KanMx his4 ura3 lys2 leu2 bar1 
RH5684 MATa erg6::KanMx his4 ura3 lys2 leu2 bar1 
RH5912 MATa isc1::KanMx his4 ura3 lys2 leu2 bar1 
RH4348 MATa sur2::LEU2 his4 ura3 leu2 bar1 
RH4524 MATa scs7::LEU2 his4 ura3 leu2 bar1 
RH5913 MATa erg2::LEU2 isc1 ::KanMx his4 ura3 lys2 leu2 bar1 
RH5935 MATa erg3::LEU2 isc1 ::KanMx his4 ura3 lys2 leu2 bar1 
RH5916 MATa erg4::LEU2 isc1 ::KanMx his4 ura3 lys2 leu2 bar1 
RH5917 MATa erg5::LEU2 isc1 ::KanMx his4 ura3 lys2 leu2 bar1 
RH6787 MATa erg6::LEU2 isc1 ::KanMx his4 ura3 lys2 leu2 bar1 
RH5818 MATa erg3::LEU2 erg6::LEU2 isc1::KanMx his4 ura3 lys2 leu2 bar1 
RH6711 MATa erg2::LEU2 sur2::LEU2 his4 ura3 lys2 leu2 bar1 
RH6749 MATa erg3::LEU2 sur2::LEU2 his4 ura3 lys2 leu2 bar1 
RH6718 MATa erg4::URA3 sur2::LEU2 his4 ura3 lys2 leu2 bar1 
RH6915 MATa erg4::ura3 sur2::LEU2 his4 ura3 lys2 leu2 bar1 
RH6732 MATa erg5 ::KanMx sur2::LEU2 his4 ura3 lys2 leu2 bar1 
RH6744 MATa erg6 ::KanMx sur2::LEU2 his4 ura3 lys2 leu2 bar1 
RH6709 MATa erg2 ::LEU2 scs7 ::LEU2 his4 ura3 leu2 bar1 
RH6741 MATa erg3::LEU2 scs7::LEU2 his4 ura3 lys2 leu2 bar1 
RH6714 MATa erg4::URA3 scs7::LEU2 his4 ura3 lys2 leu2 bar1 
RH6916 MATa erg4::ura3 scs7::LEU2 his4 ura3 lys2 leu2 bar1 
RH6734 MATa erg5::KanMx scs7::LEU2 his4 ura3 lys2 leu2 bar1 
RH6752 MATa erg6::KanMx scs7::LEU2 his4 ura3 lys2 leu2 bar1 
RH5928 MATa erg2::LEU2 erg3::LEU2 his4 ura3 lys2 leu2 bar1 
RH5864 MATa erg2::LEU2 erg4::LEU2 his4 ura3 lys2 leu2 bar1 
RH5866 MATa erg2::LEU2 erg5::LEU2 his4 ura3 lys2 leu2 bar1 
RH3616 MATa erg2::URA3 erg6Δura3 leu2 bar1 
RH5868 MATa erg3::LEU2 erg4::LEU2 his4 ura3 lys2 leu2 bar1 
RH5871 MATa erg3::LEU2 erg5::LEU2 his4 ura3 lys2 leu2 bar1 
RH5930 MATa erg3::LEU2 erg6::LEU2 his4 ura3 lys2 leu2 bar1 
RH5873 MATa erg4::LEU2 erg5::LEU2 his4 ura3 lys2 leu2 bar1 
RH5874 MATa erg5::LEU2 erg6::LEU2 his4 ura3 lys2 leu2 bar1 
RH6971  Matα PDR12::CFP::HygB ura3 leu2 his4 lys2 bar1 
RH6926  Matα sur2::LEU2 PDR12::CFP::HygB ura3 leu2 his4 lys2 bar1 
RH6919  Matα erg4::URA3 PDR12::CFP::HygB ura3 leu2 his4 lys2 bar1 
RH6930  Matα erg4::URA3 isc1::KanMx PDR12::CFP::HygB ura3 leu2 his4 lys2 bar1 
RH6925  Matα erg4::URA3 sur2::LEU2 PDR12::CFP::HygB ura3 leu2 his4 lys2 bar1 
RH6922  Matα erg4::URA3 scs7::LEU2 PDR12::CFP::HygB ura3 leu2 his4 lys2 bar1 
 
4.2.2 Lipid standards 
All lipid standards were obtained from Avanti Polar Lipids (Alabaster, AL), with 
the exception of C19:0-Cer, which was obtained from Matreya Inc., (Pleasant Gap, PA) 
and diC8:0-GPIns, which was obtained from Echelon Biosciences (Salt Lake City, UT).  
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4.2.3 Cell culture for lipid analysis 
Cells were kept on YPUAD plates (1% yeast extract, 2% peptone, 2% glucose, 40 
mg/l uracil and adenine) and single colonies were cultured overnight in YPUAD medium. 
The cells were then diluted into fresh medium and cultured to mid-logarithmic (log) 
phase (OD600 1.0 – 1.5) for lipidomic analysis. 40 OD600 units of cells were harvested 
by centrifugation, washed with twice with water and frozen. 
 
4.2.4 Lipid extraction and analysis by ESI-MS and MS/MS 
Lipids were extracted from 40 OD600 units of cells as described in Chapter 3, but 
with the following modifications. 5μg of dimyristoyl GPCho (di14:0-GPCho), 20μg of 
dimyristoyl GPEtn (di14:0-GPEtn), 4μg of dioctyl GPIns (di8:0-GPIns), 15μg of 
didocosahexaenoyl GPSer (di22:6-GPSer) and 3μg of C19:0-Cer were added as internal 
standards.  
 
The two methods of targeted and non-targeted analysis by mass spectrometry as 
described in Chapter 3 were employed, with the following modifications. (i) Instead of 
using manual direct injection, a high performance liquid chromatography system (Agilent 
Technologies, Santa Clara, CA) was coupled to the mass spectrometer and samples were 
introduced into the mass spectrometer by loop injections with chloroform-methanol (1:1, 
v/v) as a mobile phase at a flow rate of 200μL/min. (ii) For targeted lipid quantification, 
in addition to the transitions for sphingolipids described in Chapter 3 (Fig. 3.5), 
additional transitions were set up for glycerophospholipids, based on the parent → 
headgroup fragment transitions. Lipid levels were calculated relative to relevant internal 
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standards as described in Section 3.2.4. Comparison of the means of wild type and 
individual genotypes from three independent experiments were performed. The quantities 
of lipids are expressed as ion intensities relative to wild type levels, converted to a log10 
scale, and represented as a heat plot.  
 
4.2.5 Growth and plating assays 
For the plating assays, yeast were grown to stationary phase, diluted to 107 cells 
per ml in water and 10 fold serial dilutions were pinned onto agar plates containing rich 
medium with additives adjusted to pH 5.5 (40 mM MES) unless indicated (in 
collaboration with Howard Riezman). Sorbic acid sensitivity was tested on agar plates 
containing rich medium adjusted to pH 4.5 and supplemented with 1mM of sorbic acid. 
Control plates contain rich medium adjusted to pH 4.5 without any supplements.  
 
4.2.6 Polymerase chain reaction (PCR)-based generation of yeast expressing 
cerulean fluorescent protein (CFP)-tagged Pdr12p 
4.2.6.1 PCR generation of CFP-tagged PDR12 cassette 
Our collaborator, Howard Riezman, had previously used cerulean (Rizzo et al., 
2004) (CFP) to fluorescently tag Pdr12p at the N-terminus, with hygromycin B (HygB) 
as a selection marker, in the genome of yeast using the plasmid pBS10 (YRC, Univ. 
Wash) and had generously provided genomic DNA isolated from cells tagged with 
PDR12::CFP::HygB.  The cassette for genomic tagging of PDR12::CFP::HygB was 
prepared by PCR, using the Expand High Fidelity PCR kit (Roche Applied Science, 
Germany), the forward primer - GCTTCAATATTGCCGCTATGTTGATTTG, the 
reverse primer - GATTCTATACATAAAACATTAGTGTG, and the genomic DNA as 
 87
the template. The thermocycling profile was as follows: initial denaturation at 94°C for 2 
minutes, followed by 9 cycles of denaturation at 92°C for 30s, annealing at 55°C for 45 
minutes, and primer extension at 68°C for 3 minutes. This was followed by another 18 
cycles of denaturation at 92°C for 30 seconds, annealing at 50°C for 30s, and primer 
extension at 68°C for 4 minutes and 20s. Final extension was then performed at 68°C for 
7 minutes.   The PCR product was analysed using agarose gel eletrophoresis. 
 
4.2.6.2 Transformation of yeast 
Transformation of S. cerevisiae was performed using lithium acetate. Briefly, 
cells were grown to mid-log phase in YPUAD in a 10mL culture. Cells were harvested by 
centrifugation at 5000g at 4°C for 5 minutes and the cell pellet was subsequently washed 
twice with 5mL of sterile deionised water. The cells were resuspended in 100μL of 
100mM lithium acetate and transferred into two Eppendorf tubes. The cells were pelleted 
in a microfuge for 15s and the supernatant was decanted. While preparing the cells, 
sheared salmon sperm carrier deoxyribonucleic acid (DNA) (10mg/mL stock) was boiled 
for 5 minutes and placed on ice for at least 2 minutes. To one tube of cells, the following 
reagents were added according to the order they are listed – 240μL of 50% polyethylene 
glycol, 36μL of 1.0M lithium acetate, 25μL of sheared salmon sperm DNA and 45μL of 
cassette (from PCR product obtained in Section 4.2.6.1). A control tube contains 
everything except the cassette. The samples were mixed and placed in a 30°C rotator for 
45 minutes. Heat shock was then performed in a 42°C water bath for 25 minutes. Cells 
were pelleted at 6000g for one minute and resuspended in 400μL of YPUAD media. The 
cells were then plated on two YPUAD plates and incubated at 30°C overnight. Replica 
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plating was performed the next day to the selective medium, YPUAD + 200μg/mL 
hygromycin (Hygromycin B from Streptomyces hygroscopicus, Roche) and incubated at 
30°C for two days. No cells from the control experiment should grow and for cells 
transformed with the DNA cassette, a few single colonies were picked and streaked on 
selective medium. 
 
4.2.6.3 Colony PCR 
Colony PCR was performed to check for proper integration of 
PDR12::CFP::HygB into the genome. Hygromycin B-resistant colonies were selected 
and added to separate tubes containing 50µL of 5mg/mL 20T zymolyase. The samples 
were incubated at 35oC for 30 minutes, followed by centrifugation for 5 minutes at 
5000rpm. The supernatant was removed and the pellets were allowed to dry by 
incubating at 92°C for 5 minutes with caps open. PCR was carried out using ThermoPol 
polymerase (New England Biolabs Inc., USA), the same set of forward primers and 
reverse primers for the cassette, in a 25μL reaction. The thermocycling profile was as 
follows: initial denaturation at 94°C for 2 minutes, followed by 9 cycles of denaturation 
at 92°C for 30 seconds, annealing at 50°C for 30 minutes, and primer extension at 70°C 
for 3 minutes and 30s. This was followed by another 18 cycles of denaturation at 92°C 
for 30 seconds, annealing at 50°C for 30s, and primer extension at 68°C for 3 minutes 
and 20s. Final extension was then performed at 68°C for 7 minutes.   The PCR product 
was analysed using agarose gel eletrophoresis. Sorbic acid sensitivity was reassessed for 
the strains successfully tagged with PDR12::CFP::HygB (Fig. 4.5A).  
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4.2.7 Sorbic acid treatment and localization of Pdr12p in cells 
Pdr12p-CFP expressing cells were kept on YPUAD plates and single colonies 
were cultured overnight in YPUAD medium.  The cells were inoculated in fresh YPUAD 
medium and cultured till they reach log phase (OD600~0.5-0.8).Cells were washed with 
deionised water and resuspended in YPUAD, pH 4.5 containing 0.25mM of sorbic acid 
(in ethanol). A control set was resuspended in YPUAD, pH 4.5 with ethanol. The cells 
were incubated at 30°C for three hours to induce Pdr12p expression and localisation to 
the plasma membrane. Cells were washed with synthetic defined (SD) media and 
resuspended in 30 to 50 μL of synthetic defined media containing 10mM HEPES and 
viewed under an Axio Imager Z1 fluorescence microscope.  
 
4.2.8 Assay of Pdr12p activity by efflux of fluorescein diacetate (FDA) 
Pdr12p activity was assayed by monitoring the efflux of FDA as described by 
Holyoak and co-workers (Holyoak et al., 1999), with some modifications. Cells were 
grown in YPUAD media to early log phase and incubated with 0.25mM sorbic acid, pH 
4.5, for 3 hours to induce Pdr12p. After washing 3 times with water, 107 cells per time 
point were resuspended in 1mL of 50 mM HEPES-NaOH, pH 7.0 containing 5mM 2- 
deoxyglucose and 50μM FDA and were shaken at 30°C for 1 hour. Starved cells were 
washed twice with HEPES-NaOH, pH 7.0, resuspended in the same buffer, split into 
equal aliquots and incubated for 5 minutes at 30°C before the addition of glucose to one 
of the samples. Aliquots were harvested over a time course of 2.5, 5, 10 and 15 minutes 
and cells were pelleted. The supernatant was collected and FDA fluorescence was 
measured with a spectrofluorometer (SpectraMax Gemini EM, Molecular Devices, 
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Sunnyvale, CA) using an excitation wavelength of 435nm and an emission wavelength of 
525nm. The difference in fluorescence between the samples containing glucose and the 
starved cells represents the energy-dependent efflux of FDA.  
 
4.2.9 Statistical Analysis 
For the lipid analysis, the difference in levels of individual lipid species between 
wild type and individual genotypes was determined statistically using the Kruskal Wallis 
test, which is indicated by an asterisk for p-value less than 0.05 (*). 
 
For FDA efflux assay, comparison of the wild type and mutant strains was 
performed using the mean of at least 4 independent samples ± standard error of the mean 
(SEM) from individual samples. Statistical significance between wild type and mutant 




4.3.1 Mutants of sterol biosynthesis display altered lipids profiles 
Although the last five steps of ergosterol synthesis is non-essential in S. cerevisiae 
(Fig. 4.1 and Table 4.1), deletion of the genes lead to a wide variety of phenotypes. The 
Riezman laboratory has previously created an isogenic set of single and double mutants 
in ergosterol biosynthesis and have characterised them for their sterol compositions and 
endocytic phenotypes (Munn et al., 1999;Heese-Peck et al., 2002). In addition, it was 
observed that one of the double deletion mutants, erg3Δerg6Δ, which has a substantial 
growth defect, showed changes in its sphingolipid metabolism (Supplementary material 
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4.2) and that this change could be reversed by mutation of the yeast sphingomyelinase 
homolog (Sawai et al., 2000) encoded by ISC1 (Fig. 4.1). The mutation in ISC1 
aggravated the growth defect of the erg3Δerg6Δ double mutant at 37°C (Supplementary 
material 4.2). Swain and co-workers isolated a single mutant, erg26-1 and further 
characterised sphingolipid metabolism in this mutant (Baudry et al., 2001;Swain et al., 
2002). Together, these suggest an interaction between sterols and sphingolipids, but these 
particular cases might not be representative. Therefore, the lipid composition of all the 
erg deletion mutants were systematically analyzed using electrospray ionisation-mass 
spectrometry (ESI-MS), based primarily on the method described in Chapter 3. In 
addition to major yeast sphingolipids, the targeted analysis by MRM was extended to 
include both the quantification of the major glycerophospholipids (except for 
cardiolipin). Quantification was carried out and is expressed relative to wild type cells, as 
presented in Figure 4.2. Results on mannosyl diinositolphosphorylceramide (M(IP)2C) 
was not presented because the data were not easily interpretable due to the presence of 
singly and doubly charged species (Guan and Wenk, 2008), together with the fact that no 
good internal standard was available. By steady state phosphate labelling and TLC 
analysis, M(IP)2C represents less than 20% of the total sphingolipids in S. cerevisiae 





















































Figure 4.1 Structures of some abundant sphingolipid, sterol and glycerophospholipid species in 
Saccharomyces cerevisiae.   
Isc1p is an inositolphosphorylceramide (IPC) hydrolase that converts IPC to ceramide and inositol 
phosphate. Sur2p and Scs7p are enzymes responsible for hydroxylation of the sphingoid base and fatty 
acid, respectively, of sphingolipids.  The last five steps of ergosterol biosynthesis are shown. The order of 
events is not implied here. For comparison, one of the most abundant yeast glycerophospholipids, 34:1 
glycerophosphoinositol (GPIns) is shown. For details, see Supplementary material 4.1. 
 
The single erg deletion mutants showed substantial changes (>30%) in less than 
10% of their glycerophospholipid species, but showed substantial changes in over 45% of 
their sphingolipid species. Consistent trends were obtained based on unbiased profiling 
(data not shown). Remarkably, the sphingolipid pattern found in each single erg deletion 
mutant was different. Therefore, the changes cannot be due to a lack of ergosterol 
because none of the mutant strains have ergosterol, but to the presence of the abnormal 
sterols, for which the composition is different between the different mutants. This 
astounding result implies that the yeast cells have the capacity to modify their 
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sphingolipid composition in response to changes in sterol structures in their membranes. 
Double deletion mutants in ergosterol biosynthesis have substantial changes in their 
sphingolipid pattern, but also have substantially more changes in their 
glycerophospholipids (Fig. 4.2). The single erg6Δ mutant appears somewhat intermediate 
in its lipid pattern between the single and double erg mutants. This is probably due to the 
fact that the ERG2 gene product works very inefficiently in the erg6Δ mutant strain as 
noted by the accumulation of sterols with a double bond at position 8 (Heese-Peck et al., 
2002) (H. Riezman, Supplementary Table 4.1E) explaining why the erg6Δ mutant has 
partial properties of a double erg2Δerg6Δ mutant. Consistent with the radioactive 
labelling experiments, most of the double deletion mutants as well as the erg2Δ and 
erg6Δ single deletion mutant strains have less of the major IPC species, IPC-C. 
Otherwise, the patterns of sphingolipid prevalence vary considerably. Interestingly, when 
mutations in sphingolipid hydroxylation or head group turnover are introduced, there are 
no major changes in sterol compositions or quantities (H. Riezman, Supplementary Table 
4.1A). Most double erg deletion mutants show more substantial changes in their 
sphingolipid patterns than either of the corresponding single erg deletion mutants. There 
is one notable exception to this, the erg5Δerg6Δ mutant, whose sphingolipid pattern is 
closer to wild type than either of the two single mutants. This might have evolutionary 
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Figure 4.2 Glycerophospholipidome and sphingolipidome of deletion mutants in ergosterol 
biosynthesis.  
Isogenic wild type and ergosterol mutant strains were grown as indicated. Lipid standards were added to 40 
OD600-equivalents of cells and lipids were extracted and measured using ESI-MS (Guan and Wenk, 2006). 
The quantities of lipids are expressed as ion intensities relative to wild type levels, converted to a log10 
scale. Glycerophospholipids: GPCho, glycerophosphocholine; GPEtn, glycerophosphoethanolamine; 
GPIns, glycerophosphoinositol; GPSer, glycerophosphoserine. Sphingolipids: IPC, 
inositolphosphorylceramide; MIPC, mannosyl inositolphosphorylceramide. The suffixes -B, -C, and -D on 
IPC and MIPC denote hydroxylation states, having two, three, or four hydroxyl groups respectively. Data 
are presented as means of 3 independent biological samples. Statistical significance between wild type and 
individual genotypes was determined using the Kruskal Wallis test. * denotes significance P<0.05. 
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4.3.2 Sterol and sphingolipid biosynthesis pathways interact genetically 
The specificity of the sphingolipid patterns in the different single erg deletion 
mutants suggests that these changes may be an adaptive response and led to the 
hypothesis that sterols and sphingolipids functionally interact in yeast cells. To test this 
hypothesis, isogenic double deletion mutants in sterol and sphingolipid biosynthesis were 
generated. The prediction is that simultaneous defects in both pathways should lead to 
synthetic phenotypes. Most of the changes seen in sphingolipid patterns (Fig. 4.2) are 
changes in sphingolipid hydroxylation or in head group composition. Therefore, a mutant 
that affects sphingolipid head group turnover, isc1Δ, and mutants affecting sphingolipid 
hydroxylation were chosen. The sur2Δ mutant is unable to hydroxylate the sphingoid 
base and the scs7Δ mutant is defective in hydroxylation of the fatty acid on sphingolipids 
(See Fig. 4.1 and Supplementary material 4.1) (Haak et al., 1997). All 15 possible double 
mutant combinations of the 5 single erg mutants with the 3 mutants affecting 
sphingolipid metabolism were constructed and analysed for their ability to grow under a 
number of conditions. All of the single erg deletion mutants, with or without sphingolipid 
defects, grew well at 30°C on rich medium, as do all of the double erg deletion mutants 
except erg2Δerg6Δ (Fig. 4.3). At 37°C or on plates with non-fermentable carbon sources, 
several double mutants showed reduced growth when compared to the corresponding 
single mutants (marked with arrows). It was observed that the double erg deletion 
mutants often had more severe phenotypes than the single erg deletion mutants from 


















































Figure 4.3 Systematic phenotype analysis. 
The indicated strains were grown and pinned onto YPUAD or YPEG (1% Yeast Extract, 2% Peptone, 3% 
ethanol, 3% glycerol, 40mM MES, pH 5.5) plates and grown at 30°C except when indicated. Plates were 
photographed after 2 (30°C and 37°C) or 4 days (YPEG). Arrows denote conditions where sterol-
sphingolipid double deletion mutants showed different growth than the single erg deletion mutants under 
the conditions shown. Each asterisk represents where the double mutant shows a change in growth 
properties (synthetic growth defect or suppression) when compared to the single erg deletion mutant 
(Supplementary material 4.3). Of the 15 double deletion mutants constructed, 13 showed synthetic 
phenotypes (CM Souza and H Riezman).  
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Growth under a wide variety of conditions was assayed in order to uncover new 
phenotypes (Supplementary material 4.3). Some particularly illustrative examples from 
these assays are shown (Fig. 4.4). Blocking hydroxylation of either the sphingoid base or 
the fatty acid of sphingolipids is able to suppress the slow growth phenotype of the erg2Δ 
mutant at 16°C (Fig. 4.4A). The results found at 16°C are quite atypical, because changes 
in hydroxylation usually have much more specific effects on strains with aberrant sterols 
(Fig. 4.4B). Combination of a mutation in sphingolipid fatty acid hydroxylation (scs7) 
with the erg2Δ mutation completely abrogates growth on plates with low amounts of 
caffeine, an inhibitor of the Target of Rapamycin Complex (TORC) 1 signalling pathway 
(Reinke et al., 2006), whereas both corresponding single mutants grow well on caffeine 
plates. A similar result was found for sensitivity to rapamycin. Combination of sur2 
deletion with erg3 or erg6 deletion led to synthetic growth phenotypes on plates with a 
low concentration of a glycosylphosphatidylinositol synthesis inhibitor, YW3548 
(Sutterlin et al., 1997) or a low concentration of sodium dodecyl sulfate (SDS) (Fig. 
4.4C), respectively, both expected to induce cell wall defects. The specificity of the site 
of hydroxylation in combination with particular sterol biosynthesis mutations suggests 
that it is the combination of the structures that leads to the synthetic phenotype. The 
simplest way to interpret this would be to postulate that sphingolipids and sterols interact 
physically in membranes to carry out some of their required functions. At the very least, 


























































Figure 4.4 Examples of suppression and synthetic phenotypes.   
Dilutions of indicated strains were spotted onto plates  (A) containing the following additions; 1mM sorbic 
acid (C), 2mM caffeine (B),  1μg/mL YW3548 (B), or 0.01% sodium dodecyl sulfate (SDS) (B). The 
sorbic acid plates were adjusted to pH 4.5 (CM Souza and H Riezman). 
 
Sorbic acid resistance is conferred by an adenosine trisphosphate (ATP) binding 
cassette (ABC) transporter, Pdr12p (Piper et al., 1998), which exports weak acids like 
sorbic and benzoic acids. This process is most affected by the erg3 and erg6 mutations 
(Supplementary material 4.3), suggesting that a Δ5 double bond in the B-ring and 
methylation of the side chain of ergosterol are the most important features for Pdr12p 
function. The erg4Δ mutant strain grows weakly on 1mM sorbic acid plates, but 
combination with the sur2 mutation completely abrogates growth (Fig. 4.4D). 
Introduction of the isc1 mutation improves growth slightly under the same conditions. 
The effects of sphingolipid changes on the erg5Δ mutant are quite different. The sur2 and 
scs7 mutations have almost no effect on growth of erg5 mutant cells on sorbic acid 
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plates, whereas introduction of the isc1 mutation completely blocks growth under the 
same conditions. These data show that the isc1 mutation is not having a simple positive 
or negative effect that is added to the effect of the sterol mutant. These results further 
confirm that it is the specific combinations of sphingolipid and sterol structures that lead 
to the synthetic phenotypes.  
 
By using very simple tests, synthetic phenotypes in 13 of the 15 possible double 
mutants in ergosterol and sphingolipid biosynthesis was found (Fig. 4.3), providing 
genetic proof that these two pathways work together in multiple cellular functions. A 
possible explanation for the genetic interaction could be that creation of the double 
mutants causes additional changes in glycerophospholipids and/or sterols. To examine 
this, the glycerophospholipids and sphingolipids in the double mutant strains were 
analyzed by ESI-MS (Supplementary material 4.4) and the sterol composition measured 
by gas chromatography mass spectrometry (in collaboration with H. Riezman, 
Supplementary Table 4.1). As expected from the introduction of mutations in 
sphingolipid modification, dramatic changes in the sphingolipid pattern, but relatively 
minor changes in the glycerophospholipids or sterols (Supplementary material 4.4 and 
Supplementary Table 4.1) were observed, lending additional support to the conclusion 
that it is the structural interactions between the aberrant sterols and sphingolipids that 




4.3.3 Cellular sterol and sphingolipid compositions affect the activity of membrane 
transporter, Pdr12p 
Based on our phenotypic assay, it was observed that erg4 mutant grows weakly 
on 1mM sorbic acid.  Interestingly combination of erg4 with the sur2 mutation, but not 
scs7 mutation, completely abrogates growth while combination of either sur2 or scs7 
mutation has no effect on the erg5Δ mutant (Fig. 4.4). Sorbic acid is a commonly used 
food preservative that diffuses into cells when protonated at low pH and is trapped 
internally when it becomes deprotonated. It can be detoxified by yeast cells via the ABC 
transporter, Pdr12p (Piper et al., 1998) in an ATP-dependent manner. A likely molecular 
explanation for the lack of growth under these conditions is a defect in detoxification of 
sorbic acid. It is hypothesised that PDR12p function is altered by specific combinations 
of defects in sphingolipid and sterol structures. Therefore, the function of PDR12p, in 
terms of its localisation and activity, in the various ergosterol and sphingolipid mutants 















































































Figure 4.5 Sorbic acid sensitivity in erg4Δsur2Δ is due to defective export by Pdr12p. 
 (A) Assessment of sorbic acid sensitivity of PDR12::CFP::HygB-integrated strains. (B) Pdr12p-CFP 
induction and localisation in the absence and presence of sorbic acid were visualized in the indicated 
strains. (C) Strains without genomic integration of PDR12::CFP::HygB were loaded with fluorescein 
diacetate (FDA) in the presence of 2-deoxygluose to deplete ATP. The cells were harvested and 
resuspended in glucose containing medium and extracellular fluorescein was quantified after 15 and 30 
seconds. Relative rates of FDA export per minute are shown. Statistical significance between wild type and 
mutant strains was determined using Student’s t-test. **p<0.05. 
 
In order to examine Pdr12p induction and localisation, a functional, fluorescently 
labeled Pdr12p was constructed using C-terminal genomic fusion of PDR12 with 
cerulean fluorescent protein (CFP). Sorbic acid induces Pdr12p expression and the 
protein is delivered to the cell surface (Piper et al., 1998) where it exports weak organic 
acids, including sorbic and benzoic acids as well as fluorescein (Holyoak et al., 1999). In 
wild type, erg4Δ, sur2Δ and erg4Δ sur2Δ mutants, expression of Pdr12p-CFP was 
induced and the protein is transported to the cell surface normally (Fig. 4.5B). Indeed, the 
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induction and localisation of Pdr12p in other sorbic acid sensitive strains, such as erg3Δ 
mutant, was also normal. Pdr12p activity was measured based on the export of 
fluorescein. Fluorescein diacetate (FDA) was loaded into yeast in the absence of glucose. 
Glucose was added to allow fluorescein export. The double erg4Δsur2Δ mutant showed 
drastically reduced fluorescein export (Fig. 4.5C). No observed difference in the 
transcript levels of PDR12 in the double mutant was observed (H. Riezman, 
Supplementary material 4.5B). These results show that the Pdr12p is properly expressed 
and transported to the cell surface, but is not active if membranes lack functional 
sterol/sphingolipid structures.  
 
4.4 Discussion 
4.4.1 Dependence of sphingolipid metabolism on sterol composition 
One of the major new findings emanating from this study is that cells have a 
mechanism to sense and react to changes in their membrane sterol composition by 
modifying their membrane lipid compositions affecting mainly sphingolipids. The 
mechanism of the adaptation of sphingolipid levels is not clear, but is most likely not 
uniquely due to differences in transcript levels of the different genes involved in the 
pathway as most of the genes were unchanged (H. Riezman, data not shown). The 
mechanism used to detect the changes in sterol composition is currently under study and 
genetic approaches are possible. It is not the absence of ergosterol that is sensed, because 
each erg deletion mutant shows a different pattern of sphingolipids. This pathway is most 
likely fundamentally different than previously described sterol sensing mechanisms 
where different amounts of cholesterol are sensed by the SREBP pathway or other sterol 
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sensors and then control gene expression (Goldstein et al., 2006), because sterol 
intermediates, rather than the total quantity of sterols, seem to affect sphingolipid 
composition in different ways. Recently, an SREBP dependent pathway has been 
described in Schizosaccharomyces pombe, which has several features in common with 
what is observed in this study, because there is a coordinate regulation of anaerobically 
expressed genes with ergosterol biosynthesis genes (Todd et al., 2006) (Supplementary 
material 4.5) and because sterol biosynthesis intermediates seem to be important (Hughes 
et al., 2007), but no specific effects on sphingolipids have been described. The pathway 
cannot be identical in S. cerevisiae because this yeast does not have an SREBP homolog, 
although they do have oxysterol binding proteins that have been proposed to be involved 
in intracellular sterol transport (Raychaudhuri et al., 2006).  
 
The control of sphingolipid species is unlikely to be solely the result of 
transcriptional changes as few differences in sphingolipid metabolic enzymes were seen. 
In some strains, some changes in sphingolipid content are likely to be due to head group 
turnover via Isc1p (Supplementary material 4.2). The mode of activation of Isc1p in this 
case is unknown, but one possibility is regulation by localisation because its localisation 
has been shown to change due to changes in culture conditions in yeast (Vaena de et al., 
2004). 
 
The specific and major changes in sphingolipid species when sterol intermediates 
are present in the membrane show a dependence of sphingolipid metabolism on sterol 
composition, but also suggest that sterols and sphingolipids function together. In this 
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work, the genetic analysis of double deletion mutants in sterol and sphingolipid 
metabolism, which uncovered a large number of synthetic and suppression phenotypes, 
provides proof for this concept. Synthetic phenotypes can occur for different reasons; 
when there are two parallel pathways and one mutation is in each pathway or when two 
mutations affect the same pathway, quite often at the same step. Each mutation would 
affect the step partially, but the double mutant would have a much stronger phenotype. 
Classically, this can result when two proteins work together as a complex. In a similar 
manner it is possible to interpret our data by suggesting that sterols and sphingolipids 
might function in a variety of pathways as a sterol-sphingolipid complex.  
 
4.4.2 Functional interactions between sterols and sphingolipids is required for 
cellular physiology 
Many different phenotypes, including growth in presence of cell wall 
disturbances, weak organic acid sensitivity, different carbon sources, temperatures, 
various classes of inhibitors affecting a number of different pathways were tested (in 
collaboration with H. Riezman, Fig. 4.3, 4.4 and Supplementary material 4.3). In 
addition, a systematic analysis of transcript levels was performed (H. Riezman, 
Supplementary material 4.5A). It is virtually impossible that sterols and sphingolipids 
happen to act in parallel pathways to carry out each of these functions where synthetic 
phenotypes have been uncovered. Therefore, it can be concluded that sterols and 
sphingolipids function together to carry out a wide variety of cellular functions. The 
conclusion that sterols and sphingolipids function together fulfils one of the tenets of the 
(lipid) raft hypothesis. The other main tenet of the raft hypothesis is that the increased 
order produced by sterol-sphingolipid interactions is important for function. To begin to 
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test this, plasma membrane anisotropy, an indicator of membrane order, was measured 
(H. Riezman, Supplementary Table 4.2). Even though there were substantial and 
significant differences in anisotropy indicating a decrease in membrane order in several 
of the mutants, there was a lack of correlation between the measurements of membrane 
anisotropy with any of the phenotypes assayed. Therefore it is concluded that membrane 
order is not likely to have a great influence on the functions that were examined. 
Therefore, while these results strongly support one tenet of the raft hypothesis, the overall 
hypothesis does not seem useful to interpret our data.  
 
4.4.3 Sterol and sphingolipid dependence for protein localisation 
The raft hypothesis has been invoked to explain a large number of membrane 
trafficking events, which prompted the examination of the localisation of two plasma 
membrane proteins that have been shown to be localised in microdomains of the plasma 
membrane. One of the best established systems where proteins have been localized to 
specific plasma membrane microdomains is in Saccharomyces cerevisiae, where two 
distinct types of domains have been seen. One of these is patches of approximately 300 
nm on the cell surface that contain the various permeases, including the tryptophan 
transporter Tat2p and the arginine transporter, Can1p. Both transporters have been 
reported to be resistant to cold-detergent extraction, a technique that is often correlated 
with presence in rafts (Malinska et al., 2004;Malinska et al., 2003;Mayor and Riezman, 
2004;Umebayashi and Nakano, 2003). The permease-containing plasma membrane 
patches also stain for filipin indicating the presence of ergosterol (Malinska et al., 
2004;Malinska et al., 2003). The permease-containing patches are surrounded by 
membrane domains containing the plasma membrane ATPase, Pma1p, a protein that has 
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also been claimed to be functionally associated with rafts for biosynthetic delivery to the 
cell surface (Bagnat et al., 2000;Bagnat and Simons, 2002). To test further phenotypes of 
our single and double mutants, the localisation of green fluorescent protein- (GFP-) 
tagged Tat2p and Can1p, proteins found in the same domains at the cell surface,  was 
analysed (H. Riezman, Supplementary material 4.6). In wild type cells under the 
conditions tested, Tat2p is found in approximately equal amounts in the plasma 
membrane and in the vacuole. The vacuolar Tat2p may be generated by direct targeting 
from the biosynthetic pathway or via delivery to the cell surface and subsequent 
endocytosis.  
 
To compare the mutants, cell surface and vacuolar Tat2-GFP were quantified. The 
single erg deletion mutants as well as isc1Δ and sur2Δ increased the amount of Tat2-GFP 
in the vacuole and several strains showed slight ER accumulation (Supplementary 
material 4.6 and Supplementary Table 4.3). The increase in vacuole localisation in the 
erg3Δ mutant is partially suppressed by the scs7 mutation, whereas the increase in 
vacuolar localisation in the erg6Δ mutant is enhanced by isc1 and sur2 mutations. This 
demonstrates suppression and synthetic effects also for protein localisation. On the other 
hand, the effects on Can1-GFP localisation are only minor. In all mutants, the majority of 
Can1-GFP was detected at the plasma membrane (Supplementary material 4.6). In the 
erg2Δ and erg3Δ series, a small amount of vacuole staining was observed, but no 
synthetic phenotypes (Supplementary Table 4.3). The Can1-GFP construct was active in 
all strains because it conferred canavanine sensitivity. Here again, the raft hypothesis 
does not easily help to explain the results of steady state localisation of Tat2p and Can1p 
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in the various single and double mutants. Although the two transporters colocalise to the 
same plasma membrane patches, they show completely different dependence on sterols 
and sphingolipids for their localisation. Localisation of Tat2p, which was affected by 
sphingolipid and sterol mutations, did not correlate with anisotropy measurements. It 
could be that anisotropy measurements of the plasma membrane do not reflect fluidity of 
the compartment where Tat2p sorting occurs (Golgi or endosomal compartment) or that 
measuring the overall fluidity of the membrane does not indicate the fluidity in rafts.  
 
4.4.4 Complexity of sterols and sphingolipids interactions 
In what ways could sterol-sphingolipid interactions influence function in such a 
complex way? A trivial explanation would be that addition of sterol mutations with 
sphingolipid mutations cause an indirect effect by generally increasing the stress to the 
cells, which affects many functions. This is not the case for the observed 
hypersensitivities to caffeine or sorbic acid, which do not correlate with stress gene 
induction. Indirect effects, while certainly occurring in some cases, are unlikely to be a 
common explanation for the synthetic effects observed because of the specificity of the 
position of hydroxylation of the sphingolipid. Moreover, different combinations of 
specific sterol and sphingolipid mutations affect only specific cellular pathways rather 
than having highly pleiotropic effects.  
 
Biophysical (Ahmed et al., 1997;Feigenson, 2007) and molecular dynamics 
(Aittoniemi et al., 2007) experiments have clearly demonstrated that sterols and 
sphingolipids can interact preferentially in artificial membranes. This means that these 
lipids exist in at least two forms in the membrane, free sterol and sphingolipid, as well as 
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sterol-sphingolipid complexes. The results in this work suggest that this interaction will 
also be seen in vivo if suitable techniques become available. It is hypothesized that most 
of the phenotypes seen here are results of defects in direct protein-lipid interactions and 
not changes in the fluidity properties of the membrane or membrane domains. Any 
integral or peripheral membrane protein could interact with either a sterol, a sphingolipid, 
or a sphingolipid-sterol complex, helping to explain the complexity of the phenotypic 
analysis. There are various ways to interpret the enhancement of phenotypes that was 
observed. For example, in erg4Δ and sur2Δ single mutant cells Pdr12p shows substantial 
activity, but in erg4Δsur2Δ double mutants, activity is lost. Pdr12p might require 
interaction with sterol-sphingolipid complexes for full activity. The interaction could be 
reduced because of a stronger change in shape of the complex due to the combination. 
The complex might adapt a different tilt in the membrane due to the two mutations. 
Molecular dynamics studies suggest that sphingomyelin binding to cholesterol controls 
its tilt in the lipid bilayer (Aittoniemi et al., 2006). Alternatively, the combination of the 
erg4 and sur2 mutations could affect the equilibrium between the free lipids with sterol-
sphingolipid complexes any component affecting Pdr12p activity.  
 
4.4.5 Structural compatibility of sterols and sphingolipids and evolution 
In order for sterols and sphingolipids to function together, their structural 
compatibility had to be maintained through evolution? Strikingly, there was one outlier 
from the lipid analysis of the double erg deletion mutants (Fig. 4.2). The sphingolipid 
pattern in the erg5Δerg6Δ double mutant was more similar to wild type than the 
corresponding single mutants. The double mutation is “sphingolipid neutral”. The ERG5 
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and ERG6 genes are responsible for changes in the sterol side chain, the principle 
difference in the biosynthetic pathways of cholesterol and ergosterol. The two genes are 
linked in S. cerevisiae. This suggests that the ERG5 and ERG6 genes could have been 
inherited or lost together during evolution without causing major sphingolipid changes, 
allowing a co-evolution of sphingolipids and sterols.  
 
Some organisms do not synthesize sterols, but receive them from their diet. Two 
particularly well studied systems are D. melanogaster and C. elegans (Matyash et al., 
2001;Silberkang et al., 1983). Experiments with Drosophila did not detect any major 
changes in glycerophospholipid head groups or acyl group composition when grown with 
different amounts of cholesterol (Silberkang et al., 1983). Sphingolipids were not 
examined in this study. No information is available yet from either system about the lipid 
composition of these organisms when they are grown using different sterols. It is possible 
that a similar mechanism as seen here for yeast could be used to adjust membrane 
composition in response to sterol content. 
 
4.4.6 Lipids and sensitivity to drugs 
This study also shows that sterol and sphingolipid composition can affect how a 
cell responds to a drug or inhibitor. Several examples are shown here (Supplementary 
material 4.3), most prominently, the hypersensitivity of the erg2Δscs7Δ double mutant to 
caffeine and rapamycin, and the erg4Δsur2Δ double mutant to sorbic acid (Fig. 4.4D), the 
latter explained by changes in the activity of the weak acid transporter Pdr12p. Pdr12p 
belongs to the superfamily of ABC-transporter and interest in this class of proteins is 
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enormous due to their prominent ability to confer multidrug resistance (MDR) in cancer 
cells in humans, as well as drug resistance in major microbial pathogens. Various lines of 
evidence have indicated the multiple interfaces between lipid homeostasis and drug 
resistance. In addition to alterations in membrane permeability as a consequence of 
changes in lipid composition, PDR transporters and drug resistance may be functionally 
affected by specific lipids (Gulshan and Moye-Rowley, 2007). Using inhibitors to 
selectively block sphingolipid biosynthesis in various erg-null mutants in Candida 
albicans, Mukhopadhyay and co-workers demonstrated that membrane sphingolipid-
ergosterol interactions are important determinants of multidrug resistance conferred by 
Cdr1p (Mukhopadhyay et al., 2004). This study corroborated these previous findings. In 
addition, this work provides fine details of the molecular species of sterols and 
sphingolipids and how their unique interactions affect the function of an ABC-
transporter, as well as further mechanistic insights on how exquisite sterol-sphingolipid 
interactions affect other proteins and/or signalling pathways (H. Riezman, Guan et al., 
under revision).  
 
The extent to which this paradigm can be extended to higher eukaryotes, 
particularly humans is not presently clear, but it is evident that genetic factors, such as 
polymorphisms of multidrug resistance transporters, and diet affect sensitivity and effects 
of certain drugs.  It is highly intriguing that “polymorphism” of sterols and sphingolipids 
could play an important role in these variations in the population and the implications of 
pharmacolipidomics, which is defined the application of functional lipidomics to 
diagnosis, treatment, and monitoring of pathophysiological errors in lipid metabolism and 
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signalling (Prestwich, 2005), are rather provocative.  Furthermore, the findings in this 
work provide evidence of an exquisite specificity of interactions between sterols and 
sphingolipids in living cells that is critical for cellular functions. Specifically, it was 
demonstrated that functions of different proteins are altered by changes in specific 
changes in sterols and sphingolipids species of the cells, corroborating the role of lipids 
in modulating protein functions. The highly unique nature of lipid-protein relationship 
supports the possibility of modulation of membrane lipid as a potential therapeutic 
approach (Escriba et al., 2008).  
 
Prior to the emergence of lipidomics, most studies had focused on bulk membrane 
lipids, and commonly examined lipids in a highly targeted class-specific fashion (e.g. 
sphingolipids) without considering structural variants (e.g. hydroxylation or headgroup 
modifications). In this work, the genetic study is supported by the lipidomic and 
transcript data (Fig. 4.2 and Supplementary material 4.5), providing the first insights on a 
systems level scale on the intimate interaction of membrane lipids, which appear to be 
highly specific and are crucial for proper function of a cell.  
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Chapter 5. High Resolution and Targeted Profiling of 
Glycerophospholipids and Sphingolipids in Extracts from 
Drosophila melanogaster4 
                                                 
4 The results described in this Chapter is included in the following manuscript: 
Kohler K, Brunner E, Guan XL, Boucke K, Greber UF, Mohanty S, Barth J, Wenk MR 
and Hafen E. A combined proteomic and genetic analysis identifies a role for the lipid 
desaturase Desat1 in starvation induced autophagy in Drosophila. Autophagy (Under 




In Drosophila melanogaster, many molecular genetic studies have been carried out, 
particularly in embryogenesis, development, differentiation, signalling, cell cycle and in 
recent times in cancer and metastases studies (Busser et al., 2008;Crozatier et al., 
2007;Edgar and Lehner, 1996;Hardie and Raghu, 2001;Jacob and Lum, 2007;Nusslein-
Volhard and Wieschaus, 1980;O'Farrell et al., 1989;Tapon, 2003;Tenenbaum, 
2003;Weaver and Krasnow, 2008). Indeed, many studies in Drosophila have contributed 
to our current understanding of lipid signalling and functions in these diverse biological 
functions (Acharya et al., 2004;Brill et al., 2000;Chen et al., 2007;chi-Yamada et al., 
1999;Herr et al., 2004;Milligan et al., 1997;Phan et al., 2007;Rohrbough et al., 
2004;Stocker et al., 2002), and will continue to further improve our knowledge on lipid 
biology, and provide new insights on the functional significance of lipid diversity and 
differential regulation between organisms.  
 
Despite the effort to provide high quality genome annotation after the complete 
sequencing of the fly genome (Drysdale, 2003), many lipid enzymes and regulators are 
yet to be biochemically and functionally characterised. Nonetheless, the relative ease of 
genetic manipulation and the increasing availability of mutant libraries, as well as many 
previously established models for diverse biology makes Drosophila an important model 
organism to study enzymes and regulators involved in lipid biosynthesis and lipid 
functions (Rohrbough et al., 2004;Cherry et al., 2006). The development of sensitive 
techniques, such as mass spectrometry, therefore makes reverse genetics an attractive 
approach for systematic in vivo analysis of lipid biology.  
 
 114
Few reports are available on the measurements of fly lipids and these are rather 
fragmented (Table 1.5). Furthermore, they fail to provide a global view on the lipidome 
of the fly (Fyrst et al., 2004;Gamo et al., 1999;Rao et al., 2007;Rietveld et al., 
1999;Seppo et al., 2000;Stark et al., 1993a;Stark et al., 1993b;Fyrst et al., 2008). In this 
Chapter, lipids from Drosophila was isolated and the workflow described in Chapters 2 
and 3 (Guan et al., 2006;Guan and Wenk, 2006;Guan and Wenk, 2008) was adopted to 
profile and quantify major glycerophospholipids and sphingolipids (Fig. 3.1) in wild type 
larvae and a mutant deficient in a desaturase encoded by the gene DESAT1 (desat1-/-). 
Interest in this mutant stems from its isolation in a screen for fat body proteome 
associated with starvation-induced autophagy. Work is currently in progress to provide 
further biochemical and molecular insights into the function of DESAT1, which have not 
been characterised previously (Kohler et al., in preparation).   
 
5.2 Materials and Methods 
5.2.1 Fly stock 
All fly materials described in this Chapter were kindly provided by Irena Jevtov 
and Katja Kohler from the laboratory of Ernst Hafen at ETH, Zurich, Switzerland. The 
analysis of imaginal discs, kindly provided by Marcos Gonzalez from the University of 
Geneva, Switzerland, was mentioned but not described.  
 
5.2.2 Lipid extraction 
10mg (dry weight) of fly material (head or larvae) were homogenized in 100μL of 
ice-cold phosphate buffered saline using a motorised hand-held pestle. 400μL of 
methanol was added and the homogenisation was repeated, followed by the addition of 
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200μL of chloroform. 0.5μg of C19-Cer, 15μg of di24:0-GPCho, 15μg of di14:0-GPEtn, 
0.75μg of di14:0-GPSer, 0.75μg of di14:0-GPGro and 2μg of di8:0-GPIns were added as 
internal standards. The mixture was vortexed hard for one minute and incubated on a 
thermomixer at 4°C, at 1000rpm for 2 hours, with intermittent vortexing. Debris was 
pelleted by centrifugation and the supernatant was transferred to a fresh tube. The pellet 
was re-extracted once more with 300μL of chloroform-methanol (1:2, v/v) with 30 
minute incubation. The supernatants were pooled and 450μL of chloroform and 300μL of 
water were added. The mixture was vortexed hard for one minute, followed by 
centrifugation at 9000rpm for two minutes at 4°C. The organic phase was collected and 
the aqueous phase was re-extracted with 750μL of chloroform and the organic phase was 
pooled to the first extract and dried under liquid nitrogen. The dried lipid film was 
resuspended in 800μL of chloroform-methanol (1:1, v/v) and a 400μL aliquot was placed 
in a separate tube for alkaline hydrolysis treatment, while the remainder was used for 
subsequent mass spectrometry analysis.  
 
 A fraction enriched in sphingolipids was obtained by mild alkaline hydrolysis 
which degrades ester linkages found in many glycerophospholipids (Brockerhoff, 1963). 
To achieve this, the extract was adjusted to chloroform-methanol-water, (16:16:5, v/v/v). 
Glycerophospholipids were deacylated by 400μL of 0.2N NaOH and incubation at 30°C 
for 90 minutes. 400μL of 0.5M EDTA was added and the samples were neutralized with 
1N acetic acid. 400μL of chloroform was added and the mixture was vortexed for one 
minute, followed by centrifugation at 9000rpm for two minutes at 4°C. The lower organic 
phase was collected and dried under nitrogen.  
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5.2.3 Lipid analysis by ESI-MS 
ESI-MS was performed using a Waters Micromass Q-Tof micro (Waters Corp., 
Milford, MA) mass spectrometer as described in Chapters 2 and 3, except that the scan 
range was limited to m/z 400 – 1000. Lipid extracts were reconstituted in 800μL of 
chloroform-methanol (1:1, v/v), and further diluted two-fold before analysis. For 
differential profiling of WT and mutant MS spectra, plain text files obtained from 
MassLynx were loaded into Matlab (The MathWorks Inc., Natick, MA) for processing 
(Guan et al., 2006, See Chapters 2 and 3). 
 
Tandem mass spectrometry for characterisation/identification as well as 
quantification of lipid molecular species was performed using precursor ion scanning 
(PREIS), neutral loss scanning (NL) and multiple-reaction monitoring (MRM) 
respectively with an Applied Biosystems 4000 Q-Trap mass spectrometer (Applied 
Biosystems, Foster City, CA), as described in Section 2.2.6. Results are expressed as 
normalized intensities based on relevant internal standards, with the exception, for 
transitions based on parent → fatty acyl fragments, the normalized value is derived by the 
signal of each lipid transition divided by the sum of all transitions.  
 
5.2.4 Statistical analysis 
Comparison of the wild type and desat1-/- mutant was performed using the mean of 
at least 3 independent samples ± standard error of the mean (SEM) from individual 




5.3.1 A simple and rapid method to isolate and profile polar lipids from D. 
melanogaster 
Chloroform-methanol extracts of lipids were obtained from various fly parts, 
including whole flies, heads and larvae. Figure 5.1A shows a typical negative ion mode 
ESI-MS profile of wild type fly heads. The most prominent ions represent major 
glycerophospholipid species which ionize efficiently in negative mode. The inset shows a 
fatty acyl profile, derived by intra-source fragmentation of the lipids. A wide range of 
chain length for the fatty acids are present in the mixture, including odd chain fatty acids, 
which are in low abundance. Major fatty acyls are C16 and C18, with zero to three 
double bonds, consistent with previous reports based on gas chromatography mass 
spectrometry and fast atom bombardment mass spectrometry (Gamo et al., 1999;Stark et 
al., 1993a;Stark et al., 1993b;Yoshioka et al., 1985).  
 
Figure 5.1B shows a MS profile of a sphingolipid enriched fraction after mild 
alkaline hydrolysis. It should be noted that sphingolipids ionise efficiently in both ESI 
negative and positive modes. Although the measurement of phosphorylethanolamine 
ceramide (PE-ceramide) has been previously reported (Rao et al., 2007), limited 
information is available on the spectra of molecular species that exist and the detailed 
fragmentation patterns. Nonetheless, based on the simple nitrogen rule (McLafferty and 
Turecek, 1993;Han and Gross, 2005a;Guan and Wenk, 2008) since deprotonated 
molecular ions of ethanolamine sphingolipids have odd nominal masses due to the 
presence of two nitrogen atoms, while ions of ethanolamine glycerophospholipids have 
even nominal masses, it is predicted that the signals at m/z 631 and 659 in Figure 5.1A 
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are PE-ceramides, which is consistent with the fact that these signals are retained after 
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Figure 5.1 Glycerophospho- and sphingo- lipid profiles of heads of D.  melanogaster.  
Typical fatty acyl (A, left) glycerophospholipid (A, right) and sphingolipid (B) profiles of wild type (WT) 
Drosophila heads. Fatty acyl profile (A, left) is obtained from ESI-MS intra-source fragmentation of a total 
lipid extract.  
 
5.3.2 Comparative lipidomics of WT and desat1-/- Drosophila larvae by non-
targeted profiling 
Kohler and co-workers isolated desat1 in a screen for fat body proteome that is 
associated with starvation-induced autophagy. Figure 5.2A and B shows the single stage 
profiles of total lipid extracts from wild type and mutant larvae with homozygote deletion 
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of desat1 (desat1-/-). DESAT1 encodes for a fatty acyl CoA desaturase, which catalyzes 
the desaturation of saturated fatty acyls to monounsaturated fatty acyls (Fig. 5.2), some of 
which are precursors in the production of unsaturated hydrocarbons in position 7 that 
play an important role in mating behaviour (Labeur et al., 2002).  In mouse, four 
isoforms of steaoryl CoA desaturase (scd1-4) has been reported (Miyazaki et al., 
2006;Ntambi et al., 2004;Parimoo et al., 1999), while in Drosophila melanogaster, two 
isoforms, desat1 and desat2, have been annotated.  
 
A differential profile which displays differences in ion response between the 
desat1-/- and wild type conditions is shown in Figure 5.2C. Overall, the differences in 
profiles are dramatic. Although the substrates for Desat1 are hydrocarbons, these are 
precursors for more complex lipids, such as glycerophospholipids and sphingolipids, as 
well as glycerolipids. Furthermore, in mice knockout models of scd1 and scd2, alterations 
in lipid metabolism and levels have been reported (Miyazaki et al., 2005;Miyazaki and 
Ntambi, 2003;Miyazaki et al., 2000;Xu et al., 2007). 
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Figure 5.2 Changes in lipid profiles in desat1 deficient fly larvae and identification by ESI-MS/MS.  
Fly larvae were extracted using chloroform-methanol and analysed using negative ion mode ESI-MS. (A) 
Averaged normalized spectra from wild type (WT) larvae.  (B) Averaged normalized spectra from desat1 
deficient larvae (n=3). Inset represents the desaturation pathway in D. melanogaster (Dallerac et al., 2000).  
(C) Differential lipid profile to compare differences in lipid composition between desat1-deficient and WT 
larvae. (D) MS/MS of m/z 878 and chemical structure of Amadori-glycated 34:1 GPEtn. It was noted that 
two batches of samples were analysed in triplicates, and some variations were noted. Therefore, we only 
characterised and report lipids that were consistently altered and further validation is required to determine 
the source of variations for the other ions.  
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Some ions can be tentatively assigned – upregulation of glycerophospholipids 
with higher degree of saturation for instance, GPIns (m/z 809, 837 for 32:0 and 34:0 
GPIns respectively), as well as ceramides (m/z 536 and 564) and PE-ceramides (m/z 659) 
– consistent with the function of Desat1 as a fatty acid desaturase. To unambiguously 
identify the ions that were differentially regulated, further characterisation and 
identification was carried out using tandem mass spectrometry and collision-induced 
dissociation (CID) (Fig. 1.3).  
 
5.3.3 Characterisation of lipids in WT and desat1-/- larvae 
Two significant observations were made. Firstly, a strong downregulation of ions 
at m/z 878 and 904 was observed. Figure 5.2D shows the product ion spectra of the 
negative ion m/z 878. The distinct fragments are m/z 140, 153, 253 and 281 are 
diagnostic of phosphoethanolamine, glycerophosphate and the fatty acyls, 16:1 and 18:1, 
respectively. Strikingly, the daughter ion with m/z 716 corresponds to the m/z of 34:1 
GPEtn and it is equivalent to a loss of 162 mass units from the parent ion, suggesting a 
loss of a sugar group. This would suggest that a glycerophosphoethanolamine is 
glycosylated and indeed, such glycated lipids of amine containing lipids do exist due to 
the formation of a Schiff base with sugars, although they are not frequently reported. 
Nakagawa et al. reported the structural characterisation of glycated GPEtn in the positive 
ion mode (Nakagawa et al., 2005a), consistent with our data (not shown), which 
corroborate our findings that m/z 878 is a glycated GPEtn, or more commonly denoted 
Amadori-glycated GPEtn.  
 
 122
Ions corresponding to ceramides (m/z 536 and 564) and PE-ceramides (m/z 659, 
687) accumulated in desat1-/- larvae. Product ion spectra in the negative ion mode of m/z 
564 and 687 are represented in Figure 5.3B and C. Although descriptions of Drosophila 
sphingolipids had been previously reported (Acharya and Acharya, 2005;Acharya et al., 
2003;Fyrst et al., 2004;Rao et al., 2007;Seppo et al., 2000), this work reports for the first 
time the characterisation of some of these lipids. Figure 5.3A shows the fragmentation 
pattern of a synthetic d18:1/18:0 ceramide (m/z 564), which is commonly found in 
mammalian cells. The ion, m/z 564, in the Drosophila extract, yields a completely 
different pattern as compared to the standard. However, annotation to the structure can be 
made and it is derived that this ion corresponds to a mixture of d14:1/22:0 ceramide 
(major) and d16:1/20:0 ceramide (minor). The fragmentation of m/z 687 yields a major 
fragment ion of m/z 140 in the negative ion mode, which potentially corresponds to the 
dehydrated ion of phosphoethanolamine headgroup. A similar pattern is observed with a 
qualitative PE-ceramide (d17:1/12:0) standard (data not shown). The structural 
information from a negative ion mode analysis is limited. Thus, the lipids were analyzed 
in the positive ion mode. The gain of proton would yield an ion at m/z 689 for the major 
PE-ceramide.  The fragments ions of m/z 548, 208 and 236 are from the neutral loss of 



























































Figure 5.3. Characterisation of Drosophila sphingolipids by tandem MS.  
Tandem mass spectrometry and collision-induced dissociation (CID) of (A) d18:1/18:0 ceramide standard; 
(B) m/z 564 and (C) m/z 687 in Drosophila larvae lipid extraction in the negative ion mode; and (D) m/z 
689 in the positive ion mode.  Structures in (A)-(C) represents possible fragmentation pathways for the 
various lipids.  
 
In summary, these results indicate that disruption of the DESAT1 gene leads to 
dramatic changes in glycerophospholipids as well as sphingolipids, most notably 
accumulation of glycerophospholipids containing saturated fatty acids, increase in both 
ceramides and PE-ceramides and decreased levels of glycated GPEtn. Note however that 
further detailed characterisation is required for some of the ions that were misregulated in 
the desat1 deficient mutant.  
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5.3.4 Targeted quantification of glycerophospholipids and sphingolipids of WT 
and desat1-/- Drosophila larvae 
Multiple-reaction monitoring (MRM) is a highly selective and sensitive (though 
biased) way for quantification of small molecules in complex mixtures and has the 
advantage of differentiating isobaric compounds.  
 
5.3.4.1 Glycerophospholipids 
Dallerac and co-workers previously demonstrated the substrate specificity of 
Desat1 for palmitoyl- and stearoyl- CoA (Dallerac et al., 2000). Glycerophospholipids 
with combinations of acyl chains of either 16 and/or 18 carbons in WT and desat1-/- 
larvae were selectively measured by MRM and Figure 5.4A and B show the analysis of 
GPIns and GPEtn. For all classes of glycerophospholipids analysed (Fig. 5.4A and B, and 
data not shown), a change in the saturation profile of the fatty acyl composition of 
glycerophospholipids was observed. Levels of all molecular species with no double 
bonds in both acyl chains (e.g. 16:0/16:0) are elevated in the mutant and levels of all 
molecular species with both acyl chains containing monounsaturated fatty acids (e.g. 
16:1/16:1) are decreased, consistent with the function of DESAT1 (Fig. 5.2).  However, 
levels of glycerophospholipids with a fatty acyl containing two double bonds (e.g. 
16:0/18:2, 18:0/18:2) were found to be elevated, which may be compensatory effect by 
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Figure 5.4 Quantification of glycerophospholipids in WT and desat1-/- larvae. 
Multiple-reaction monitoring was used to quantify major glycerophospholipids in WT and desat1-/- larvae 
(n=3). Relative abundance of major GPIns (A) and GPEtn (B) are presented. Statistical significance 
between wild type and mutant strains was determined using Student’s t-test. **p<0.05.  
 
5.3.4.2 Sphingolipids 
Quantitative analysis of Drosophila ceramides and PE-ceramides by ESI-MS has 
been described previously. However, these studies have been limited to sphingolipid 
containing the major sphingoid base d14:1. Furthermore, in the case of PE-ceramide, a 
transition based on the neutral loss of phosphoethanolamine in the positive ion mode was 
employed, and information on the sphingoid and fatty acyl compositions is lost. In this 
work, ceramides and PE-ceramides were extensively characterized and data for 
quantification of d14:1, d15:1 and d16:1-sphingoid base (sphingosine) containing 
sphingolipids is presented. This is however not an exhaustive list as sphingolipids with 
sphingoid bases  containing no double bond or two double bonds (dihydrosphingosine 
and sphingadiene) are also found in Drosophila (Fyrst et al., 2004;Fyrst et al., 2008).  
 
Figure 5.5A and B show the relative levels of the ceramide and PE-ceramide levels 
measured. Overall, there is a general increase across all the major sphingolipid species. 
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The degree of change is noted to be more pronounced for d14:1 sphingoid containing 
sphingolipids.  A technical issue to note is, due to the lack of PE-ceramide standards, 


































































































































































































Figure 5.5 Quantification of membrane sphingolipids in wild type and desat1 deficient larvae. 
Data represent sphingosine-containing- (A) Ceramides and (B) PE Ceramides (n=3). Statistical significance 
between wild type and mutant strains was determined using Student’s t-test. **p<0.05.  
 
5.4 Discussion 
A non-targeted profiling and targeted quantification approach described in 
Chapters 2 and 3 was adopted for lipidomic analysis of Drosophila lipids, with a focus on 
glycerophospholipids and sphingolipids. Using a rather simple extraction protocol it is 
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possible to obtain semi-quantitative information of overall changes in lipid levels (Fig. 
5.2) as well as fully quantitative levels of a large number of lipids, including PE-
ceramides (Fig. 5.5A).  
 
It is not in the context of the present work to correlate the changes in lipid 
composition to the function of DESAT1 in Drosophila without any further functional 
studies. However, the preliminary results from this study have demonstrated the powerful 
nature of the non-targeted profiling approach developed in this work, as illustrated by the 
detection of changes in ions which can be attributed to Amadori-glycated GPEtn. The 
presence of Amadori-glycated GPEtn is reported for the first time in Drosophila, the 
levels of which is lower in desat1 deficient larvae. It was proposed that its formation is 
due to the exposure of GPEtn to glycation under hyperglycemic conditions in vivo 
(Lertsiri et al., 1998;Pamplona et al., 1995). While studies on Amadori-glycated GPEtn is 
currently limited and its precise function is not known, Amadori-glycated GPEtn has 
been associated with angiogenesis, lipid peroxidation, and lipoprotein uptake, and its 
level is found to be elevated in red blood cells and plasma of diabetic animals (Miyazawa 
et al., 2008;Miyazawa et al., 2005;Nakagawa et al., 2005b;Oak et al., 2000;Oak et al., 
2003). Manipulation of the levels of this lipid to reveal functions may be technically 
challenging since it may be formed from the non-enzymatic Maillard reaction. An 
attractive tool to probe to function of Amadori-glycated GPEtn was described Higuchi 
and co-workers, who demonstrated the in vivo inhibition of lipid glycation by pyridoxal 
5’-phosphate (Higuchi et al., 2006).  
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The comparative lipidomics approach provides evidence that deficiency in desat1 
in Drosophila larvae is distinct from scd1 and scd2 deficiency in mice (Dobrzyn et al., 
2005;Miyazaki et al., 2005). In both Drosophila and mice, deficiency of the fatty acid 
desaturase resulted in reduction of monounsaturated C16 and C18 acyl chains of 
glycerophospholipids. However, the effect sphingolipid biosynthesis between the 
organisms was different. In desat1-/- larvae, a dramatic increase in ceramide and PE-
ceramide levels was noted, and levels of these lipids (in the case of mice, the 
phosphosphingolipid is sphingomyelin instead of PE-ceramide), were similar, if not 
slightly lowered, in the epidermis of scd2-/-. Nonetheless, clearly, alterations in fatty acid 
desaturation resulted in pleiotropic effects at the level of lipid aberrations, as well as 
phenotypic changes. Notably, homozygote larvae of desat1 deletion arrest in 
development at a very early larval stage (Kohler et al., in preparation). A possible 
explanation is that Desat1 is involved in regulation of ceramide synthesis and ceramide is 
known to induce cell death and growth arrest (Obeid and Hannun, 1995;Low et al., 
2008). Furthermore, fatty acids and/or their derivatives are potent signalling molecules 
(Duplus et al., 2000;Farrell and Merkler, 2008;Mansilla et al., 2008;Serhan, 2005;Brock 
and Peters-Golden, 2007) and Desat1 functions to produce and maintain the balance of 
unsaturated and saturated fatty acids, which may be critical for cellular physiology.  
 
In addition to discovery of novel metabolites by unbiased profiling, the partial 
characterisation of the Drosophila lipidome, using whole organism (whole adult fly and 
larvae) (Fig. 5.2 and data not shown), body parts (head and body) (Fig. 5.1 and data not 
shown) and organs (imaginal discs) (data not shown) was carried out in this study. In 
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addition, as opposed to previous work (Acharya et al., 2003), the analysis described in 
this work allowed the discrimination of isobaric species of PE-ceramides based on their 
sphingoid base composition. However, the coverage of the fly lipidome is not exhaustive. 
For instance, glycosylated ceramides have not been included as these require separation 
by liquid chromatography due to isobaric complications. Nonetheless, the 
characterisation of major Drosophila glycerophospholipids and sphingolipids offers the 
possibility of targeted quantification using as little as two larvae for comprehensive 
profiling of these two major classes of membrane lipids. Together with non-targeted 
differential profiling, these methods offer a highly sensitive tool for discovery lipidomics. 
 
The motivation for the establishment of the measurement of mammalian and yeast 
glycerophospholipids and sphingolipids applies to fly lipids – it is hoped that such a tool 
will allow us to characterise many annotated but biochemically uncharacterised lipid 
enzymes as well as a discovery tool for many applications. Imperative applications of the 
tool developed include (i) analysis of mutants of the sphingolipid pathway to ‘isolate’ 
sphingolipids which have not been characterised, such as ceramide ciliatine and (ii) 
extending the studies on functional interactions between membrane lipids to a fly model. 
In Chapter 4, it was demonstrated that in S. cerevisiae, cells sense alterations in sterols 
composition by altering their sphingolipid composition and levels. Drosophila is a sterol 
auxotroph and acquires this lipid from their diet. Manipulation of sterol levels, and 
composition, can be achieved through the feed, for instance using the ergosterol mutants 
described in Chapter 4, or by providing different sterol derivatives, which can be 
obtained commercially.  
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Chapter 6. Discussion and Conclusion 
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In the preceding chapters, I have described the development of a novel MS-based 
approach for non-targeted differential profiling of lipids and the advantage of the tool is 
the non-essential requirement for the prior knowledge of the chemistry of the lipids under 
investigation and is well-suited for surveying poor characterised or uncharacterised 
lipidomes (Fig. 1.4). The method is therefore generally applicable to analyze complex 
mixtures obtained from various biological sources, including mammalian cells/ tissues 
(Chapter 2), the budding yeast S. cerevisiae (Chapters 3 and 4) and the fruit fly D. 
melanogaster (Chapter 5). The lipid fingerprint of each organism is clearly unique (Fig. 
6.1) and with a focus on glycerophospholipids and sphingolipids, the selective 
measurement of each unique chemical entity, based on the fine chemical details (for 
instance headgroup modifications, hydroxylations and fatty acyl heterogeneity), was 
developed. As discussed in Chapter 1, the diversity of membrane lipids is enormous and 
the number of lipids is estimated to be in the range of hundreds of thousand (Yetukuri et 
al., 2008). The diversity of glycerophospholipids stems from the various headgroups and 
heterogeneity in the hydrophobic tails derived from different fatty acyls, alkyls and 
alkenyls and the permutations of their positions on the glycerol backbone (Fig. 1.1). 
Overall, the biosynthetic pathways of glycerophospholipids are well understood and 
generally well-conserved among species ranging from prokaryotes to eukaryotes 
(Lykidis, 2007;Dowhan et al., 2004;Dowhan, 1997). The analysis of this class of lipids 
was in fact facilitated by the prior knowledge on the chemistry and biology of 
glycerophospholipids in different organisms as well as the availability of well-established 













































































































































































































































S. cerevisiae D. melanogaster H. sapiens
 
Figure 6.1 Theoretical portion of glycerophospholipids (GPL) and sphingolipids (SPL) inventory of 
various eukaryotic organisms. 
The grey bars denote the typical range of fatty acyl compositions (varying chain length and degree of 
unsaturation) for a number of prominent GPL and SPL. The relative levels are represented by the intensity 
of the symbols (the darker the more abundant the respective lipid). The inset is an enlarged region which 
provides information of the various molecular species of GPIns lipids present in the yeast S. cerevisiae, the 
fruit fly D. melanogaster and mammalian cells, in this case human, H. sapiens. Different organisms have 
strikingly different lipid inventories. In the case of the yeast these are more saturated and shorter fatty acyls 
(dotted lines and ceramides with unique phosphoryl mannoside headgroups (IPC, MIPC, M(IP)2C). While 
in the fly, the fatty acyls are slightly longer (but shorter than in mammals) and the ceramides contain the 
unique phosphoryl ethanolamine headgroup. Abbreviations: FA, fatty acyl; GPL, 
glycerophospholipids; SPL, sphingolipids; GPA, phosphatidic acid; GPCho, glycerophosphocholine; 
GPEtn, glycerophosphoethanolamine; GPGro, glycerophosphoglycerol; GPIns, glycerophosphoinositol; 
GPInsP, glycerophosphoinositol-phosphate; GPInsP2, glycerophosphoinositol-bisphosphate; GPSer, 
glycerophosphoserine; PE-Ceramide, phosphorylethanolamine ceramide; IPC, inositolphosphorylceramide; 
MIPC, mannosyl inositolphosphorylceramide; M(IP)2C, mannosyl diinositolphosphorylceramide. This 
graphical representation is modified from (Wenk, 2006). 
 
Sphingolipids, on the other hand, are found with few exceptions only in 
eukaryotic cells. While numerous reports are available for targeted analysis of 
sphingolipids (Han, 2002;Pettus et al., 2004;Sullards and Merrill, Jr., 2001;Sullards et al., 
2007), these are typically restricted to mammalian tissues/ cells and not entirely 
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applicable to other organisms due to the distinct structural variants between different 
eukaryotes (see Section 6.1 onwards for a discussion on sphingolipid diversity and 
function). In this work, a subset of the sphingolipidome of the model organisms, S. 
cerevisiae and D. melanogaster, was characterised and a method for the relative 
quantification of each unique entity was established.   
 
Model organisms are an invaluable biological reagent to study lipid function and 
with the development of a tool for system scale analysis of lipids, it is now possible to 
combine genetic-biochemical and functional investigations to extend and complement 
our knowledge of lipid functions at a very high resolution. In addition to their function in 
regulating membrane properties such as thickness and fluidity, the work in this thesis 
demonstrated for the first time an exquisite specificity of interactions between sterols and 
sphingolipids in living cells, specifically in S. cerevisiae, which is critical for cellular 
functions.  
 
With the rapid advances in lipid biology and analytics, our knowledge of how 
distinct lipid and its interacting partners function in a systems context is crystallising and 
the field is one step closer to the endeavour of unveiling Nature’s intention for the 
creation such enormous diversity among lipids. The next section of this Chapter is 
intended to discuss the diversity of sphingolipids structures and how they affect cellular 
functions because although their structures are distinct between organisms, this enigmatic 
class of lipids seems to be ubiquitous in many cellular processes and peculiarly, inference 
from model organisms such as S. cerevisiae has proven especially useful in our 
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understanding of sphingolipid metabolism and function in higher eukaryotes (Dickson, 
1998).  
 
6.1 Diversity of Sphingolipids 
6.1.1 Biosynthesis of sphingolipids 
The general structure of a sphingolipid comprise of a long-chain amino alcohol 
backbone (also known as a sphingoid base) to which a fatty acid can be covalently linked 
to form ceramide (Refer to section 1.1.1, Fig. 1.1B). Structural variants arise from head 
group substitutions as well as chain length differences and hydroxylation in the sphingoid 
base and fatty acyl chains (Fig. 1.1D and Fig. 1.2).  Interestingly, these structural 
variations seem to serve as ‘molecular signatures’ of the three organisms we’ve discussed 
in this thesis, namely, mammals, the yeast, S. cerevisiae and the fruit fly, D. 
melanogaster. S. cerevisiae has the simplest sphingolipid inventory, with only three 
headgroup modifications reported, while in mammals and fly, more than a hundred 
different modifications exist (Merrill, Jr. et al., 2007). In addition to the obvious 
headgroup differences of the sphingolipids, the biosynthesis of sphingolipids in fact 
diverge at steps upstream of headgroup modifications and structural variations in terms of 
degree of hydroxylation and desaturation of the ceramide backbone are found between 
the three eukaryotic organisms. Despite several differences, the overall biosynthetic 
machinery as well as the functions of sphingolipids is nonetheless considered highly 




The first and rate-limiting early step in sphingolipid synthesis is similar and 
involves condensation of L-serine and acyl-coenzyme A (acyl-CoA) (Figure 6.2) by the 
enzyme complex, serine palmitoyltransferase, forming the sphingoid base, 3-
ketodihydrosphingosine (3-KDS). 3-KDS is reduced into dihydrosphingosine (DHS) by a 
3-KDS reductase. In yeast, DHS can be phosphorylated or hydroxylated to form DHS-1-
phosphate and phytosphingosine (PHS) respectively, and the latter is the primary 
sphingoid base. The enzyme responsible for sphingoid base hydroxylation is Sur2p (Haak 
et al., 1997). Both DHS and PHS are condensed with a very long chain fatty acid 
(typically C24 and C26) to make dihydroceramide and phytoceramide. In yeast, 
hydroxylation of the fatty acyl chain is common and is catalyzed by the hydroxylase, 
Scs7p (Haak et al., 1997). Phosphoinositol is transferred to yeast ceramide catalyzed by 
the inositol phosphotransferase, AUR1, forming the first complex sphingolipid in the 
series, inositolphosphorylceramide (Nagiec et al., 1997), which can be further modified 
with additional mannosyl and phosphoinositol moieties to form mannosyl 
inositolphosphorylceramide (MIPC) and mannosyl diinositolphosphorylceramide 
(M(IP)2C) respectively (details of the sphingolipid biosynthesis pathway in yeast can be 
found in Supplementary material 4.1). 
 
In mammals and Drosophila, instead of forming phytoceramide, a double bond is 
introduced in dihydroceramide to form ceramide (Michel et al., 1997). Furthermore, the 
primary sphingoid base in mammals and fly is formed from the deacylation of ceramide. 
In mammals, hydroxylation of sphingoid base and fatty acyl hydroxylation has been 
reported but is less common compared to yeast and tend to be organ and lipid specific. 
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For instance, phytoceramide is abundant in various organs including skin, kidney and 
brain and hydroxylated sphingolipids are uniquely abundant in myelin 
galactosylceramide and sulfatide, but not in free ceramides or other sphingolipids 
(Alderson et al., 2006). However, in Drosophila, the presence of hydroxylated 
sphingolipids and the enzymes have not been reported to date, and in fact, many 
sphingolipids enzymes have been annotated in the fly based on homology, but not 
biochemically. 
 
In addition to the difference in the hydroxylation and desaturation profiles, the 
acyl groups in yeast typically have long carbon chains (C24 and C26) while in mammals 
and fly, the N-acyl group range from 16 to 26 carbons. Another point of divergence of 
sphingolipid biosynthesis between the various organisms is at the level of headgroup 
modifications (Fig. 1.1 and 6.2). In fly and mammals, the major phosphosphingolipids 
are phosphoethanolamine and phosphocholine respectively. The enzyme that is 
responsible for the transfer of these headgroups is known as sphingomyelin synthase 
(SMS) or SMS-related protein (Tafesse et al., 2006). Furthermore, in mammals and fly, 
in contrast to S. cerevisiae, sugar groups are directly linked to ceramide, giving rise to a 
sub-class of sphingolipids, known as glycosphingolipids (Merrill, Jr. et al., 2007).With 
these differences in headgroup modifications and in mammals and fly, phospho- and 
glyco- sphingolipids are functionally distinct, a fundamental question is which category 
does yeast complex sphingolipids functionally belong to, since they comprise of both 
phospho- as well as sugar groups which are not found as separate moieties.   
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Figure 6.2 Simplified sphingolipid metabolic pathways of various eukaryotic organisms. 
Metabolites in black have been reported in all three organisms, yeast, fly and humans, with the exception of 
those in italics, which have not been reported in fly and were not measured in this work. The colored fonts 
represent the unique sphingolipids found in distinct organism. It should be noted that although PE-ceramide 
biosynthesis may be a minor pathway for sphingomyelin synthesis, its presence has not been reported in 
mammals. In purple are the sphingolipid metabolites common in both the fly and mammals. Abbreviations: 
CoA, Coenzyme A; DAG, diacylglycerol; DHS1P, dihydrosphingosine-1-phosphate; GPCho, 
glycerophosphocholine; GPEtn, glycerophosphoethanolamine; GPIns, glycerophosphoinositol; NADPH, 




6.1.2 Sphingolipid Structure and Functions 
Clearly, unique structure of individual species of sphingolipids has distinct 
function, either by itself or through interaction with other lipids. For instance, in Chapter 
4, it was demonstrated that the hydroxylation of either the sphingoid base or fatty acyl, 
and headgroup turnover affect interactions with sterols and have an impact on cellular 
functions in S. cerevisiae. Structural variations in lipids affect functions via various 
possible mechanisms, including changes in membrane biophysical properties and 
permeability, alterations in signalling processes, as well as direct and indirect effects on 
protein functions (Figure 6.3). In this section, I will review how hydroxylation and 
desaturation status and headgroup differences affect these processes and attempt to 
compare existing reports that support similar functions for sphingolipids that are found in 














































































































Figure 6.3 Membrane lipids, organisation and function. 
Structural variations in membrane lipids affect their propensity to interact with each other and with other 
components including proteins and small molecules. The packing density and therefore membrane 
permeability is affected by the conformation of specific lipids. In addition, certain lipids, for instance 
sterols and sphingolipids exhibit a preference for partitioning into distinct domains, and are segregated 
from phospholipids (A). Inset shows the organisation of the three major classes of membrane lipids, sterols, 
sphingolipids and glycerophospholipids as reviewed by Harder and Simons (Harder and Simons, 1997). It 
was proposed that sphingolipids and intercalating cholesterol form a tightly packed microdomain in a 
glycerophosphocholine (GPCho)-rich environment. The GPCho regions are less densely packed and more 
fluid than are the sphingolipid-sterol-rich domains. Variations in lipid structures may affect protein 
functions through as they influence membrane thickness, which is important for the hydrophobic matching 
of integral membrane proteins (B). In addition, a lateral pressure profile is exerted by lipids on the two 
layers of biological membrane, which affects the conformational changes of proteins (C). The function of a 
protein may be regulated by its lipid microenvironment (D). Lipids may also function as cellular receptors. 
For instance, glycosylated sphingolipids, particularly gangliosides, serve as recognition sites through their 
highly decorated sugar headgroup and their charge (E). In addition, lipids affect cellular functions through 
their signalling roles, either by recruiting and regulating signalling complexes (F) or acting as a signalling 
molecule themselves (G). Membrane lipids affect drug action since interactions of certain drugs (or small 
molecules) with the cellular protective barrier are lipid-structure dependent (H).  
 
6.1.2.1. Membrane organization and integrity 
Lipid-lipid and lipid-protein interactions are thought to provide the underlying 
basis for membrane domain formation, with sterols and sphingolipids being particularly 
prominent components of these domains (Simons and Ikonen, 1997;Ramstedt and Slotte, 
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2006). Like compartmentalisation of cellular components by organelles to bring about 
localized effects, domain formation in membranes is also thought to segregate (and 
concentrate) biological activities. The association of specific proteins to distinct domains 
further suggest specific lipid requirement for protein functions. Although lipid domains 
have been a subject of debate and remain a challenging topic (Jacobson et al., 
2007;Munro, 2003;Pike, 2008), they nonetheless contributed to our knowledge and 
rekindled our interest in the interactions between sterols and sphingolipids in membranes 
and their effects on cellular functions . It should be noted that the propensity to form 
clusters/domains in biological membranes is not restricted solely to sterols and 
sphingolipids, for instance, polyunsaturated fatty acids (PUFA) and sterols possess a 
natural aversion that drives the lateral segregation of PUFA-containing 
glycerophospholipids into highly disordered domains away from cholesterol (Wassall et 
al., 2004). Numerous biophysical analyses have been carried out to determine the 
structural determinants for sterol-sphingolipids interactions in the context of lipid domain 
formation and provide a starting point to understand how structural differences in 
sphingolipids affect membrane organisation and function.  
 
Sphingolipids in general exhibit a preference for partitioning into domains in 
membranes which are proposed to be critical in the control of cellular functions (Goni 
and Alonso, 2006;Maggio et al., 2006;Zhang et al., 2008). The distinction between 
sphingolipids and glycerophospholipids is that the latter carries only fatty acyl carbonyl 
groups which act as hydrogen bond acceptors, while sphingolipids have both hydrogen 
bond donating and accepting capacities conferred by the hydroxyl and amide group 
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respectively. This property of sphingolipids has often been associated with their 
propensity for lateral organisation in membranes. Structural variations including 
headgroups (single hydroxyl for ceramide versus phospho- headgroup versus large 
assemblies of carbohydrates), hydroxylation of sphingoid base and fatty acyl chain as 
well as chain length asymmetry affect the partitioning of these lipids. With respect to 
hydroxylation and desaturation, like ceramide, dihydroceramide show similar membrane 
modulation properties in terms of stabilizing effect on domains and sterol displacing 
propensity (Alanko et al., 2005). Phytoceramide, with an additional hydroxyl group on 
the sphingoid base, has additional hydrogen-bonding capability, which is associated with 
its effect of increased domain stability (Megha et al., 2007).  Indeed, early structural 
analyses revealed distinct conformational differences between the hydroxylated forms of 
ceramides which affect their packing and their hydrogen bonding network (Dahlen and 
Pascher, 1972;Pascher and Sundell, 1992).  
 
Interestingly, the lipid envelope of the human immunodeficiency virus is 
selectively enriched in dihydrosphingomyelin, instead of the usual sphingomyelin 
(Brugger et al., 2006). Dihydrosphingomyelin is proposed to form a more ordered 
domain with a higher melting temperature and confers resistance to oxidation, probably 
serving as a protective shield for the virus and its persistence. The effect of lipid 
composition and ordering in membranes on the stability and transmission of viruses 
further extend to other viruses including influenza virus (Polozov et al., 2008). In fact, 
Pascher proposed in an early work on the apparent relation of ceramide hydroxylation to 
membrane stability against environment (Pascher, 1976). Notably, erythrocytes 
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occupying a stable environment has only one free hydroxyl group, while epithelial of 
small intestine, kidney and skin have three hydroxyl groups; and yeast cells, which have a 
non-regulated environment for cell growth, typically have three, if not four hydroxyl 
groups. These suggest that hydroxylation and desaturation of sphingolipids are important 
determinants of membrane integrity and may be a mechanism cells adopt to survive in 
their respective environments. Changes in the permeability of the barrier is often 
associated with alterations in solute and compound movement across membranes and 
partly attribute to cellular sensitivity or resistance to drugs, although other possible 
mechanisms may exist (See section 6.1.2.3). In addition to regulating membrane stability/ 
permeability, changes in membrane lipid composition may influence the curvature 
propensity of membranes, which is related to endocytic and fusogenic processes, as well 
as the lateral pressure profiles of the lipid bilayer (Cantor, 1999), thereby affecting 
protein functions (See section 6.1.2.3).  
 
Clearly, the preferential segregation of specific lipids into distinct domains has 
been extensively reported, primarily based on biophysical analysis of artificial 
membranes and the functional relevance of these interactions is beginning to be revealed 
in biological systems. Studies on the phospho- headgroup size on intermolecular 
association and on sphingomyelin-cholesterol interactions and ordered domain formation 
demonstrated that phosphoethanolamine containing ceramide has a markedly lower 
affinity for cholesterol than sphingomyelin (Terova et al., 2005). Sphingolipids 
concentrate into domains in plasma membrane which play a role as receptors and uptake 
of toxins and viruses (Fantini et al., 2000;Pelkmans, 2005) (Section 6.1.2.3). The 
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individual interactions of sugar headgroups of glycosphingolipids may affect the 
efficiency of close lateral packing and form lateral domains which are spatially and 
functionally separated from sphingomyelin-cholesterol domains (Ramstedt and Slotte, 
2006). On the other hand, the ordering effects of modifications of sterol structures in 
model membrane have been addressed and ergosterol tends to have a greater ordering 
effect (Urbina et al., 1995;Xu et al., 2001). While a significant part of our knowledge on 
sphingolipid metabolism is attributed to studies in yeast, most of our understanding on 
the biophysical interactions between lipids has been derived from model membrane 
systems employing the mammalian sterol and sphingolipid counterparts. In Drosophila 
and yeast, the major phosphosphingolipids contain phosphoethanolamine and 
phosphoinositol respectively, and the major sterol tends to be ergosterol (depending on 
the diet in the case of fly) and it would be of great relevance to incorporate these variants 
in biophysical investigations to represent the interactions between lipids from these 
model organisms. Probing for such interactions in cells will provide invaluable insight 
into the functional relevance. An attractive potential of capitalizing on the differences in 
lipid structures between organisms is the possibility to engineer the lipid structures by 
introducing enzymes that produces non-endogenous structural variants, especially since 
many of these enzymes have been cloned.  Nonetheless, the existing studies that propose 
the segregation of distinct lipids into different domains support the specific interactions 
between cholesterol and unique variants of sphingolipids and while a neutral stand is 
taken with regards to the actual existence of lipid domains in biological membranes, it is 
proposed that the exquisite interactions is physiologically relevant, supported by the 
study described in Chapter 4. Moreover, the differential affinity between sterol and 
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sphingolipid variants may in part account for the coexistence of structural variations 
between different organisms which may contribute to conservation of functions.  
 
6.1.2.2. Bioeffector functions of sphingolipids 
Sphingolipids are well known for their functions as second messenger in 
signalling pathways for vital cellular processes including apoptosis, cell survival and 
aging. The yeast has provided numerous opportunities for understanding the functions of 
sphingolipids, particularly sphingoid bases, their phosphorylated products, and ceramides 
on diverse cellular processes, which appeared to be conserved in humans (Dickson, 
1998). On the contrary, the signalling functions of complex sphingolipids have been 
largely derived from mammalian studies and our knowledge of the functions of complex 
sphingolipids in yeast is only beginning to be unravelled.  The chemical structure of 
sphingolipids and their biological functions have been previously discussed 
(Dyatlovitskaya, 1998;Dyatlovitskaya, 2000). I will limit the discussion on the 
correlation between structure and bioeffector function of sphingolipid to growth 
inhibition and/or apoptosis induction, with emphasis on the structural variants between 
organisms, as one of the recurrent observations in this thesis and our published work 
based on metabolite profiling is ceramide accumulation in degenerating rat hippocampal 
neurons (Guan et al., 2006) and mutant fly larvae that ceased growth (Chapter 5, Kohler 
et al., in preparation). However, it should be noted that various stimuli induce the 
formation of these signalling lipids, which may mediate attenuation of cell growth and 
induction of apoptosis through several potential signalling pathways and though 
important, the function of sphingolipids as signalling molecules has not been adequately 
investigated in this work.  
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Enzymes of sphingolipid metabolism are intimately linked in an interconnected 
network that serves to regulate the levels of individual bioactive lipids and their 
metabolic conversion, serving as a rheostat that allows a rapid switch between functions 
(Maceyka et al., 2002;Taha et al., 2006). For example, ceramide (i.e. acylated 
sphingosine) and sphingosine are associated with cell growth arrest and are important 
regulatory components of stress responses and apoptosis. In contrast, phosphorylated 
products of sphingosine have been implicated in cellular proliferation and survival, 
illustrating how metabolic conversion result in structurally distinct lipids which act as a 
molecular switch between life and death (Fig. 6.4A). While ceramide induces apoptosis 
in cells (Bielawska et al., 1993) the equivalent dihydroceramide species which lacks the 
double bond is inactive, or very weakly active (Karasavvas et al., 1996). 
Dihydroceramide in this case is considered an inert compound which serves as an 
intermediate of ceramide metabolism, for instance, in the generation of the bioactive 
dihydrosphingosine-1-phosphate and ceramide (Fig. 6.2). Nonetheless, it should be 
acknowledged that dihydroceramide and ceramide differs in biophysical properties, 
which may attribute to the biological function of dihydroceramide in other aspects (See 
section 6.1.2.1). Although the double bond in ceramide appears to be important for its 
apoptotic activity, phytoceramide, which has no double bond but has an additional 
hydroxyl group compared to dihydroceramide, exhibit a greater potency in the induction 
of apoptosis than ceramide (Hwang et al., 2001;Kyogashima et al., 2008). These suggest 
that functionally, the major yeast ceramide, which is phytoceramide, is similar to 






















































































Figure 6.4 The sphingolipid rheostat in mammalian cells. 
The metabolic conversion of sphingolipids generates metabolites with antagonistic functions, forming a 
rheostat system that controls the balance of life and death. Ceramide (Cer) is deacylated by ceramidase 
(CDase) to form sphingosine (SPH). Both Cer and SPH are pro-apoptotic mediators. SPH is 
phosphorylated by sphingosine kinase (SK) to form the anti-apoptotic and mitogenic sphingosine-1-
phosphate (S1P) and the reaction can be reversed by sphingosine phosphate phosphatise (SGPP) (A). 
Sphingomyelin (SM) is formed by the transfer of the phosphocholine headgroup from 
glycerophosphocholine (GPCho) to Cer, catalysed by the enzyme, sphingomyelin synthase (SMS).  The 
other product, diacylglycerol (DAG), formed from this reaction is mitogenic. The reverse reaction is 
catalysed by the enzyme, sphingomyelinase (SMase) (B).  
 
The sphingomyelin cycle represents yet another molecular and cellular rheostat in 
the sphingolipid pathway with a role in the control of cellular proliferation and apoptosis 
(Fig. 6.4B). While ceramide is associated with attenuation of cell growth (Obeid and 
Hannun, 1995), diacylglycerol, a physiological agonist of protein kinase C, is associated 
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with mitogenesis (Rozengurt et al., 1984). The formation of sphingomyelin is derived 
from the transfer of the phospho- headgroup, in this case, phosphocholine, from the 
glycerophospholipid, glycerophosphocholine, to ceramide, generating diacylglycerol 
(Fig. 6.2 and 6.4B). Therefore, in producing sphingomyelin, the reaction results in 
consumption of ceramide and production of diacylglycerol, possibly shifting the balance 
of growth-attenuation to growth promotion. Despite the differences in the phospho- 
headgroup, this signalling function is conserved between yeast and mammals (Cerbon et 
al., 2005). However, although the deacylated form of sphingomyelin (lysosphingomyelin 
or sphingosine-1-phosphocholine) is known for its bioeffector function, for instance as a 
potent mitogen, neither the ethanolamine nor the inositol containing variants have been 
reported in Drosophila and yeast and if present, their functions are currently unknown. 
With the increasing availability of synthetic lipids, which includes sphingosine-1- 
phosphocholine, sphingosine-1-phosphoethanolamine, and sphingosine-1-
phosphoinositol, a comparison of their in vitro functions is technically feasible.  
 
6.1.2.3. Lipid-protein and lipid-small molecule interactions 
In a general context, lipids regulate cellular functions through interactions with 
their interacting partners. The organisation of lipids biological membranes is likely to 
affect the functions of integral and peripheral membrane proteins at the very least. Apart 
from being one of the topological determinants of membrane proteins, the structures of 
lipids are critical for modulating membrane thickness. Based on the hydrophobic 
matching theory, it is suggested that the hydrophobic part of intergral membrane proteins 
has to be matched to the hydrophobic thickness of the lipid bilayer membrane in which 
they are embedded in and the degree of match affects protein function (Jensen and 
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Mouritsen, 2004). Furthermore, lipid molecules contribute to the lateral stress profile of 
the membrane layer, which is structure-dependent, and between the two lipid layers of a 
membrane bilayer, the catalogue of lipids is distinct, and this in turn leads to 
conformational changes in protein. Therefore, the mechanic coupling between lipids and 
proteins plays a regulatory role in protein functions.  
 
In Section 6.1.2.1, I’ve discussed several aspects of lipid interactions and their 
organisation in biological membranes, and while it is still a subject of controversy if 
lipids are the driving forces for clustering of proteins into specific domains, or vice versa, 
early studies in T-cell signalling postulated such segregation function to concentrate 
certain proteins within domains which define zones for signal transduction, for instance. 
The specificity of this interaction between lipids and proteins can be illustrated by the 
preferential partitioning of CD40 into ceramide-enriched platforms while a CD40/45 
chimera does not cluster in these regions, similar to CD45 (Bock and Gulbins, 2003). In 
Chapter 4, the localisation of two plasma membrane proteins, Tat2p and Can1p was 
examined. Although both proteins have been shown to be localized in microdomains of 
the plasma membrane in yeast (Umebayashi and Nakano, 2003;Malinska et al., 2004), 
they exhibited completely different dependence on sterols and sphingolipids for their 
localisation (Supplementary material 4.6). In addition, numerous lines of evidence have 
implicated the direct association and potent regulation of proteins by specific lipids 
(Osenkowski et al., 2008;Ledeen and Wu, 2006). This highlights the complexity and 
specificity of protein-lipid interactions in regulating protein localisation and functions.  
 
 149
Membrane lipids also serve as receptors and the structural signature of 
sphingolipids play a crucial role in their binding properties. Interactions between cell 
surface glycosphingolipids with lipids, proteins and/or glycans mediate cell-cell and cell-
matrix interactions in multi-cellular organisms (Regina and Hakomori, 2008). Although 
yeast is a unicellular eukaryote, it does not necessarily mean that it lives as an isolated 
individual independent of other cells. In fact, yeast colonies are organised, multi-cellular 
structures which display dynamic cell-cell communication (Palkova et al., 1997). 
However, direct cell-cell contact between yeast and a role of yeast (complex) 
sphingolipids in cell-cell communication has yet to be reported. The interactions of 
membrane lipids with the cell’s surrounding environment can be further demonstrated by 
the entry of viruses, which have been reported to depend on the binding of envelope 
proteins on the surface of the pathogens to glycolipids with specific structural 
determinants on the host cells’ surface (Aoki et al., 2006;Neu et al., 2008;Suzuki et al., 
1985). In addition, the glycosylated sphingolipid, globotriaosyl ceramide is a verotoxin 
receptor, and toxin binding is increased with hydroxylation of fatty acid, which is 
probably a determinant of cellular specificity of the toxin since hydroxylated 
sphingolipids are more abundant in the kidney (Binnington et al., 2002). When pathogens 
and toxins bind to membrane sphingolipids, the hydrogen bond-based stability of 
membrane conferred by these lipids is compromised and serve as a potential invasion 
mechanism. 
 
While many drugs are known to target lipid enzymes directly, and structural 
analogues of lipids have been designed for therapeutic purposes, an important aspect of 
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structural variations in membrane lipids is the effects on drug responses. In Chapter 4, it 
was demonstrated that cellular sensitivity to sorbic acid is affected by a mere difference 
in the position of hydroxylation of sphingolipids, which resulted in alteration in function 
of a membrane transporter that exports the weak acid  (Fig. 4.5) and the role of lipids in 
regulation of multidrug resistance transporter was further discussed (Section 4.4.6). In 
fact, numerous studies in yeast have demonstrated distinct mechanisms for drug 
sensitivity/resistance which is associated with variation in sphingolipid structures. For 
instance, the antifungal action of DmAMP1, a peptide defensin produced by the plant, 
dahlia, involves interaction with sterols and sphingolipids, specifically M(IP)2C in yeast 
(Thevissen et al., 2003). Other drugs which demonstrated sphingolipid-dependence for 
their action include the antifungal syringomycin E, and the antitumor drug, PM02734. 
Yeast mutants deficient in phosphoinositol transferase, Ipt1p, fatty acid elongases, Fen1p 
and Sur4p, as well as sphingolipid hydroxylases, Sur2p and Scs7p, are resistant to 
syringomycin, suggesting that the complex M(IP)2C with a very long chain fatty acid and 
phytosphingosine but not dihydrosphingosine is essential for interactions of the drug with 
the plasma membrane and its antifungal activity (Grilley et al., 1998;Stock et al., 
2000;Hama et al., 2000). In contrast, while the yeast mutant lacking the fatty acid 
hydroxylase, scs7Δ, is resistant to the antitumor drug, PM02734, deletion of other genes 
in sphingolipid biosynthesis, including CSG2 and SUR2 renders the cells sensitive to 
PM02734 (Herrero et al., 2008). The striking contrast of the sphingolipid dependence on 
drug sensitivity/resistance of cyclic compounds demonstrates the exquisite interactions 
between small molecules with specific membrane proteins. In addition, in the case of 
PM02734, mammalian cells lacking FA2H, the homologue for fatty acid hydroxylase, are 
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reported to be resistant to the compound, suggesting the similarity in the function of 
hydroxylated sphingolipids the action of the drug in both yeast and mammals.  
 
An interesting observation based on our genetic analysis of yeast deficient in 
various steps of sterol and sphingolipid pathways is the effects on the components of the 
Target of Rapamycin (TOR) signalling network (Guan et al., under revision). TOR is a 
nutrient-regulated protein kinase that assembles into two distinct protein complexes, TOR 
complex 1 and 2 (TORC1 and TORC2). TORC1 is the target of caffeine and rapamycin 
in yeast both in vivo and in vitro (Wanke et al., 2008), whereas TORC2 is not 
significantly inhibited by either drug. However, one of the double mutants, erg2Δscs7Δ, 
which exhibits extreme sensitivity to these two drugs (Fig. 4.4B and Supplementary 
material 4.6), possesses normal TORC1 activity and expression of effector genes. 
Surprisingly, TORC2 activity and its effector genes are compromised in the mutant 
(Guan et al., under revision). It is highly intriguing how the combination of sterols and 
sphingolipids results in a switch in the signalling complex targeted by a drug or inhibitor 
and affect how a cell responds to the compound. As inhibitors of mammalian TOR are 
currently in use to treat graft rejection and restenosis and are also tested in clinical trials 
for several human pathologies including cancers (Tsang et al., 2007), it would be of great 
interest to determine how this observation translates to other organisms and these 
information on drug-membrane lipid interactions will provide additional insights to how 
lipids affect drug activities and help in drug target or even patient selection.  
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6.2 Conclusion and Future Perspectives 
Lipids are a critically important class of metabolites, yet many of their functions 
remain poorly understood. The incremental advances in analytics, particularly mass 
spectrometry, are instrumental to lipid research. A novel analytical approach, based on 
mass spectrometry, for comparative lipidomics was developed. Specifically, the 
methodology encompasses non-targeted differential profiling of high resolution mass 
spectra, as well as targeted quantification of glycerophospholipids and sphingolipids from 
mammals, yeast and fly. The method is generally applicable to any biological system of 
interest and prior knowledge on the chemistry of the lipids is not required.  However, the 
coverage of lipids analysed in this study is limited and requires alternative MS methods 
to probe other lipid classes such as sphingoid bases and sterol variants, although the latter 
was measured in this work by gas capillary mass spectrometry.  Mass spectrometry-based 
analysis yields an extensive dataset on how much of a particular lipid species is present 
under a given condition, and allows the monitoring of the changes in the levels upon 
perturbation and identification of the associated biochemical pathways. However, this is a 
highly static view of the cellular lipidome and a wider perspective of the biological 
network that lipids are involved in should take into consideration of their relative 
organisation and their interacting partners. This would require integration of other tools 
such as optical imaging, genetics and biophysical methods. Indeed, genetics analysis, in 
combination of lipidomics, has provided evidence for the complex interactions between 
sphingolipids and sterols in cells. Further investigations are now required to provide 
mechanistic insights on this functional partnership. Since sterol structures and the most 
prevalent sphingolipid species differ between the organisms, an ongoing work is in 
progress (in collaboration with H. Riezman) to address how yeast cells respond when 
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they are genetically engineered to produce structurally distinct “non-self” sterols or 
sphingolipids, in terms of changes in their lipid composition as well as the effects on 
cellular function. Furthermore, the functional interaction between lipids can be addressed 
by manipulation of lipid enzymes, and therefore lipid levels, based on gene silencing in 
Drosophila or mammalian cell cultures. Through these series of investigations, it is 
hoped not only to address the structure-dependence of lipid interactions in biological 
membranes, but also the evolutionary and functional consequences of lipid diversity 
between organisms. Finally, this work described differences in lipids between various 
organisms, which to a certain degree, may be functionally conserved. It is envisioned that 
via the use of model systems including yeast and fly, and through the integration of 
extensive datasets from different fields, including lipidomics, genomics and proteomics, 
interaction networks can be constructed for which the complex biological processes in 
mammals, especially human, can be inferred.  
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Supplementary Material 2.1 – Matlab algorithm for Q-ToF mass spectrometry data 
analysis.  
Mass spectra were aligned using COW and relative differences in lipid levels between conditions 
were computed based on the ratio of the peak intensity of treated samples relative to that of 
control samples.  
% read spectrum lists obtained from MassLynx 
control1 = dlmread('RAT_HC1.txt'); 
control2 = dlmread('RAT_HC2.txt'); 
control3 = dlmread('RAT_HC3.txt'); 
spiked1 = dlmread('DMPG1.txt'); 
spiked2 = dlmread('DMPG2.txt'); 
spiked3 = dlmread('DMPG3.txt'); 
%detect minimum number of rows 
num_of_rows = [length(control1) length(control2) length(control3) length(spiked1) length(spiked2) length(spiked3)]; 
minimum_rows = min(num_of_rows); 
% Normalisation of individual ion intensity to the total ion intensities 
control1_mass = control1(1:minimum_rows,1); 
control1_intensity = control1(1:minimum_rows,2)/sum(control1(1:minimum_rows,2)); 
control2_mass = control2(1:minimum_rows,1); 
control2_intensity = control2(1:minimum_rows,2)/sum(control2(1:minimum_rows,2)); 
control3_mass = control3(1:minimum_rows,1); 
control3_intensity = control3(1:minimum_rows,2)/sum(control3(1:minimum_rows,2)); 
spiked1_mass = spiked1(1:minimum_rows,1); 
spiked1_intensity = spiked1(1:minimum_rows,2)/sum(spiked1(1:minimum_rows,2)); 
spiked2_mass = spiked2(1:minimum_rows,1); 
spiked2_intensity = spiked2(1:minimum_rows,2)/sum(spiked2(1:minimum_rows,2)); 
spiked3_mass = spiked3(1:minimum_rows,1); 
spiked3_intensity = spiked3(1:minimum_rows,2)/sum(spiked3(1:minimum_rows,2)); 
%warp control spectra 
[xW,warping,diagnos] = cow(control1_intensity',control2_intensity',1000,[],[0 1 1]); 
control2_warped_intensity = xW'; 
[xW,warping,diagnos] = cow(control1_intensity',control3_intensity',1000,[],[0 1 1]); 
control3_warped_intensity = xW'; 
% average control spectra 
WARPED_control_intensity = [control1_intensity control2_warped_intensity control3_warped_intensity]; 
Mean_WARPED_control_intensity = mean(WARPED_control_intensity,2); 
% warp spiked spectra 
[xW,warping,diagnos] = cow(spiked1_intensity',spiked2_intensity',1000,[],[0 1 1]); 
spiked2_warped_intensity = xW'; 
[xW,warping,diagnos] = cow(spiked1_intensity',spiked3_intensity',1000,[],[0 1 1]); 
spiked3_warped_intensity = xW'; 
% average spiked spectra 
WARPED_spiked_intensity = [spiked1_intensity spiked2_warped_intensity spiked3_warped_intensity]; 
Mean_WARPED_spiked_intensity = mean(WARPED_spiked_intensity,2); 
%Warp averaged spiked spectrum towards averaged control spectrum 
[xW,warping,diagnos]= cow(Mean_WARPED_control_intensity',Mean_WARPED_spiked_intensity',1000,[],[0 1 1]); 
spiked_warped_intensity = xW'; 
%Noise reduction 
added_denom = Mean_WARPED_control_intensity+0.000005; 
added_num = spiked_warped_intensity + 0.000005 
%Computation of differential profile 












Supplementary Material 2.2 – List of transitions for quantification of mammalian 
glycerophospholipids and sphingolipids in brain tissue and blood by multiple-reaction 
monitoring (MRM). 
No. Precursor Ion (Q1) Daughter Ion (Q3) Lipid Species 
1 409.4 255.2 409.4/255.3>GPA:Lyso 16:0 
2 423.4 269.2 423.4/269.3>GPA:Lyso 17:0 
3 433.4 279.2 433.4/279.3>GPA:Lyso 18:2 
4 435.4 281.2 435.4/281.3>GPA:Lyso 18:1 
5 437.4 283.2 437.4/283.3>GPA:Lyso 18:0 
6 457.4 303.2 457.4/303.3>GPA:Lyso 20:4 
7 459.6 305.2 459.6/305.5>GPA:Lyso 20:3 
8 461.6 307.2 461.6/307.5>GPA:Lyso 20:2 
9 463.7 309.2 463.7/309.5>GPA:Lyso 20:1 
10 465.7 311.2 465.7/311.5>GPA:Lyso 20:0 
11 481.4 327.3 481.4/327.3>GPA:Lyso 22:6 
12 483.4 329.3 483.4/329.3>GPA:Lyso 22:5 
13 494.4 407.4 494.4/407.4>GPSer:Lyso 16:1 
14 496.4 409.4 496.4/409.4>GPSer:Lyso 16:0 
15 522.4 435.4 522.4/435.4>GPSer:Lyso 18:1 
16 524.4 437.4 524.4/437.4>GPSer:Lyso 18:0 
17 544.4 457.4 544.4/457.4>GPSer:Lyso 20:4 
18 568.4 481.4 568.4/481.4>GPSer:Lyso 22:6 
19 570.4 483.4 570.4/483.4>GPSer:Lyso 22:5 
20 732.6 645.6 732.6/645.6>GPSer:32:1 
21 734.6 647.6 734.6/647.6>GPSer:32:0 
22 758.6 671.6 758.6/671.6>GPSer:34:2 
23 760.8 673.8 760.8/673.8>GPSer:34:1 
24 762.8 675.7 762.8/675.7>GPSer:34:0 
25 782.6 695.7 782.6/695.7>GPSer:36:4 
26 784.8 697.8 784.8/697.8>GPSer:36:3 
27 786.8 699.8 786.8/699.8>GPSer:36:2 
28 788.8 701.8 788.8/701.8>GPSer:36:1 
29 790.8 703.8 790.8/703.8>GPSer:36:0 
30 796.6 699.6 796.6/699.6>GPSer:37:4 
31 808.6 721.6 808.6/721.6>GPSer:38:6 
32 810.8 723.8 810.8/723.8>GPSer:38:5 
33 812.8 725.8 812.8/725.8>GPSer:38:4 
34 814.6 727.6 814.6/727.6>GPSer:38:3 
35 816.8 729.8 816.8/729.8>GPSer:38:2 
36 818.8 731.8 818.8/731.8>GPSer:38:1 
37 834.8 747.8 834.8/747.8>GPSer:40:6 
38 836.8 749.8 836.8/749.8>GPSer:40:5 
39 838.8 751.8 838.8/751.8>GPSer:40:4 
40 840.6 753.7 840.6/753.7>GPSer:40:3 
41 878.6 791.6 878.6/327.3>GPSer:44:12 
42 764.9 97 764.9/97>Sulfatide:17:0 
43 778.9 97 778.9/97>Sulfatide:16:0 
44 806.9 97 806.9/97>Sulfatide:18:0 
45 822.9 97 822.9/97>Sulfatide:18:0 (OH) 
46 834.9 97 834.9/97>Sulfatide:20:0 
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47 850.9 97 850.9/97>Sulfatide:20:0 (OH) 
48 862.9 97 862.9/97>Sulfatide:22:1 
49 876.9 97 876.9/97>Sulfatide:23:0 
50 878.9 97 878.9/97>Sulfatide:22:1 (OH) 
51 888.9 97 888.9/97>Sulfatide:24:1 
52 890.9 97 890.9/97>Sulfatide:24:0 
53 904.9 97 904.9/97>Sulfatide:25:0 
54 906.7 97 906.7/97>Sulfatide:24:0 (OH) 
55 424.6 196.1 424.6/196.1>GPEtn:Lyso 14:0 
56 436.6 196.1 436.6/196.1>GPEtn:Lyso 16:1e, 16:0p 
57 450.4 196.1 450.4/196.1>GPEtn:Lyso 16:1 
58 452.4 196.1 452.4/196.1>GPEtn:Lyso 16:0 
59 462.4 196.1 462.4/196.1>GPEtn:Lyso 18:2e, 18:1p 
60 464.5 196.1 464.5/196.1>GPEtn:Lyso 18:1e, 18:0p 
61 476.6 196.1 476.6/196.1>GPEtn:Lyso 18:2a 
62 478.4 196.1 478.4/196.1>GPEtn:Lyso 18:1 
63 480.4 196.1 480.4/196.1>GPEtn:Lyso 18:0 
64 492.5 196.1 492.5/196.1>GPEtn:Lyso 20:1e, 20:0p 
65 500.4 196.1 500.4/196.1>GPEtn:Lyso 20:4 
66 524.4 196.1 524.4/196.1>GPEtn:Lyso 22:6 
67 688.6 196.1 688.6/196.1>GPEtn:32:1 
68 690.7 196.1 690.7/196.1>GPEtn:32:0 
69 698.6 196.1 698.6/196.1>GPEtn:34:2p, 34:3e 
70 700.6 196.1 700.6/196.1>GPEtn:34:1p, 34:2e 
71 702.6 196.1 702.6/196.1>GPEtn:34:0p, 34:1e 
72 710.8 196.1 710.8/196.1>GPEtn:34:4 
73 712.8 196.1 712.8/196.1>GPEtn:34:3 
74 714.7 196.1 714.7/196.1>GPEtn:34:2 
75 716.7 196.1 716.7/196.1>GPEtn:34:1 
76 718.6 196.1 718.6/196.1>GPEtn:34:0 
77 722.6 196.1 722.6/196.1>GPEtn:36:4p, 35:5e 
78 724.6 196.1 724.6/196.1>GPEtn:36:3p, 36:4e 
79 726.6 196.1 726.6/196.1>GPEtn:36:2p, 36:3e 
80 728.6 196.1 728.6/196.1>GPEtn:36:1p, 36:2e 
81 730.7 196.1 730.7/196.1>GPEtn:35:1 
82 732.8 196.1 732.8/196.1>GPEtn:16:0/19:0 
83 738.8 196.1 738.8/196.1>GPEtn:36:4 
84 740.8 196.1 740.8/196.1>GPEtn:36:3 
85 742.8 196.1 742.8/196.1>GPEtn:36:2 
86 744.6 196.1 744.6/196.1>GPEtn:36:1 
87 746.8 196.1 746.8/196.1>GPEtn:36:0 
88 748.6 196.1 748.6/196.1>GPEtn:38:5p, 38:6e 
89 750.6 196.1 750.6/196.1>GPEtn:38:4p, 38:5e 
90 752.6 196.1 752.6/196.1>GPEtn:38:3p, 38:4e 
91 754.6 196.1 754.6/196.1>GPEtn:38:2p, 38:3e 
92 756.6 196.1 756.6/196.1>GPEtn:38:1p, 38:2e 
93 758.7 196.1 758.7/196.1>GPEtn:37:1, 38:1e 
94 762.8 196.1 762.8/196.1>GPEtn:38:6 
95 764.8 196.1 764.8/196.1>GPEtn:38:5 
96 766.8 196.1 766.8/196.1>GPEtn:38:4 
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97 768.8 196.1 768.8/196.1>GPEtn:38:3 
98 770.6 196.1 770.6/196.1>GPEtn:38:2 
99 772.6 196.1 772.6/196.1>GPEtn:38:1 
100 776.6 196.1 776.6/196.1>GPEtn:40:5p, 40:6e 
101 778.6 196.1 778.6/196.1>GPEtn:40:4p, 40:5e 
102 780.6 196.1 780.6/196.1>GPEtn:40:3p, 40:4e 
103 784.6 196.1 784.6/196.1>GPEtn:40:1p, 40:2e 
104 788.8 196.1 788.8/196.1>GPEtn:40:7 
105 790.8 196.1 790.8/196.1>GPEtn:40:6 
106 792.6 196.1 792.6/196.1>GPEtn:40:5 
107 794.6 196.1 794.6/196.1>GPEtn:40:4 
108 796.8 196.1 796.8/196.1>GPEtn:40:3 
109 798.6 196.1 798.6/196.1>GPEtn:40:2 
110 569.4 241.1 569.4/241.1>GPIns:Lyso 16:1 
111 571.3 241.1 571.3/241.1>GPIns:Lyso 16:0 
112 585.7 241.1 585.7/241.1>GPIns:8:0/8:0 
113 595.4 241.1 595.4/241.1>GPIns:Lyso 18:2 
114 597.4 241.1 597.4/241.1>GPIns:Lyso 18:1 
115 599.4 241.1 599.4/241.1>GPIns:Lyso 18:0 
116 619.5 241.1 619.5/241.1>GPIns:Lyso 20:4 
117 621.5 241.1 621.5/241.1>GPIns:Lyso 20:3 
118 623.5 241.1 623.5/241.1>GPIns:Lyso 20:2 
119 625.5 241.1 625.5/241.1>GPIns:Lyso 20:1 
120 627.5 241.1 627.5/241.1>GPIns:Lyso 20:0 
121 679.5 241.1 679.5/241.1>GPIns:Lyso 24:2 
122 821.8 241.1 821.8/241.1>GPIns:34:1 
123 833.7 241.1 833.7/241.1>GPIns:34:2 
124 835.7 241.1 835.7/241.1>GPIns:34:1 
125 835.7 281.1 835.7/281.1>GPIns:34:1 
126 857.7 241.1 857.7/241.1>GPIns:36:4 
127 859.8 241.1 859.8/241.1>GPIns:36:3 
128 861.8 241.1 861.8/241.1>GPIns:36:2 
129 863.7 241.1 863.7/241.1>GPIns:36:1 
130 865.8 241.1 865.8/241.1>GPIns:36:0 
131 873.8 241.1 873.8/241.1>GPIns:37:3 
132 883.8 241.1 883.8/241.1>GPIns:38:5 
133 885.8 241.1 885.8/241.1>GPIns:38:4 
134 887.8 241.1 887.8/241.1>GPIns:38:3 
135 889.8 241.1 889.8/241.1>GPIns:38:2 
136 891.8 241.1 891.8/241.1>GPIns:38:1 
137 893.8 241.1 893.8/241.1>GPIns:38:0 
138 909.8 241.1 909.8/241.1>GPIns:40:6 
139 911.8 241.1 911.8/241.1>GPIns:40:5 
140 913.8 241.1 913.8/241.1>GPIns:40:4 
141 915.8 241.1 915.8/241.1>GPIns:40:3 
142 917.8 241.1 917.8/241.1>GPIns:40:2 
143 919.8 241.1 919.8/241.1>GPIns:40:1 
144 963.9 241.1 963.9/241.1>GPInsP:38:5  
145 963.9 321.1 963.9/321.1>GPInsP:38:5  
146 965.9 241.1 965.9/241.1>GPInsP:38:4 
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147 965.9 321.1 965.9/321.1>GPInsP:38:4 
148 967.9 241.1 967.9/241.1>GPInsP:38:3  
149 967.9 321.1 967.9/321.1>GPInsP:38:3  
150 1045.9 241.1 1045.9/241.1>GPInsP2:38:4 
151 1045.9 321.1 1045.9/321.1>GPInsP2:38:4 
152 1045.9 401.1 1045.9/401.1>GPInsP2:38:4 
153 1047.9 241.1 1047.9/241.1>GPInsP2:38:3  
154 1047.9 321.1 1047.9/321.1>GPInsP2:38:3  
155 1047.9 401.1 1047.9/401.1>GPInsP2:38:3  
156 1125.9 241.1 1125.9/241.1>GPInsP3:38:4 
157 1125.9 321.1 1125.9/321.1>GPInsP3:38:4 
158 1125.9 401.1 1125.9/401.1>GPInsP3:38:4 
159 1125.9 481.1 1125.9/481.1>GPInsP3:38:4 
160 494.4 184.1 494.4/184.1>GPCho:Lyso 16:1 
161 496.4 184.1 496.4/184.1>GPCho:Lyso 16:0 
162 520.4 184.1 520.4/184.1>GPCho:Lyso 18:2 
163 522.4 184.1 522.4/184.1>GPCho:Lyso 18:1 
164 524.4 184.1 524.4/184.1>GPCho:Lyso 18:0 
165 544.4 184.1 544.4/184.1>GPCho:Lyso 20:4 
166 568.4 184.1 568.4/184.1>GPCho:Lyso 22:6 
167 570.4 184.1 570.4/184.1>GPCho:Lyso 22:5 
168 678.5 184.1 678.5/184.1>GPCho:28:0 
169 704.6 184.1 704.6/184.1>GPCho:30:1a 
170 706.6 184.1 706.6/184.1>GPCho:30:0a 
171 718.6 184.1 718.6/184.1>GPCho:32:0p, 32:1e 
172 730.8 184.1 730.8/184.1>GPCho:32:2 
173 732.6 184.1 732.6/184.1>GPCho:32:1a 
174 734.6 184.1 734.6/184.1>GPCho:32:0a 
175 742.6 184.1 742.6/184.1>GPCho:34:2p, 34:3e 
176 744.6 184.1 744.6/184.1>GPCho:34:1p, 34:2e 
177 746.6 184.1 746.6/184.1>GPCho:34:0p, 34:1e 
178 748.6 184.1 748.6/184.1>GPCho:34:0e 
179 756.6 184.1 756.6/184.1>GPCho:34:3a 
180 758.7 184.1 758.7/184.1>GPCho:34:2a 
181 760.6 184.1 760.6/184.1>GPCho:34:1a 
182 762.6 184.1 762.6/184.1>GPCho:34:0a 
183 768.6 184.1 768.6/184.1>GPCho:36:3p, 36:4e 
184 770.6 184.1 770.6/184.1>GPCho:36:2p, 36:3e 
185 772.6 184.1 772.6/184.1>GPCho:36:1p, 36:2e 
186 774.6 184.1 774.6/184.1>GPCho:36:0p, 36:1e 
187 782.6 184.1 782.6/184.1>GPCho:36:4a 
188 784.6 184.1 784.6/184.1>GPCho:36:3a 
189 786.6 184.1 786.6/184.1>GPCho:36:2a 
190 788.6 184.1 788.6/184.1>GPCho:36:1a 
191 790.8 184.1 790.8/184.1>GPCho:36:0 
192 792.6 184.1 792.6/184.1>GPCho:38:5p, 38:6e 
193 794.6 184.1 794.6/184.1>GPCho:38:4p, 38:5e 
194 796.6 184.1 796.6/184.1>GPCho:38:3p, 38:4e 
195 798.6 184.1 798.6/184.1>GPCho:38:2p, 38:3e 
196 800.6 184.1 800.6/184.1>GPCho:38:1p, 38:2e 
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197 808.6 184.1 808.6/184.1>GPCho:38:5a 
198 810.6 184.1 810.6/184.1>GPCho:38:4a 
199 812.6 184.1 812.6/184.1>GPCho:38:3a 
200 814.6 184.1 814.6/184.1>GPCho:38:2a 
201 816.6 184.1 816.6/184.1>GPCho:38:1a 
202 820.6 184.1 820.6/184.1>GPCho:40:5p, 40:6e 
203 822.6 184.1 822.6/184.1>GPCho:40:4p, 40:5e 
204 824.6 184.1 824.6/184.1>GPCho:40:3p, 40:4e 
205 826.6 184.1 826.6/184.1>GPCho:40:2p, 40:3e 
206 828.6 184.1 828.6/184.1>GPCho:40:1p, 40:2e 
207 834.6 184.1 834.6/184.1>GPCho:40:6a 
208 836.6 184.1 836.6/184.1>GPCho:40:5a 
209 838.6 184.1 838.6/184.1>GPCho:40:4a 
210 647.7 184.1 647.7/184.1>SM:d18:1/12:0   
211 701.8 184.1 701.8/184.1>SM:d18:1/16:1 
212 703.8 184.1 703.8/184.1>SM:d18:1/16:0   
213 705.8 184.1 705.8/184.1>SM:d18:0/16:0   
214 727.8 184.1 727.8/184.1>SM:d18:1/18:2 
215 729.8 184.1 729.8/184.1>SM:d18:118:1 
216 731.8 184.1 731.8/184.1>SM:d18:1/18:0 
217 733.8 184.1 733.8/184.1>SM:d18:0/18:0   
218 757.8 184.1 757.8/184.1>SM:d18:1/20:1 
219 759.8 184.1 759.8/184.1>SM:d18:1/20:0 
220 761.8 184.1 761.8/184.1>SM:d18:0/20:0   
221 787.8 184.1 787.8/184.1>SM:d18:1/22:0;d18:0/22:1 
222 789.8 184.1 789.8/184.1>SM:d18:0/22:0   
223 813.8 184.1 813.8/184.1>SM:d18:1/24:1 
224 815.8 184.1 815.8/184.1>SM:d18:1/24:0;d18:0/24:1 
225 817.9 184.1 817.9/184.4>SM:d18:0/24:0   
226 841.9 184.1 841.9/184.1>SM:d18:1/26:1   
227 843.9 184.1 843.9/184.1>SM:d18:1/26:0;d18:0/26:1  
228 845.9 184.4 845.9/184.1>SM:d18:0/26:0   
229 538.7 264.4 538.7/264.4>Cer:d18:1/16:0   
230 540.7 266.4 540.7/266.4>Cer:d18:0/16:0   
231 580.9 264.4 580.9/264.4>Cer:d18:1/19:0 
232 566.7 264.4 566.7/264.4>Cer:d18:1/18:0   
233 568.7 266.4 568.7/266.4>Cer:d18:0/18:0   
234 594.7 264.4 594.7/264.4>Cer:d18:1/20:0   
235 596.7 266.4 596.7/266.4>Cer:d18:0/20:0   
236 622.8 264.4 622.8/264.4>Cer:d18:1/22:0   
237 624.8 266.4 624.8/266.4>Cer:d18:0/22:0   
238 648.9 264.4 648.9/264.4>Cer:d18:1/24:1   
239 650.9 264.4 650.9/264.4>Cer:d18:1/24:0   
240 650.9 266.4 650.9/266.4>Cer:d18:0/24:1   
241 652.9 266.4 652.9/266.4>Cer:d18:0/24:0   
242 676.9 264.4 676.9/264.4>Cer:d18:1/26:1   
243 678.9 264.4 678.9/264.4>Cer:d18:1/26:0   
244 678.9 266.4 678.9/266.4>Cer:d18:0/26:1   
245 680.9 266.4 680.9/266.4>Cer:d18:0/26:0   
246 588.8 264.4 588.8/264.4>MonoGluCer:d18:1/8:0 
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247 700.7 264.4 700.7/264.4>MonoHexCer:d18:1/16:0   
248 702.7 266.4 702.7/266.4>MonoHexCer:d18:0/16:0   
249 728.7 264.4 728.7/264.4>MonoHexCer:d18:1/18:0   
250 730.7 266.4 730.7/266.4>MonoHexCer:d18:0/18:0   
251 756.7 264.4 756.7/264.4>MonoHexCer:d18:1/20:0   
252 758.7 266.4 758.7/266.4>MonoHexCer:d18:0/20:0   
253 784.8 264.4 784.8/264.4>MonoHexCer:d18:1/22:0   
254 786.8 266.4 786.8/266.4>MonoHexCer:d18:0/22:0   
255 810.9 264.4 810.9/264.4>MonoHexCer:d18:1/24:1   
256 812.9 264.4 812.9/264.4>MonoHexCer:d18:1/24:0   
257 812.9 266.4 812.9/266.4>MonoHexCer:d18:0/24:1   
258 814.9 266.4 814.9/266.4>MonoHexCer:d18:0/24:0   
259 838.9 264.4 838.9/264.4>MonoHexCer:d18:1/26:1   
260 840.9 264.4 840.9/264.4>MonoHexCer:d18:1/26:0   
261 840.9 266.4 840.9/266.4>MonoHexCer:d18:0/26:1   
262 842.9 266.4 842.9/266.4>MonoHexCer:d18:0/26:0   
263 862.7 264.4 862.7/264.4>DiHexCer:d18:1/16:0   
264 864.7 266.4 864.7/266.4>DiHexCer:d18:0/16:0   
265 890.7 264.4 890.7/264.4>DiHexCer:d18:1/18:0   
266 892.7 266.4 892.7/266.4>DiHexCer:d18:0/18:0   
267 918.7 264.4 918.7/264.4>DiHexCer:d18:1/20:0   
268 920.7 266.4 920.7/266.4>DiHexCer:d18:0/20:0   
269 946.8 264.4 946.8/264.4>DiHexCer:d18:1/22:0   
270 948.8 266.4 948.8/266.4>DiHexCer:d18:0/22:0   
271 972.9 264.4 972.9/264.4>DiHexCer:d18:1/24:1   
272 974.9 264.4 974.9/264.4>DiHexCer:d18:1/24:0   
273 974.9 266.4 974.9/266.4>DiHexCer:d18:0/24:1   
274 976.9 266.4 976.9/266.4>DiHexCer:d18:0/24:0   
275 1000.9 264.4 1000.9/264.4>DiHexCer:d18:1/26:1   
276 1002.9 264.4 1002.9/264.4>DiHexCer:d18:1/26:0   
277 1002.9 266.4 1002.9/266.4>DiHexCer:d18:0/26:1   
278 1004.9 266.4 1004.9/266.4>DiHexCer:d18:0/26:0   
Lipids in bold are synthetic standards that are spiked into the lipid mixture for relative 
quantification. Each transition requires optimisation of several parameters such as declustering 
potential and collision energy, as these are compound-dependent parameters, but are also 
dependent on instrument settings. Abbreviations: Cer, ceramide; GPA, phosphatidic acid; GPCho, 
glycerophosphocholine; GPEtn, glycerophosphoethanolamine; GPIns, glycerophosphoinositol; 
GPInsP, glycerophosphoinositol monophosphate; GPInsP2, glycerophosphoinositol bisphosphate; 
GPInsP3, glycerophosphoinositol triphosphate; DiHexCer, dihexosylceramide; MonoGluCer, 
monoglucosylceramide; MonoHexCer, monohexosylceramide; SM, sphingomyelin. a, e and p on 
the fatty acyl groups refer to the diacyl, ether and plasmalogen species respectively.  
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Supplementary Material 3.1 – List of theoretically calculated mass for yeast 
glycerophospholipids and sphingolipids (see attached softcopy or www.lipidprofiles.com 
(Protocols)).  
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Supplementary Material 4.2 – Isc1p mediated turnover of IPC-C in erg3 erg6 double 
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Synthetic phenotypes were 
found for 13 of 15 possible 
double mutants in the final 
steps of ergosterol
biosynthesis and hydroxylation 
and turnover of sphingolipids30°C
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Supplementary Material 4.5 – Transcript levels in various mutants deficient in sterols 
and/ or sphingolipids (H. Riezman). (A) Cluster map of transcripts that change in the 
sterol and sphingolipid mutants. Transcript levels were determined in the indicated 
strains. Data for transcripts that changed at least two fold under one condition were 
clustered. Predominant characteristics of gene clusters are indicated on the right. The 
scale is a log transformed base 2. (B) Transcript levels PDR12 in wild type cells and 





















































































































































































Supplementary Table 4.1 – Sterol compositions in the yeast strains used in this study 
(single determinations) (H. Riezman). 
 
A. Wild type and sphingolipid mutant cells. 
 
                                                        Strain wt isc1Δ sur2Δ scs7Δ 
                                                        µg sterols / 
108 cells 
26 33 30 31 
Sterol Mass     
Cholesta-5,8,24(25)-trienol 382 1.0 % 0.6 % 0.9 % 0.6 % 
Cholesta-8,24(25)-dienol 384 9.6 % 7.9 % 8.6 % 9.3 % 
Ergosta-5,8,14,22-tetraenol * 394 4.8 % 3.7 % 4.9 % 4.6 % 
Ergosta-5,7,22,24(28)-tetraenol 394 2.8 % 2.9 % 3.3 % 3.0 % 
Ergosta-5,7,22-trienol 396 58.5 % 59.1 % 61.4 % 64.7 % 
Ergosta-5,8,14-trienol * 396 1.4 % 1.7 % 1.2 % 1.1 % 
Ergosta-7,22,24(28)-trienol * 396 2.0 % 1.0 % 1.2 % 0.9 % 
Ergosta-8,24(28)-dienol 398 1.0 % 1.5 % 2.6 % 2.1 % 
Ergosta-5,7-dienol 398 16.5 % 17.2 % 12.2 % 11.7 % 
Ergosta-7,24(28)-dienol 398 1.4 % 1.5 % 1.5 % 1.0 % 
4,4,14-Trimethyl cholesta-
8,24(25)-dienol 
426 1.0 % 0.9 % 1.2 % 0.4 % 
 
B. erg2 mutant and erg2-derived strains. 
 








µg sterols / 
108 cells 62 52 51 59 
Sterol Mass     
Cholesta-5,8,14,24(25)-tetraenol 
* 380 9.3 % 8.5 % 8.9 % 6.2 % 
Cholesta-8,24(25)-dienol 384 1.5 % 1.3 % 1.2 % 2.4 % 
Ergosta-5,8,14,22-tetraenol * 394 2.9 % 2.5 % 2.3 % 1.6 % 
Ergosta-5,8,22-trienol 396 23.1 % 22.6 % 27.1 % 20.7 % 
Ergosta-5,8,24(28)-trienol * 396 2.7 % 1.8 % 1.5 % 1.9 % 
?? 396 2.0 % 1.2 % 1.1 % 1.5 % 
Ergosta-8,22-dienol 398 1.7 % 2.0 % 1.6 % 1.2 % 
Ergosta-5,8-dienol 398 3.8 % 5.4 % 5.0 % 3.0 % 
Ergosta-8,24(28)-dienol 398 24.5 % 20.0 % 19.4 % 32.9 % 
?? 398 3.6 % 3.9 % 3.6 % 3.2 % 
Ergosta-8-enol 400 23.8 % 29.9 % 27.6 % 24.5 % 
4,4,14-Trimethyl cholesta-
8,24(25)-dienol 426 0.4 % 0.3 % 0.2 % 0.5 % 
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 µg sterols / 
108 cells 63 52 51 62 
Sterol Mass     
Cholesta-7,22,24(25)-trienol 382 0.2 % 0.2 % 0.2 % 0.3 % 
Cholesta-8,24(25)-dienol 384 2.5 % 2.4 % 2.8 % 4.2 % 
Ergosta-8,22,24(28)-trienol 396 0.5 % 0.7 % 0.5 % 0.4 % 
Ergosta-8,14,24(28)-trienol * 396 1.0 % 1.0 % 0.8 % 0.7 % 
Ergosta-7,22,24(28)-trienol 396 1.2 % 1.3 % 1.0 % 0.9 % 
Ergosta-8,22-dienol 398 1.6 % 1.7 % 1.8 % 1.6 % 
Ergosta-7,22-dienol  398 44.3 % 41.1 % 41.2 % 40.4 % 
Ergosta-8,24(28)-dienol 398 6.4 % 6.5 % 7.5 % 7.5 % 
Ergosta-7,24(28)-dienol 398 15.5 % 15.0 % 15.5 % 18.7 % 
Ergosta-8-enol 400 4.2 % 4.5 % 4.7 % 4.3 % 
Ergosta-7-enol 400 20.9 % 23.1 % 22.8 % 19.0 % 
4,4,14-Trimethyl cholesta-
8,24(25)-dienol 426 0.1 % 0.3 % 0.2 % 0.2 % 
 
D. erg4 mutant and erg4-derived strains**. 
 






µg sterols / 
108 cells 43 57 43 
Sterol Mass    
Cholesta-8,24(25)-dienol 384 3.7 % 2.3 % 3.4% 
Ergosta-5,8,14,22,24(28)-
pentaenol * 392 3.3 % 2.8 % 2.7% 
Ergosta-5,7,14,22,24(28)-
pentaenol * 392 1.9 % 3.1 % 2.9 % 
?? 392 ~ 6 % ~ 7 % ~6 % 
Ergosta-5,8,22,24(28)-tetraenol 394 1.3 % 1.0 % 1.1 % 
Ergosta-5,7,22,24(28)-tetraenol 394 79.2 % 79.1 % 80.5% 
Ergosta-5,8,24(28)-trienol  396 ~ 2 % ~ 2 % ~2 % 
4-Methyl cholesta-8,24(25)-
dienol 398 0.8 % 0.7 % 0.6 % 
Ergosta-7,24(28)-dienol 398 0.7 % 0.9 % 0.7 % 
4,4,14-Trimethyl cholesta-








 µg sterols / 
108 cells 39 38 
Sterol Mass   
Cholesta-8,24(25)-dienol 384 2.1 % 3.0 % 
Ergosta-5,8,14,22,24(28)-
pentaenol * 392 0.8 % 0.8 % 
Ergosta-5,7,22,24(28)-tetraenol 394 86.8 % 85.5 % 
Ergosta-5,8,22,24(28)-tetraenol * 394 1.0 % 1.0 % 
Ergosta-5,8,24(28)-trienol 396 ~6  % ~5 % 
4-Methyl cholesta-8,24(25)-
dienol 398 1.4 % 1.2 % 
4,4-Dimethyl cholesta-8,24(25)-
dienol 412 0.6 % 0.8 % 
4,4,14-Trimethyl cholesta-
8,24(25)-dienol 426 0.9 % 1.7 % 
 
E. erg5 mutant and erg5-derived strains. 
 








µg sterols / 
108 cells 54 32 43 35 
Sterol Mass     
Cholesta-8,24(25)-dienol 384 5.6 % 4.2 % 5.0% 6.1 % 
Ergosta-5,8,14-trienol * 396 4.5 % 5.3 % 5.6 % 5.8 % 
Ergosta-5,7,14-trienol  * 396 5.3 % 5.6 % 5.6 % 5.3 % 
Ergosta-5,7,24(28)-trienol 396 2.3 % 2.3 % 3.2 % 2.2 % 
Ergosta-5,8-dienol  398 1.5 % 1.6 % 1.5 % 1.3 % 
Ergosta-5,7-dienol 398 77.2 % 78.1 % 76.0 % 77.0 % 
Ergosta-8,24(28)-dienol 398 0.8 % 0.6% 1.0 % 0.8 % 
Ergosta-8-enol 400 0.1 % - 0.2 % - 
4,4,14-Trimethyl cholesta-




F. erg6 mutant and erg6-derived strains**. 
 




 µg sterols / 
108 cells 
43 29 42 
Sterol Mass    
Cholesta-5,8,14,24(25)-tetraenol 
* 
380 2.9 % 3.2 % 2.5 % 
?? 380 6.6 % 3.9 % 5.0 % 
Cholesta-8,22,24(25)-trienol * 382 0.7 % 0.7 % 0.5 % 
Cholesta-5,8,24(25)-trienol 382 5.8 % 7.8 % 6.3 % 
Cholesta-7,22,24(25)-trienol * 382 2.1 % 2.5 % ~ 3 % 
Cholesta-5,7,24(25)-trienol 382 34.5 % 27.4 % 30.1 % 
Cholesta-8,24(25)-dienol 384 41.1 % 44.7 % ~ 46 % 
Cholesta-7,24(25)-dienol 384 4.1 % 4.8 % 3.3 % 
4-Methyl cholesta-8,24(25)-
dienol 
398 0.6 % 0.8 % 0.5 % 
4,4-Dimethyl cholesta-8,24(25)-
dienol 
412 0.9 % 1.0 % 0.8 % 
4,4,14-Trimethyl cholesta-
8,24(25)-dienol 
426 0.5 % 1.1 % 0.4 % 
 
 Strain erg6Δ erg6Δ 
isc1Δ 
 µg sterols / 
108 cells 
48 39 
Sterol Mass   
Cholesta-5,8,14,24(25)-tetraenol 
* 
380 0.9 % 0.7 % 
?? 380 7.8 % 8.3 % 
Cholesta-5,8,24(25)-trienol 382 7.1 % 6.9 % 
Cholesta-5,7,24(25)-trienol 382 46.6 % % 50.2 % 
Cholesta-8,24(25)-dienol 382 25.1 % 23.7 % 
Cholesta-7,24(25)-dienol 382 5.8 % 5.9 % 
4-Methyl cholesta-8,24(25)-
dienol 
384 1.5 % 1.1 % 
4,4-Dimethyl cholesta-8,24(25)-
dienol 
384 1.9 % 1.1 % 
4,4,14-Trimethyl cholesta-
8,24(25)-dienol 
398 2.0 % 1.2 % 
 
* denotes sterols whose identity is not certain.  
 
**Sterol determinations for some of the erg4 and erg6 deletion mutant strains were 
determined in two separate experiments. The data from each experiment is presented in a 
separate table.  
 
Data on some minor sterols (less than 2% of total) whose identity was not certain is not 
shown. 
 
Isogenic wild type and ergosterol mutant strains were grown overnight in 2% peptone, 1% 
yeast extract, 2% glucose, 20 mM MES, 40 mg/l each adenine, uracil, tryptophan at 30°C, 
harvested at 1-2 OD600/ml and washed three times with water. 4 μg of cholesterol was added 
as an internal standard to 5 x 108 cells and total sterols were extracted, derivatized and 
analysed as described previously (Heese-Peck et al., 2002). One can see that there are some 
differences in sterols between experiments, however these differences sometimes exceed 
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those found between erg and erg-derived strains in a single experiment. Therefore, the 
differences in sterol composition in erg strains that are caused by introduction of the 
sphingolipid mutations is insignificant. In particular, in the wild type sterol background no 
substantial differences in sterol amounts or composition were detected (A). With the possible 
exception of the sur2 erg6 strain all erg mutant strains show an increase in total sterols over 
wild type cells, although the sterol overproduction varies greatly between erg mutants. It 
should be noted that the analysis did not discriminate whether the increased sterol amount is 
due to an increase in free and/or esterified sterols, but it is likely that the increases are mainly 
reflected in esterified sterols. 
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Supplementary Table 4.2 – Summary of Tat2p and Can1p localisation data (H. 
Riezman). 
Strain Tat2 localisation Can1p localisation 
 PM Vacuole SD PM Vacuole small patches large patches 
WT 46 54 6 mostly no yes yes 
isc1Δ 28 72 5 mostly no yes no 
sur2Δ 35 65 6 mostly no yes no 
scs7Δ 41 59 5 mostly no yes no 
erg2Δ 35 65 6 mostly no yes yes 
erg2Δisc1Δ 36 64 8 mostly yes yes no 
erg2Δsur2Δ 34 66 6 mostly yes yes no 
erg2Δscs7Δ 34 66 6 mostly yes yes yes 
erg3Δ 28 72 5 mostly yes yes yes 
erg3Δisc1Δ 24 76 5 mostly yes yes yes 
erg3Δsur2Δ 26 74 7 mostly yes nd nd 
erg3Δscs7Δ 37 63 7 mostly yes nd nd 
erg4Δ 34 66 6 mostly no yes yes 
erg4Δisc1Δ 47 53 4 mostly no yes yes 
erg4Δsur2Δ 35 65 7 mostly no yes no 
erg2Δscs7Δ 38 62 6 mostly no yes no 
erg5Δ 33 67 5 mostly no no mainly 
erg5Δisc1Δ 36 64 5 mostly no yes yes 
erg5Δsur2Δ 37 63 4 mostly no yes yes 
erg5Δscs7Δ 35 65 5 mostly no yes yes 
erg6Δ 35 65 6 mostly no yes yes 
erg6Δisc1Δ 24 76 6 mostly no yes yes 
erg6Δsur2Δ 24 76 6 mostly no yes yes 
erg6Δscs7Δ 34 66 7 mostly no yes reduced 
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Supplementary Table 4.3 – Anisotropy measurements using TMA-DPH, a cationic 
derivative of the membrane probe, 1,6-Diphenyl-1,3,5-hexatriene (DPH) (H. Riezman).  
Strain Mean SD Significance
WT 0.283 0.004   
isc1Δ 0.278 0.005 P<0.2 
sur2Δ 0.284 0.011   
scs7Δ 0.270 0.015 P<0.2 
erg2Δ 0.274 0.008 P<0.2 
erg2Δisc1Δ 0.267 0.014 P<0.2 
erg2Δsur2Δ 0.276 0.005 p>0.2 
erg2Δscs7Δ 0.275 0.010   
erg3Δ 0.276 0.009   
erg3Δisc1Δ 0.270 0.015   
erg3Δsur2Δ 0.273 0.006 P<0.1 
erg3Δscs7Δ 0.291 0.010   
erg4Δ 0.280 0.006   
erg4Δisc1Δ 0.268 0.006 P<0.05 
erg4Δsur2Δ 0.291 0.012   
erg2Δscs7Δ 0.278 0.008   
erg5Δ 0.276 0.004 P<0.2 
erg5Δisc1Δ 0.285 0.005   
erg5Δsur2Δ 0.279 0.019   
erg5Δscs7Δ 0.277 0.005 P<0.2 
erg6Δ 0.249 0.015 P<0.05 
erg6Δisc1Δ 0.265 0.008 P<0.05 
erg6Δsur2Δ 0.270 0.008 P<0.1 
erg6Δscs7Δ 0.268 0.009 P<0.1 
 
 
 
 
 
